Biometals (2010) 23:1–17 DOI 10.1007/s10534-009-9262-z
EfeO-cupredoxins: major new members of the cupredoxin superfamily with roles in bacterial iron transport Mohan B. Rajasekaran Æ Sanjay Nilapwar Æ Simon C. Andrews Æ Kimberly A. Watson
Received: 15 May 2009 / Accepted: 10 August 2009 / Published online: 23 August 2009 ! Springer Science+Business Media, LLC. 2009
Abstract The EfeUOB system of Escherichia coli is a tripartite, low pH, ferrous iron transporter. It resembles the high-affinity iron transporter (Ftr1pFet3p) of yeast in that EfeU is homologous to Ftr1p, an integral-membrane iron-permease. However, EfeUOB lacks an equivalent of the Fet3p component— the multicopper oxidase with three cupredoxin-like domains. EfeO and EfeB are periplasmic but their precise roles are unclear. EfeO consists primarily of a C-terminal peptidase-M75 domain with a conserved ‘HxxE’ motif potentially involved in metal binding. The smaller N-terminal domain (EfeO-N) is predicted to be cupredoxin (Cup) like, suggesting a previously unrecognised similarity between EfeO and Fet3p. Our structural modelling of the E. coli EfeO Cup domain identifies two potential metal-binding sites.
Site I is predicted to bind Cu2? using three conserved residues (C41 and 103, and E66) and M101. Of these, only one (C103) is conserved in classical cupredoxins where it also acts as a Cu ligand. Site II most probably binds Fe3? and consists of four well conserved surface Glu residues. Phylogenetic analysis indicates that the EfeO-Cup domains form a novel Cup family, designated the ‘EfeO-Cup’ family. Structural modelling of two other representative EfeO-Cup domains indicates that different subfamilies employ distinct ligand sets at their proposed metal-binding sites. The *100 efeO homologues in the bacterial sequence databases are all associated with various iron-transport related genes indicating a common role for EfeO-Cup proteins in iron transport, supporting a new copper-iron connection in biology.
Electronic supplementary material The online version of this article (doi:10.1007/s10534-009-9262-z) contains supplementary material, which is available to authorized users.
Keywords Iron transport ! Homology modelling ! Cupredoxin ! Electron transfer ! GRID prediction ! Metal binding site ! DUF451 ! Peptidase-M75
M. B. Rajasekaran ! S. C. Andrews (&) ! K. A. Watson School of Biological Sciences, University of Reading, Whiteknights, Reading RG6 6AJ, UK e-mail:
[email protected] M. B. Rajasekaran ! K. A. Watson Structural Biology Unit at The Biocentre, University of Reading, Reading RG6 6AJ, UK S. Nilapwar Manchester Interdisciplinary Biocentre, University of Manchester, Manchester M1 7DN, UK
Introduction Many major biological processes depend upon iron including oxygen transport and storage, nitrogen fixation, photosynthesis, DNA biosynthesis and the citric acid cycle (Andrews et al. 2003). The predominant environmental form of iron is the poorly soluble ferric form (10-18 M at pH 7.0). Relatively soluble (0.1 M at pH 7.0) ferrous iron is mainly restricted to anaerobic/microaerobic niches or low pH
123
2
environments. Unsurprisingly, the low solubility of ferric iron leads to problems of poor bioavailability. In addition, iron can cause toxicity in the presence of oxygen due to its tendency to engage in Fenton chemistry generating highly-reactive free-radical species. Thus, under aerobic conditions, iron causes problems of both availability and toxicity (Andrews et al. 2003; Carrondo 2003; Chiancone et al. 2004). Consequently, organisms have developed various strategies that allow them to acquire sufficient iron for growth whilst avoiding any deleterious effects caused by iron toxicity. Bacteria often employ a range of iron transporters, with specificities for alternative sources of iron, to enable them to overcome low iron availability. Within bacteria, the most common type of iron uptake system appears to involve siderophore-dependent transporters. These utilise extracellular chelators (siderophores) as ferric-iron solubilising agents. For Gram-negative bacteria, the resulting ferri-siderophore complexes are translocated across the outer-membrane (OM) by a TonB-dependent OM receptor (TBDR) (Andrews et al. 2003; Braun et al. 1998; Stintzi et al. 2000). The complexes are then bound by corresponding periplasmic-binding proteins and delivered to innermembrane ABC-transporters. Host iron-containing compounds [transferrin, lactoferrin, haemoglobin, haem, haem-haemopexin] (Andrews et al. 2003; Bracken et al. 1999; Wandersman and Delepelaire 2004) can also be directly acquired by similar transporters involving binding of the host iron complexes to specific TBDRs. In contrast to ferric iron, ferrous iron can be directly imported using FeoAB transporters, which are thought to function under anaerobic-microaerophilic conditions (Cartron et al. 2006; Hantke 1987). In addition, metal-type ABC transporters like (Kehres et al. 2002) [e.g. SitABCD of Salmonella typhimurium] and NRAMPlike transporters (Kehres et al. 2000; Makui et al. 2000) [e.g. MntH of Escherichia coli] also translocate Fe2?, although these systems appear to have greater affinity for Mn2? than Fe2?. ZupT in E. coli also has affinity for Fe2?, along with a range of other divalent metals (Grass et al. 2002). Recently, a new type of ferrous-iron transporter, designated EfeUOB, has been identified in E. coli. It consists of three protein components and acts mainly at low pH (Cao et al. 2007). Homologous systems are present in many other bacteria including Bacillus
123
Biometals (2010) 23:1–17
subtilis and Neisseria meningitides (Baichoo et al. 2002; Grifantini et al. 2003; Ollinger et al. 2006). EfeUOB resembles the high-affinity Fe2? uptake system (Fet3p-Ftr1p) found in fungi (such as Sacchromyces cerevisiae) and some algae (Askwith and Kaplan 1997, 1998; De Freitas et al. 2003; Fang and Wang 2002; Fu et al. 2004; Paronetto et al. 2001) in that EfeU is homologous to Ftr1p, and both systems are ferrous-iron transporters. Ftr1p is a polytopic, cytoplasmic-membrane located, ferric permease containing seven transmembrane helices (TMH), belonging to the oxidase dependent Fe2? transporter family (Debut et al. 2006). It possesses two ‘RExxE’ motifs, one in TMH 1 and the other in TMH 4, both of which are required for iron-uptake function (Severance et al. 2004; Stearman et al. 1996). These are thought to form an iron-binding site, with the conserved Glu residues acting as the direct ligands. Fet3p is a multicopper ferroxidase and is absolutely required for high-affinity Fe2? uptake. It has three cupredoxinlike domains binding four copper ions and belongs to the multi-copper oxidase family (De Silva et al. 1995). This protein is anchored to the outer face of the cytoplasmic (or inner) membrane and closely associates with Ftr1p. The mechanism of Fet3p-Ftr1p iron transport involves reduction of environmental ferric ion to ferrous ion by means of the ferric/cupric reductases, Fre1p/Fre2p. The ferrous iron thus generated is bound by Fet3p and re-oxidised, using oxygen as the oxidant, to the ferric form which is then transferred to Ftr1p for translocation across the cytoplasmic membrane into the cytosol. EfeUOB is encoded by a three gene operon, efeUOB, that is Fe2?-Fur repressed and alkalirepressed (acid induced) by CpxAR. EfeU, like Ftr1p, is predicted to be located within the cytoplasmic membrane and to contain seven TMHs. EfeU possesses 27% amino acid sequence identity with Ftr1p and the two ‘RExxE’ motifs are conserved. EfeB is a periplasmic haem-containing peroxidaselike protein (Cartron et al. 2007) that is exported into the periplasm by the Tat pathway (Sturm et al. 2006). EfeO is also periplasmic and contains a predicted Nterminal signal sequence suggesting export to the periplasm in a Sec-dependent manner. EfeO consists of a C-terminal peptidase-M75 (M75) domain (*225 residues) and an N-terminal domain of *100 residues that appears to resemble the copper-containing cupredoxins.
Biometals (2010) 23:1–17
In this study, the amino acid sequences of cupredoxins (Cup) and domains resembling the EfeO N-terminal domain (the EfeO-Cup domain) were compared and their phylogenetic relationship analysed. Results suggest that EfeO-Cup-like domains represent a distinct new bacterial group within the cupredoxin superfamily and form two sub-groups: Cup-M75 proteins and solo-Cup proteins. Structural modelling of representative EfeO-Cup-like domains indicates either one or two novel metal-binding sites (distinct from the Cu-site of classical cupredoxins) employing different sets of conserved ligands in each case, with one site favouring Cu2? and the other preferring Fe3?. These findings provide a new insight into the biochemical properties of EfeO and related proteins and suggest a potential iron uptake role as iron-binding and/or electron-transfer components.
Materials and methods Secondary structure prediction, domain topology and multiple sequence alignment The amino acid sequence of EfeO used in this study is from E. coli K-12 and is available at Uniprot Knowledgebase (Bairoch et al. 2005) (UniprotKB/ SwissProt accession no: P0AB24). The SignalP server (Bendtsen et al. 2004) was used to predict the signal peptide cleavage site in EfeO. GeconcT (Ciria et al. 2004), was used to identify genes neighbouring efeO and efeO homologues. Domain predictions were obtained using various databases and servers: Superfamily (Gough et al. 2001), INTERPRO (Mulder et al. 2007), Pfam (Finn et al. 2006), SCOP (Murzin et al. 1995) and DomFOLD (Jones et al. 2005; Marsden et al. 2002; Ward et al. 2004) [incorporating DomSSEA, DISOPRED, mGenTHREADER and nFOLD]. The presence of low complexity regions in EfeO amino-acid sequence was indicated by NCBI-BLAST (Wheeler et al. 2006) and the Pfam database. The prediction of disordered regions in EfeO was performed by PrDOS (Ishida and Kinoshita 2007) and RONN (Yang et al. 2005). EfeO homologues (125 sequences) were identified using EBI-WU-BLAST2 (Altschul et al. 1990) using the default settings. Multiple-sequence alignments for either the Cup or peptidase-M75 domains (101 sequences containing Cup domain, and 92 sequences
3
containing peptidase-M75 domain) were achieved using EBI-CLUSTALW (Thompson et al. 1994). Secondary-structure predictions were obtained using the PSIPRED (Bryson et al. 2005) and Jpred servers (Cuff et al. 1998). Multiple-sequence alignments obtained from EBI-CLUSTALW were analysed using GENEDOC (Nicholas et al. 1997) to generate improved alignments satisfying secondary structure element locations. Phylogenetic analysis was carried out using MEGA4 version software (Tamura et al. 2007) and the multiple-sequence alignments obtained above. The Neighbour-joining method with default settings was employed for the construction of trees. Structural modelling of the Cup domain of EfeO and its select homologues A search for suitable structural templates was performed using local similarity search algorithms (NCBI-BLAST, EBI-WU-BLAST2) against the Protein Data Base (PDB) (Berman et al. 2000) and fold recognition tools [Phyre (Kelley et al. 2000), mGenTHREADER (Bryson et al. 2005)] using the default settings. Amicyanin (Carrell et al. 2004) from Paracoccus denitrificans (PDB id: 1SFD) was the nearest structural homologue for EfeO according to mGENTHREADER (Table S3). Based on the multiple sequence alignment (Fig. 5a) and the mGENTHREADER result (Table S3), modelling of the EfeO homologues: Jan and Buc2 from domain I & V organisation (Janibacter sp. and Burkholderia cepacia, Table S1), respectively, was performed. For all models, amicyanin was used as the template, in order to maintain the sequence and structural alignment found between these homologues. The comparative modelling program, MODELLER (Marti-Renom et al. 2000), was used to construct all three theoretical models. The three models herein are referred to as Cupecoli, Cupjani and Cupburk, respectively. The validation programs PROCHECK (Laskowski et al. 1993), and MODFOLD (ModFOLDclust v 1.1) (McGuffin 2007; McGuffin 2008) were used for assessing the overall stereochemical quality of the models and selecting the final model in each case. The overall structural superimpositions and local superimpositions of metal binding sites between pairs of structures were performed using the program LSQKAB as provided by CCP4 (Collaborative Computational Project 1994).
123
4
Metal-binding site prediction for the Cup domain of EfeO and selected homologues by GRID The program GRID (Goodford 1985) was used to predict potential metal binding sites for amicyanin (PDB id: 1SFD), as a control, the Cup domain of EfeO from E. coli (Cupecoli), and the Cup domain from B. cepacia (Cupburk) and Janibacter sp. (Cupjani). GRID predicts energetically favourable interactions between a probe (i.e. a small biologically active species such as water, carbohydrates, metals) and a protein. The results are represented in the form of 3-dimensional (3D) energy contours, showing the location of energetically favourable binding sites. The interaction energy EXYZ of the probe at each xyz position on the GRID is calculated as a summation of energy components, specifically van der Waals, hydrogen bond, electrostatic interactions and a hydrophobic term as defined by Exyz = RElj ? REel?REhb. Contours at negative energy levels indicate favourable regions of attraction representing the most likely points of interaction between a probe (in this case, metal) and the protein. In this work, interactions between each of the Cup domains, Cupecoli, Cupjani and Cupburk, and their structural homologue amicyanin (PDB id: 1SFD) against relevant metal cation probes (Fe2?, Cu2?, Zn2?, Mg2?, Fe3?) were carried out by GRID. All HETATM records (i.e. all non-protein atoms such as water, Cu2?, sulphate, etc.) were first removed from the PDB file for amicyanin. There were no HETATM records in the homology models for Cupecoli, Cupjani and Cupburk. The program GRIN, the first step in the GRID calculation, was used to prepare each of the atomic coordinate files by removing hydrogens (in the case of the homology models) adding counterions (Na? was used in each case) to neutralise the overall charge on the protein taking care not to include counterions near any potential binding sites, and including the associated energy variables to individual atom types as defined in GRIN. The move directive in GRID was set to -1 to allow the counterions to move in response to the probe. The GRID calculations were performed in two stages; firstly, over the entire protein using a grid spacing ˚ , and secondly, over those regions (NPLA) of 1 A highlighted by this first run which indicated the most promising regions for metal binding using a grid ˚ . GRID allows assignment of the spacing of 0.5 A
123
Biometals (2010) 23:1–17
metal cation probes (JTYPE) to reflect the fact that these metals do not participate in hydrogen bonding and to emphasise the relative hardness or softness of the metal thus affecting the type of interaction. For example, a metal that interacts favourably with nitrogen and sulphur ligands but not oxygen would be assigned JTYPE 113. In GRID, metal cation probes by default are assigned JTYPE 110. For amicyanin and site I of Cupecoli, Cupjani and Cupburk, all metal probes were assigned JTYPE 113, to reflect the increased number of sulfhydryl ligands found at site I for each of these proteins. For site II in Cupecoli, all metals probes were assigned a JYTPE of 111, favouring interaction with oxygen ligands. All other GRID parameters used were default. The program MINIM, provided as part of the GRID package, was used to convert the GRID output to a readable format suitable for input to PYMOL (Delano 2002) for graphical viewing and interpretation.
Circular dichroism (CD) spectroscopy of EfeOecoli The CD measurements for the mature EfeOecoli protein were carried out using a JASCO J-810 spectropolarimeter. CD spectra of EfeOecoli at 3.2 mg/ml in 30 mM MES buffer (pH 6.0) were measured at 25"C with a 0.01 cm pathlength cell in the far UV (190–260 nm) region, at a bandwidth of 1 nm using an average of four scans. The raw spectral data, ellipticity (h), were expressed as mean residue ellipticity, [h]mrwk (deg cm2 dmol-1), according to the equation: ½h#mrwk ¼ MRW % hk =10 % d % c where ‘MRW’ (mean residue weight for peptide bond) is described as M/N - 1 and M is the molecular weight of the mature EfeOecoli (M = 38,313 Da), ‘N’ is the total number of amino acids (N = 349), ‘hk’ is the observed ellipticity in degrees at each wavelength, ‘d’ is the path length of the cuvette (0.01 cm), ‘c’ is the concentration of the protein in (3.2 mg/ml, in this case). The raw CD spectral data for EfeOecoli were submitted to the DICHROWEB (Whitmore and Wallace 2004) server for qualitative and quantitative secondary structure analysis. The dataset SP175, (Lees et al. 2006) consisting of 72 reference proteins ˚ from high resolution crystal structures (average 1.9 A resolution) of type b and mixed a/b, was used as the
Biometals (2010) 23:1–17
reference set for the analysis with an aim to reduce the spectral variability in the b-sheets of proteins.
Results and discussion Domain topologies The domain analysis results from the Superfamily server, Pfam (PF04302), DomFOLD and the INTERPRO database (IPR008972) indicate the presence of a cupredoxin (Cup) like domain at the N-terminus of the E. coli EfeO protein (residues 8–116) and a ‘peptidaseM75’ domain (M75, residues 135–372; Pfam PF09375, also known as ‘DUF451’) in the C-terminal region. Signal P predicted an N-terminal signal sequence for EfeO with the most likely cleavage site between residues 26 and 27 (ANA-AD). Together, the above predictions strongly suggest a two-domain organisation for EfeO of E. coli K-12 (EfeOecoli): an N-terminal Cup-like domain (Cupecoli) and a C-terminal M75 domain (M75ecoli) separated by a flexible linker (Fig. 1 and Supplementary Information). WU-BLAST2 analysis of the non-redundant database using the EBI site revealed 125 proteins displaying significant (E-value threshold 10) aminoacid sequence similarity ([20% identity) to EfeOecoli, all of which are from bacteria and possess either an M75 domain or a Cup domain. Of these, five domain organisations (I–V) are apparent (Fig. 1). The most common organisation (I) is that observed for E. coli consisting of an N-terminal Cup
Fig. 1 Domain topology of EfeO. Five domain topologies (I–V) are apparent for EfeO homologues. The unknown domain found in the Listeria and B. subtilis proteins is indicated as ‘Dom X’ (Domain X). The putative flexible linker region is indicated (not to scale). The SignalP-predicted signal peptide cleavage site for EfeO of E. coli K-12 is between
5
domain plus a C-terminal M75 domain (65 examples). All such proteins appear to possess an appropriately positioned signal sequence and so all are expected to be secreted. The second most common organisation (V) consists of an isolated Cup domain (without any C-terminal M75 domain, 34 examples) which implies that the N-terminal Cup domain can function independently of the M75 domain. The third most common domain organisation (II) comprises an isolated M75 domain (apparently secreted) without any Cup domain (18 examples). This indicates that the Cup domain may not be essential for the iron uptake process mediated by EfeO-like proteins. The fourth most frequent domain arrangement (III) contains an undefined N-terminal domain (*130 residues, designated ‘domain X’, found in B. subtilis and Listeria species) linked to a C-terminal M75 domain (seven examples) and so also lacks a recognisable Cup domain, again indicating that the Cup domain is not essential for EfeO function. Note that the B. subtilis efe-like locus, ywbLMN, has been shown to have a role in iron uptake (Baichoo et al. 2002; Ollinger et al. 2006) yet the protein corresponding to EfeO (YwbM), lacks the Cup domain. A signal sequence is predicted for the B. subtilis protein indicating these class III EfeO proteins are secreted. Finally, there is just one example of the class IV domain organisation where an N-terminal Ftr1p/EfeU-like domain is followed by a central Cup domain which is in turn followed by a C-terminal M75 domain giving an ‘EfeU-EfeO fusion’ protein. This fusion
residues 26 and 27. The predicted N-terminal Cup-like domain of EfeOecoli extends from residue 30 to 116 followed by the Cterminal M75 domain (135–372). The low complexity region between the two domains (117–134) is also predicted by Pfam and the disorder prediction tools RONN and PrDOS
123
6
suggests that EfeU and EfeO interact during the iron uptake process. Genetic context analysis Seven gene organisations (from 58 loci) were identified for efeO homologues, all of which consisted of genes encoding M75 domains and/or Cup-M75 domain fusions (Fig. 2a). The most frequent arrangement is efeUOIB (type A; 29 cases found in proteobacteria, actinobacteria and firmicutes), as found for E. coli. Given the similar genetic organisation and composition, it is highly likely that all 29 of these loci specify analogous ferrous-iron transporters. The next most common arrangement is efeOIIBU (type B; 13 cases found in firmicutes) where efeU is located at the end of the efe operon and the efeO gene is of class II (i.e. it does not specify a Cup domain). Such systems thus lack any Cup domain indicating, as suggested above, that this
Fig. 2 Schematic representations of the genetic contexts of efeO-like loci. Loci containing genes specifying a EfeO-like M75 domains (domain organization I–IV; Fig. 1) or b soloCup domains (of domain V organization; Fig. 1). The EfeOecoli amino acid sequence was used as input for Gene Context Tool 2 analysis, using default variables to search 580 genomes for sequence similarity (probability score minimum of 1 9 10-10). A total of 58 matches were reported and seven genetic organizations were observed (A–G). Slight differences in the total number of matches discovered in Figs. 1, 2 reflect
123
Biometals (2010) 23:1–17
domain is not essential for function of Efe transporters. The next most common gene arrangement is efeUOIBOII (type C; 9 cases all from proteobacteria) which also resembles the type A organisation except for the presence of an additional efeO gene, at the end of the operon, which is of class II (lacking the Cup domain). The presence of two efeO genes, each specifying a different class of EfeO protein, indicates that EfeOI and EfeOII may have distinct, but related, functions in transport. The fourth most common organisation is efeUOIIIB (type G; 3 cases from actinobacteria) which again resembles the type A arrangement except that the efeO gene encodes a class III EfeO protein containing domain X in place of the Cup domain. In addition, there are three other gene organisations that are found only once or twice: efeOIBU; efeUOIVB; and efeOIIB. Interestingly, all seven arrangements include an efeB homologue along with efeO, and in all but one case there is also an efeU equivalent. This indicates that EfeO is functionally
differences in cutoff scores applied and the sequence databases utilized. b Gene context analysis for the solo-Cup domain. Among the 38 matches obtained, three distinct gene organizations (H–J) were apparent. The presence of two solo-Cup domain gene clusters (of the H and I organizations) in B. cenocepacia, B. cepacia and B. pseudomallei, is indicated with thick and dotted black lines. ‘Rr’ and ‘His_kin’ indicate genes specifying a histidine kinase and response regulator from the two component signal transduction systems
Biometals (2010) 23:1–17
7
The above analyses indicate that the M75 domain of EfeO is crucial for EfeUOB transporters. Indeed, no loci could be found where efeU- and efeB-like genes are both present in the absence of an M75-encoding efeO-like gene. To date, the only other characterized member of the peptidase-M75 family is the Zn-containing membrane-located metallopeptidase ‘imelysin’ protein from Pseudomonas aeruginosa. Secondary-structure prediction for the M75 domain of EfeO (residues 135–372) using Jpred and PSIPRED indicates a high a-helix content (55 and 65%, respectively) and no b-strand composition. Furthermore, quantitative estimation based on the far-UV
CD spectrum of EfeOecoli (Fig. S1; residues 27–375) indicates a secondary structure composition of 48% a-helix, 13% b-strand and 39% random coil or turn. Subtraction of the anticipated secondary structure contribution of the EfeO Cup domain (50% b-strand; Fig. 4) from the CD-derived composition suggests that all the b-strands of EfeO are contributed by the Cup domain whereas all the a-helices are within the M75 domain, consistent with the PSIPRED and Jpred predictions. Alignment of the amino acid sequence of the M75 domain of E. coli (K-12) EfeO with that of 91 EfeOhomologues (65 class I, 18 class II, 7 class III and one class IV sequences; Table S1; Fig. 3 and S2) shows that the highly conserved HxxE motif, that acts as a potential Zn-binding site for M75 metallopeptidases, is completely conserved within the M75-domain of EfeO proteins. This suggests that the M-75 domain is likely to be metal binding with the HxxE motif corresponding, at least in part, to a metal-binding site (here designated ‘site III’). The above observations would be consistent with a role for the M75 domain of EfeO in specific inter-protein iron transfer, with the peptidase similarity providing protein–protein interaction capacity (perhaps with EfeU) and the HxxE motif acting as part of an Fe2?-binding site enabling delivery of iron to EfeU.
Fig. 3 Multiple-sequence alignment of a region of the M75 domain (residues 196–258) of EfeO from E. coli K-12 with selected homologues. The M75 domain region of class I, II, III and IV domain organization members were aligned and manually edited using EBI-CLUSTALW and GENEDOC software, respectively. The HxxE motif (site III), a potential zinc-binding site for the M75 metallopeptidases, is fully conserved. Absolutely conserved residues are shown in white
bold letters against a black background whereas 80 and 60% conserved residues are shown in white or black bold type against a grey background, respectively. Residue numbers are based on those of EfeOecoli. Representatives from all four domain organizations are shown here for simplicity and the complete alignment with all members is provided in the supplementary material (Fig. S2). A description of each protein is provided in Table S1
dependent upon both EfeB and EfeU, and is consistent with a similar biological function for all 58 loci in ferrous iron uptake (Cao et al. 2007). Gene-context analysis for those genes encoding a solo-Cup domain of the EfeO family (solo-Cup, domain V organisation), all from proteobacteria, revealed 38 gene clusters containing solo-Cup encoding genes. These divide into three major types (H–J; Fig. 2b), all possessing features suggestive of an iron (or metal) transport function and are discussed further in the Supplementary Information. The peptidase-M75 domain of EfeO
123
8
The cupredoxin (Cup) domain of EfeO The Cup domain of the EfeO proteins is not fully conserved, it is present in more than 70% of all cases observed, indicating an important, although not vital, function in ferrous transport. In addition, it is found as a solo domain associated with 38 potential bacterial iron/metal transporters which is again indicative of an important iron (or metal) transportrelated function. Cupredoxins (blue-copper proteins) are copper-containing, mono-domain, electron-transfer proteins possessing a ‘Greek key’ b-barrel topology. They generally contain a single ‘type I’ (or ‘blue-copper binding’) copper ion acting as a highpotential ([250 mV) electron carrier. The copper is held in a distorted tetrahedral fashion by one conserved Cys and two conserved His residues, together with one or two variable axial ligands (e.g. Met, Gln, Leu) (Adman 1991; Carrell et al. 2004; Dennison 2005; Messerschmidt et al. 2001). The so called ‘multicopper oxidases’ (MCO) possess two, three or six cupredoxin domains (Adman et al. 1995; Suzuki et al. 2000; Messerschmidt et al. 1993; Ducros et al. 2001; Zaitseva et al. 1996). Such proteins either function as oxidases or reductases and typically possess four Cu atoms classified into three types: a type I, II and III (Solomon et al. 1996). Since only a single Cup domain is found within EfeO proteins, this domain would appear more closely similar to the cupredoxins suggesting a role in electron transfer. Sequence conservation and phylogenetic relationships of the Cup domains of EfeO proteins A multiple-sequence alignment of the Cup domain of 119 EfeO-like sequences and cupredoxins (Fig. 1) (Table S1; Fig. 4 and S3) shows that the sequences fall into three major groups on the basis of shared conservation, designated Cup-I (Cup domains from class I and IV EfeO proteins), Cup-II (solo domain Cup proteins from class V EfeO proteins) and Cup-III (classical cupredoxin proteins). Unsurprisingly, these three groups form three distinct clads in the corresponding phylogenetic tree (Fig. S4). The defined secondary-structure elements of cupredoxins appear well conserved with few interruptions caused by insertions or deletions. In addition, the predicted
123
Biometals (2010) 23:1–17
secondary structure for the Cup domain of EfeO and its homologues matches the defined structure well (80%), suggesting an accurate alignment has been achieved (Fig. 4 and S3). Thus, all of the proteins included in Fig. 4 (and S3) are likely to adopt a cupredoxin fold. Only three residues are absolutely conserved (G51, G97 and Y99), which indicates the divergence of these sequences (Fig. S3; see Table 1 for roles played by such residues). Of particular note is the manner in which the patterns of conserved residues acting as defined, or potential, Cu ligands varies between the three distinct groups (Fig. 4). For the Cup-I group (class I and IV EfeO Cup domains), only the Cys (position 103) is conserved among the four Cu ligands (two His and one Cys and one Met) typically employed by cupredoxins. However, an alternative potential ligand (C41) is highly conserved in the CupI proteins, but not in the other groups, indicating that this residue may act as a novel metal ligand for members of this group. An EEREN motif (residues 77–81) is also highly conserved in the Cup-I group only, that may also contribute to metal binding. For the Cup-II group, a different pattern of potential metal ligands is observed. Of the four classical type I Cu ligands, only H106 is conserved. However, there is a well conserved Asp residue at the same position as the Cys residue normally employed as a Cu ligand in cupredoxins (position 103) which could therefore act as a metal ligand for Cup-II proteins. In addition, there is an absolutely conserved RKEKV motif (residues 77–81) that replaces the (E/D)EREN motif observed in the Cup-I group and this may also contribute to metal binding through its Glu residue. Both the Cup-I and -II groups share a very well conserved E(W/F)E motif (66–68) that may also act in metal binding. This motif is absent from the classical cupredoxins of the Cup-III group suggesting a specific purpose within the EfeO-like Cup proteins. It is interesting that both the Cup-I and -II proteins possess just one of the four highly conserved Cu ligands employed by the Cup-III proteins, but the identity of the conserved residue is different in each case. This highlights the cupredoxin-like nature the Cup-I and -II proteins but also indicates that they have each evolved in a different manner presumably to perform somewhat different functions.
Biometals (2010) 23:1–17
9
Fig. 4 Multiple-sequence alignment of the Cup domain of EfeO from E. coli K-12 with related proteins. a The complete alignment (Fig. S3) includes 65 and 34 EfeO-like Cup-I and Cup-II domains, respectively, together with 19 classical (CupIII) cupredoxins from the ‘copper bind’ family (PF00127). Representatives from each species for the three families are shown here for simplicity. Alignment of the Cup-I and -II domains was achieved as for Fig. 3. The ‘copper bind’ cupredoxin alignment was taken from Pfam and then aligned with the Cup-I and -II sequences to generate a final combined alignment. The sequences are organized into three groups (Cup-I, -II and -II) on the basis of sequence similarity and phylogeny, with the Cup-I family further divided into four subfamilies: Cup-IA, IB, IC, ID (Fig. S4). Conserved known (or potential) metal ligands for each families are indicated in bold
letters at the bottom of the alignment. The consensus defined secondary structure (b-strands only) for 19 classical cupredoxins (Cup-III proteins) is indicated by grey arrows, and that predicted by PSIPRED and Jpred for the Cup domain of EfeOecoli is shown with black arrows on the bottom of the alignment. The conserved motifs and potential metal ligands in the case of Cup I–III families are highlighted with dotted boxes whereas the potential metal ligands which are common among these families are in solid-line boxes. b Pairwise sequencestructure based alignment between Cupecoli and P. denitrificans amicyanin. The pair-wise alignment was generated using mgenTHREADER and this alignment was used to generate the homology model of Cupecoli (Fig. 5). The b-strands for Cupecoli and amicyanin are indicated with black and grey arrows, respectively
Structural modelling of the Cup domain of EfeO and select homologues
used to find structural homologues of Cupecoli (residues 27–116). Phyre and mGenTHREADER gave highest predicted matches for amicyanin, a known cupredoxin, from P. denitrificans (PDB id: 1SFD), and the derived structural alignment gave a sequence identity of 18%. PSIPRED and Jpred evaluation of the alignment of secondary structural elements for EfeO and amicyanin gave an overall agreement of 90%, with slight differences in the third and fourth b-strands of Cupecoli (III and IV; Fig. 5b). MODELLER was used to construct an amicyanin-based model for Cupecoli (Table S3). There were no irregularities in the stereochemical parameters according
Although the above sequence comparison indicates that there are two major types of EfeO-like Cup domain and that each has a unique pattern of potential metal ligands, it remains unclear whether the observed motifs occupy positions within the corresponding tertiary structures that would allow them to form metal-binding sites. To determine whether this is possible, a structural model was generated of the Cup domain of EfeO from E. coli K-12. A protein fold recognition method (McGuffin et al. 2001) was
123
10
Biometals (2010) 23:1–17
Table 1 Summary of the GRID predicted metal binding ligands for site I & site II of Cupecoli, Cupburk, Cupjani and the known copper binding site of amicyanin (PDB id: 1SFD)
program LSQKAB as provided by CCP4, gave an ˚ (Fig. 5a). RMS deviation of 0.7 A
GRID probe Residues in contact with GRID probe
The Cupecoli domain model structure
41 62 66 68 77 78 80 101 103 106 111 Cu site: amicyanin Cu2?
H
C
H
a
H
C
H
Cu2?
M
Site I Cupecoli (Cup-IA) Cu2? Fe2?
C C
E E
M M
C C
Zn2?
C
E
M
C
E
M
C
Mg
2?
C
Fe3?
E
C
Cupjani (Cup-ID) Cu2?
C
E
C
Fe2?
C
E
C
2?
Zn
C
E
C
Mg2?
C
E
C
E
C
Cu2?
E
D
H
Mg2?
E
D
H
2?
Fe
E
D
H
Zn2?
E
D
H
Fe3? Site II
E
D
Fe3? Cupburk (Cup-II)
Cupecoli (Cup-IA) Fe3?
E
E
E
E
Fe2?
E
E
E
E
Cu2?
E
E
E
E
Zn2?
E
E
E
E
Mg2?
E
E
E
E
a
Crystallographic copper for amicyanin. The preferred metals for the different binding sites in each protein are listed, according to their relative interaction energies for the respective M2? and M3? probes used. Residues in bold are potential Cup-I/II Cu ligands that are conserved in classical cupredoxins (e.g. amicyanin)
to a PROCHECK analysis, and the Ramachandran plot showed 95% of residues in the most favoured regions with no residues in the disallowed regions suggesting a stereochemically accurate model. A pairwise Ca structural superimposition between the Cupecoli model and amicyanin (1SFD), using the
123
The Cupecoli domain structural model consists of seven b-strands (strand I, residues 32–36; II, 52–59; III, 65–70; IV, 75–81; V, 88–94; VI, 98–103; VII, 110–116) accounting for 50% of the Cup portion of the EfeOecoli polypeptide (Fig. 5a). The b-strands are organised into two sheets forming a Greek key b-barrel structure typical of cupredoxins. In accordance with the multiple-sequence alignment (Fig. 4), the model suggests a metal-binding site (designated site I) comprising two conserved Cys residues (residues 41 and 103), the conserved E66 residue, and the partially-conserved M101, all of which appear to be in close structural proximity (Fig. 5b). A comparison between the site I motif of Cupecoli (C41, E66, M101 and C103) and the copper-binding site of classical cupredoxins (amicyanin, azurin and pseudoazurins) (Carrell et al. 2004; Crane et al. 2001; Inoue et al. 1999) shows both sequence and structural conservation for these proteins of a single Cys residue (Cys103; Fig. 4 alignment, Fig. 5b, c), supporting a role for this Cys in metal binding for Cupecoli. The two His residues involved in copper binding in cupredoxins, as mentioned above, are not conserved in Cupecoli. These His residues superimpose with two Leu residues in the Cupecoli model. However, C41 of Cupecoli is well conserved in Cup-I sequences and together with C103 forms part of putative metal binding site I in Cupecoli. The potential role of Cys residues as ligands in metal binding is well known (Cobbett and Goldsbrough 2002; Kojima et al. 1999; Klaassen et al. 1999; Murphy and Taiz 1995; Palmiter 1998; Solioz and Vulpe 1996). The Met residue (M111 in amicyanin) that usually occurs as an axial ligand in cupredoxins is not present in the Cupecoli model; instead there is a Pro. However, an alternative residue, M101, appears able to act as a distal ligand at site I in the model. The final residue in site I, E66, structurally replaces the Asn residue (not a Cu ligand in classical cupredoxins) typically observed in other cupredoxins. It is possible that the carboxylate (or carbonyl) of E66 of Cupecoli could perform a role in metal binding at site I. The Cupecoli model contains a negatively-charged cluster of residues (E68, 77, 78 and 80) on the protein
Biometals (2010) 23:1–17
11
(A)
(B)
(C)
Fig. 5 Cup domain homology models and metal-binding site prediction for the Cup domain of EfeO from E. coli K-12. a The Cupecoli domain homology model (orange) was generated using amicyanin of P. denitrificans (PDB id: 1SFD) as template (blue). The b-strands are numbered: S1S7. b Structural comparison of representatives from the Cup-IA (Cupecoli), Cup-ID (Cupjani), Cup-II (Cupburk) and Cup-III (amicyanin) groups, based on the homology models and the crystallographic structure of amicyanin. The comparison demonstrated conservation of two residues (E66 and C103) for Cupecoli (green) and Cupjani (green), conservation a His residue (H106) between Cupburk (green) and amicyanin (red). A conserved Asp residue, found only in the Cup-II family (as represented by Cupburk), structurally superimposes with the otherwise highly conserved C103 in the remaining Cup family members. Residue numbering is according to EfeO and the view is approximately 90" rotated in the y axis with respect to the view in A. c Close up view of the copper-binding site in the crystallographically determined amicyanin structure. Metalbinding residues (H62, C103, H106, M111) are shown as red sticks and surrounding residues, forming a hydrophobic patch
(D)
(P52, M71, P96) are shown as grey sticks. The crystallographic and GRID predicted position for copper are represented as green and yellow spheres, respectively. d Close up view of the predicted metal-binding sites showing specific residues, according to GRID, for the Cupecoli domain. According to GRID, site I has preference for an M2? (with preference for Cu2?, indicated by a green sphere) in tetrahedral geometry (C41, E66, M101 and C103) and site II has preference for Fe3? (indicated by a magenta sphere) in square planar geometry (E68, 77, 78 and 80), highlighted with red and blue sticks (respectively) with a surrounding hydrophobic patch of residues (V36, I56, L65, W67) shown as grey sticks. The views in the case of c and d are approximately 90" rotated in the x axis with respect to the view in b. Structural comparisons of amicyanin and the third Cup domain (residues 382–500) of Fet3p (the third Cup domain of Fet3p was selected because, unlike the other two, it has a type 1 copper centre) with Cupecoli, show an overall similarity in fold but with much ˚ , and RMSD closer similarity to the amicyanin (RMSD 0.7 A ˚ , respectively) reflecting the corresponding sequence 2.8 A identities (18 and 6%, respectively) (Color figure online)
123
12
surface, adjacent to the proposed copper binding site. Three of these residues (E68, 78 and 80) are absolutely or highly conserved in the Cup-I group. This negative patch of Glu residues represents a second potential metal-binding motif, designated site II (Fig. 5d; Pastore et al. 2007; Taylor et al. 2005; Fang and Wang 2002). And finally, there is a hydrophobic patch comprised mainly of residues V34, I56, I57, L65 and W67 surrounding and below site I (Fig. 5d). A similar hydrophobic patch (M28, Met51, M71, P52, P94, P96 and F97), surrounding an exposed His residue, is also seen in amicyanin and acts as potential electron transfer site (Durley et al. 1993). Collectively, these highly conserved residues and motifs in the Cup-I proteins may play a significant role in metal binding and electron transfer as part of the EfeUOB-mediated iron uptake process. Structural comparison of the metal-binding sites of Cup-IA, Cup-ID, Cup-II and Cup-III proteins It is interesting to observe that while all four site I ligands (C41, E66, M101, C103) found in the Cup-IA group proteins (e.g. Cupecoli) are conserved in the Cup-IB group, only three out of four site I ligands (all but M101) are conserved in Cup-IC and Cup-ID groups. For the solo-domain Cup-II proteins, C41 and M101 are absent and C103 is replaced with an Asp. This leaves E66 as the only conserved potential ligand at site I for the EfeO-Cup family as a whole. However, there are other well-conserved residues that could act as alternative potential metal ligands for the Cup-IC, D and -II proteins (Fig. 4). In order to explore the distinctive features of the various EfeO-like Cup domains in more detail, representative proteins from the Cup-IC, D (Cupjani) and Cup-II groups (Cupburk) were selected for model building and structural comparison with Cupecoli and amicyanin (Cup-IA and -III groups). Both Cupjani and Cupburk produced classical cupredoxin folds with RMSD values of 0.5 and 0.9, respectively, when superimposed upon the amicyanin structure (Table S3). Comparison of the site I region in the three model structures indicates that all have the potential to bind metal but, as expected, would employ slightly different ligand sets. Residues E66 and C103 of Cupjani (Cup-ID) are well conserved within the Cup-IC-D groups and align structurally with the corresponding site I residues in the Cup-IA and -II structures, and so could contribute
123
Biometals (2010) 23:1–17
to metal binding at site I (Fig. 5b). In addition, potential ligand C41, which is well conserved in the Cup-I group, may also act as a metal ligand at site I for Cupjani. For Cupburk (Cup-II), although potential ligand, C103, is replaced by an Asp (conserved in Cup-II proteins), D103 could still act as a metal ligand at this site (Fig. 5b). The absence of potential ligand C41 is compensated by the presence of H106 which is structurally aligned with the same residue in the Cu-binding site of amicyanin. This residue is highly conserved in the Cup-II and -III proteins only. This suggests a plausible, yet distinct, metal binding motif at site I of the Cup-II proteins comprising three residues: E66, D103 and H106 (Fig. 5b). Structural superimposition of the predicted site II metal-binding residues (EWE—EEREN; potential metal ligands non-subscripted) of Cupecoli, with the equivalent residues in the other two models, Cupjani (EFY—GEVEN) and Cupburk (EWE—RKEKV), shows that two of the four proposed ligands of this site are well conserved in Cupjani (and other Cup-ID proteins) with one of the other two replaced with Tyr, an alternative potential metal ligand. However, in Cupburk (and other Cup-II protein) site II is poorly conserved with just one of the four Glu ligands in Cupecoli present, and none of the three alternative residues are likely to be able to bind metal (Fig. 4). This suggests that site II is unlikely to be a metalbinding site in the solo-Cup-II domain proteins, but could be in all of the Cup-I proteins. GRID prediction of metal-binding sites in Cup-IA, Cup-ID, Cup-II and Cup-III proteins To further assess the validity of these potential metalbinding sites, the program GRID was used to predict possible metal (Cu2?, Zn2?, Fe2?, Fe3?, Mg2?) binding sites for each of the three Cup domain models as well as amicyanin. For amicyanin, the top ˚ of the most favourable interaction site was within 2 A 2? known crystallographic position for Cu and showed interaction with three of the four key residues (H62, C103, H106) known to bind copper (Fig. 5c). For Cupecoli, GRID predicted two favourable metalbinding sites corresponding to sites I and II (Table 1; Fig. 5d). GRID identified site I as a mononuclear divalent-metal (Cu2?, Fe2?, Zn2? or Mg2?) binding site (Fig. 5d) with an energetically favoured interaction with Cu2? employing all four site I ligands,
Biometals (2010) 23:1–17
namely C41, E66, M101 and C103. These residues are in agreement with the potential metal ligands predicted above. In addition, GRID predicted a potential interaction of a trivalent Fe3? at site I, however, only two (C103 and E66) of the four potential ligand residues are predicted to interact with the trivalent metal. This suggests a potential of site I in EfeO to support either a trivalent or divalent metal, but with a preference of Cu2? over Fe3?. Analogous GRID calculations for Cupjani (Cup-ID) showed an equal preference for Cu2? and Fe2? at site I, with the three anticipated metal-binding ligands (C41, E66, C103) suggested in the multiple sequence alignment (Fig. 4) interacting with the metal (Table 1). For the Cupburk domain model (Cup-II), the GRID predictions also showed a preference for Cu2? at site I, again showing energetically favourable interactions (Table 1) with the three conserved metal-binding residues (E66, C103 and H106) indicated by the multiple sequence alignment (Fig. 4). As with Cupecoli, both the Cup-II and -ID models also show potentially favourable interactions with Fe3? at site I (Table 1) but only two of the three possible ligands are predicted. In addition to the potential Cu2?-binding site I, GRID also predicted a second metal-binding site (matching site II) for Cupecoli with a preference for Fe3? involving residues E68, E77, E78 and E80 (corresponding to the EWE—EEREN motif, see above). In contrast, there were no analogous GRID interactions predicted for an equivalent site II in either Cupburk (EWE—RKEKV) or Cupjani (EFY—GEVEN).
Conclusion Sequence comparison coupled with homology modelling suggest that the Cupecoli domain contains two ˚ well-conserved metal-binding sites separated by 12 A with site I binding Cu2? and site II favouring Fe3?. Potential Cu-binding site I differs from that of the well characterised cupredoxins since Cupecoli employs ligand-residues that are mostly distinct from those of classical cupredoxins and the site is located in a slightly different region of the structure. The predicted Fe3?-binding site II has no apparent equivalent in the cupredoxins and it is therefore probable that, if this site is genuine, it represents an adaptation to enable the iron-transport associated function of EfeO.
13
From 125 Cupecoli homologous, two major types of EfeO-like Cup domain were recognisable on the basis of domain organisation, metal-binding sites, phylogeny and genetic co-localisation. One type (Cup-I) is composed of two domains, an N-terminal Cup domain and a C-terminal peptidase-M75 domain (e.g. EfeO of E. coli), and the other (Cup-II) consists of a Cup domain only. All appear to be secreted beyond the cytoplasmic membrane and nearly all are encoded by genes adjacent to ftr1/efeU homologues suggesting interaction of the Cup domain with the Ftr1p-like ferric permease. All of the Cup-I proteins were additionally associated with an EfeB homologue, although in some cases the EfeO proteins consist of an M75 domain only. The Cup-II solo domain proteins lack the predicted Fe3?-binding site II of the Cup-I proteins, employ a different set of ligands at the proposed Cu-binding site I and in no case are they associated with EfeB-like or M75domain proteins. Instead, they tend to be associated with a cytosolic polyferredoxin and a periplasmic iron-transporting ‘p19’ protein. These differences in domain organisation, predicted metal-binding sites and transporter composition indicate a functional distinction between the Cup-I and Cup-II systems. Phylogenetic analysis (Fig. S4) shows that the EfeOlike Cup-I and -II proteins populate two distinct, but related, branches of the cupredoxin superfamily. The tree organisation suggests that the EfeO-Cup proteins form a major new cupredoxin sub-family. As far as we are aware, there is no other well defined case of a cupredoxin domain (excluding MCOs) functioning as part of any type of transporter, yet the data presented here strongly suggest that all the EfeO-like Cup proteins are components of iron (or metal) transporters. Thus, we suggest that the EfeO-like Cup proteins represent a new family of cupredoxins with all known members serving roles in iron transport. A proposed mechanism of action for EfeO in the iron transport process is presented in Fig. 6. The model suggests that ferrous iron initially binds to EfeO and is then oxidised prior to transfer to EfeU. The electrons released from the ferroxidation process are delivered initially to the copper at site I, and are then passed on to the haem group of EfeB for disposal by combination with an unknown oxidant (which is unlikely to be molecular oxygen). Two potential ironbinding sites (II and III) are suggested for EfeO, one in the Cup domain and the other in the M75 domain—
123
14
(A)
Biometals (2010) 23:1–17
(B)
(C)
Fig. 6 Schematic representation of three types of Ftr1p/EfeUdependent ferrous-iron transporter and the suggested mechanisms employed. Three types of defined or putative Ftr1p/ EfeU—dependent transporter are shown: a the Cup-I type, exemplified by EfeUOB of E. coli; b the Cup-II type, for which the poorly characterised C. jejuni system is the best known example; and c the well characterized Ftr1p-Fet3p type, typified by the corresponding system of S. cerevisiae. In each case, environmental ferrous ion is the initial substrate and is first engaged within the intermembrane space (periplasm) by a specific ferrous iron binding protein (EfeO-M75, p19 or Fet3p). The ferrous iron is then oxidised and the released electrons delivered to an oxidant (such as molecular oxygen) via a Cu site (located in EfeO-Cup, solo-Cup or Fet3p). The oxidised iron is then transferred to the Ftr1p ferric-iron permease for translocation across the CM. For the Ftr1p-Fet3p system,
ferrous-iron binding and disposal of electrons released through ferrous-iron oxidation occur within a single protein (Fet3p). For the other two systems, it is suggested that these processes are mediated by different components. In the case of the Cup-I system, EfeB (a DyP haem peroxidise) is proposed to function as the reductase using its haem (Hm) group as an intermediate electron acceptor, whereas for the Cup-II system the Pfr (polyferredoxin) is suggested to fulfil this purpose employing its four [4Fe-4S] clusters to accept and pass on electrons to an intracellular acceptor. The extracellular ferric-iron reductases, Fre1p and Fre3p, are indicated for the Frt1p-Fet3p system. Equivalent reductases have not yet been indentified for bacteria. Subcellular locations are indicated: CM, cytoplasmic membrane; IMS/P, intermembrane space/periplasm; and OM/ CW, outer membrane/cell wall
this indicates that iron may bind to one site initially, and then move to the other site following oxidation. The transfer of iron between sites III and II could be mediated by the proposed inter-domain mobility of EfeO enabled by the inter-domain flexible linker. This mobility could also assist the proposed site I mediated electron transfer between the M75 domain and EfeB. As there are examples where the Cup domain is absent in EfeUOB-like transporters, it seems likely that the M75 domain would provide the primary ferrous-iron-binding site and that the proposed role of the Cup domain in electron transfer is
not an essential requirement. This suggests that if iron does move between sites III and II then it is most likely to transfer in the site III to II direction, possibly following oxidation of the iron bound at site III. Thus, the presence of the Cup domain could enhance the efficiency of the iron transport process by increasing the rate of electron exchange, by acting as an intermediary in the transfer of iron from the M75 domain to EfeU and by increasing the availability of site III for ferrous iron binding. In cases where there are two EfeO proteins (with and without a Cup domain) it is possible that the two
123
Biometals (2010) 23:1–17
EfeO proteins offer different metal affinities or selectivities. For the solo EfeO-Cup proteins, the compositions of the corresponding iron transport systems differ considerably to those of the EfeUOB-like systems (Fig. 6). The differences in composition likely reflect the use of a distinct mechanism and/or discrete oxidants for the two types of transporter. It is possible that the p19 protein functionally replaces the M75 domain in ferrous-iron binding and that the polyferredoxin takes the place of EfeB in disposing of electrons, whereas the Cup protein retains its role in electron transfer. However, if this model is true it is unclear how electrons could pass from the periplasmic components to the polyferredoxin, unless the Ftr1p/EfeU homologue is able to mediate this. Clearly, an understanding of the details of these two types of bacterial transporter will require further study. A major presumption is that the Cup-I and Cup-II transporter systems both utilise ferrous iron as substrate but deliver iron across the cytosolic membrane in the ferric form and so thus engage in ferroxidation. This assumption of a ferroxidation step is based upon the established mechanism employed by the related Ftr1p-Fet3p system and on the apparent inclusion of redox components (cupredoxins, haem peroxidases, polyferredoxins) within the Cup-I and Cup-II systems. However, the purpose of such a oxidation step within the transport processes mediated by these transporters is not clear. It is possible that an oxidation step would provide the driving force to energise the translocation process, or that the inclusion of a redox step enhances transport specificity. Currently, the energy mode employed by the Ftr1p-Fet3p system is unknown so ferroxidation remains a possibility. Indeed, a combination of enhanced specificity along with energy provision would provide a very satisfactory justification for the utilisation of a ferroxidation step within the iron-translocation pathways of the Ftr1p/EfeU-dependent transporters, as depicted in Fig. 6. Acknowledgments We thank Peter Goodford and Jim Dunwell for helpful discussions in the preparation of the manuscript. We also thank Liam McGuffin for the helpful discussions related with the evaluation of structural models. Authors thank FELIX trust, Biotechnology and Biological Sciences Research (BBSRC) and Lister Institute of Preventive Medicine for providing funding for this study. We thank Sue Mitchell and Nick Spencer (Structural Biology Unit, The Biocentre) for technical support.
15
References Adman ET (1991) Copper protein structures. Adv Protein Chem 42:145–197 Adman ET, Godden JW, Turley S (1995) The structure of copper-nitrite reductase from Achromobacter cycloclastes at five pH values, with NO2- bound and with type II copper depleted. J Biol Chem 270:27458–27474 Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403–410 Andrews SC, Robinson AK, Rodriguez-Quinones F (2003) Bacterial iron homeostasis. FEMS Microbiol Rev 27: 215–237 Askwith C, Kaplan J (1997) An oxidase-permease-based iron transport system in Schizosaccharomyces pombe and its expression in Saccharomyces cerevisiae. J Biol Chem 272:401–405 Askwith C, Kaplan J (1998) Iron and copper transport in yeast and its relevance to human disease. Trends Biochem Sci 23:135–138 Baichoo N, Wang T, Ye R, Helmann JD (2002) Global analysis of the Bacillus subtilis Fur regulon and the iron starvation stimulon. Mol Microbiol 45:1613–1629 Bairoch A, Apweiler R, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, Martin MJ, Natale DA, O’Donovan C, Redaschi N, Yeh LS (2005) The universal protein resource (UniProt). Nucleic Acids Res 33:D154–D159 Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340:783–795 Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242 Bracken CS, Baer MT, Abdur-Rashid A, Helms W, Stojiljkovic I (1999) Use of heme-protein complexes by the Yersinia enterocolitica HemR receptor: histidine residues are essential for receptor function. J Bacteriol 181:6063–6072 Braun V, Hantke K, Koster W (1998) Bacterial iron transport: mechanisms, genetics, and regulation. In: Sigel A, Sigel H (eds) Metal ions in biological systems. Dekker, New York, pp 67–145 Bryson K, McGuffin LJ, Marsden RL, Ward JJ, Sodhi JS, Jones DT (2005) Protein structure prediction servers at University College London. Nucleic Acids Res 33:W36–W38 Cao J, Woodhall MR, Alvarez J, Cartron ML, Andrews SC (2007) EfeUOB (YcdNOB) is a tripartite, acid-induced and CpxAR-regulated, low-pH Fe2? transporter that is cryptic in Escherichia coli K-12 but functional in E. coli O157:H7. Mol Microbiol 65:857–875 Carrell CJ, Sun D, Jiang S, Davidson VL, Mathews FS (2004) Structural studies of two mutants of amicyanin from Paracoccus denitrificans that stabilize the reduced state of the copper. Biochemistry 43:9372–9380 Carrondo MA (2003) Ferritins, iron uptake and storage from the bacterioferritin viewpoint. EMBO J 22:1959–1968 Cartron ML, Maddocks S, Gillingham P, Craven CJ, Andrews SC (2006) Feo—transport of ferrous iron into bacteria. Biometals 19:143–157
123
16 Cartron ML, Mitchell SA, Woodhall MR, Andrews SC, Watson KA (2007) Preliminary X-ray diffraction analysis of YcdB from Escherichia coli: a novel haem-containing and Tat-secreted periplasmic protein with a potential role in iron transport. Acta Crystallogr Sect F 63:37–41 Chiancone E, Ceci P, Ilari A, Ribacchi F, Stefanini S (2004) Iron and proteins for iron storage and detoxification. Biometals 17:197–202 Ciria R, Abreu-Goodger C, Morett E, Merino E (2004) GeConT: gene context analysis. Bioinformatics 20:2307– 2308 Cobbett C, Goldsbrough P (2002) Phytochelatins and metallothioneins: roles in heavy metal detoxification and homeostasis. Annu Rev Plant Biol 53:159–182 Collaborative Computational Project N (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D B 50:760–763 Crane BR, Di Bilio AJ, Winkler JR, Gray HB (2001) Electron tunneling in single crystals of Pseudomonas aeruginosa azurins. J Am Chem Soc 123:11623–11631 Cuff JA, Clamp ME, Siddiqui AS, Finlay M, Barton GJ (1998) JPred: a consensus secondary structure prediction server. Bioinformatics 14:892–893 De Freitas J, Wintz H, Kim JH, Poynton H, Fox T, Vulpe C (2003) Yeast, a model organism for iron and copper metabolism studies. Biometals 16:185–197 De Silva DM, Askwith CC, Eide D, Kaplan J (1995) The FET3 gene product required for high affinity iron transport in yeast is a cell surface ferroxidase. J Biol Chem 270:1098–1101 Debut AJ, Dumay QC, Barabote RD, Saier MH Jr (2006) The iron/lead transporter superfamily of Fe2?/Pb2? uptake systems. J Mol Microbiol Biotechnol 11:1–9 Delano W (2002) The PyMOL molecular graphics system. www.pymol.org. Accessed Apr 2009 Dennison C (2005) Investigating the structure and function of cupredoxins. Coord Chem Rev 249:3025–3054 Ducros V, Brzozowski AM, Wilson KS, Ostergaard P, Schneider P, Svendson A, Davies GJ (2001) Structure of ˚ resolution: the laccase from Coprinus cinereus at 1.68 A evidence for different type 2 Cu-depleted isoforms. Acta Crystallogr D 57:333–336 Durley R, Chen L, Lim LW, Mathews FS, Davidson VL (1993) Crystal structure analysis of amicyanin and apoamicyanin ˚ and 1.8 A ˚ resofrom Paracoccus denitrificans at 2.0 A lution. Protein Sci 2:739–752 Fang H-M, Wang Y (2002) Characterization of iron-binding motifs in Candida albicans high-affinity iron permease CaFtr1p by site-directed mutagenesis. Biochem J 368:641–647 Finn RD, Mistry J, Schuster-Bockler B, Griffiths-Jones S, Hollich V, Lassmann T, Moxon S, Marshall M, Khanna A, Durbin R, Eddy SR, Sonnhammer EL, Bateman A (2006) Pfam: clans, web tools and services. Nucleic Acids Res 34:D247–D251 Fu Y, Lee H, Collins M, Tsai HF, Spellberg B, Edwards JE Jr, Kwon-Chung KJ, Ibrahim AS (2004) Cloning and functional characterization of the Rhizopus oryzae high affinity iron permease (rFTR1) gene. FEMS Microbiol Lett 235:169–176
123
Biometals (2010) 23:1–17 Goodford PJ (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem 28:849–857 Gough J, Karplus K, Hughey R, Chothia C (2001) Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure. J Mol Biol 313:903–919 Grass G, Wong MD, Rosen BP, Smith RL, Rensing C (2002) ZupT is a Zn(II) uptake system in Escherichia coli. J Bacteriol 184:864–866 Grifantini R, Sebastian S, Frigimelica E, Draghi M, Bartolini E, Muzzi A, Rappuoli R, Grandi G, Genco CA (2003) Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B. Proc Natl Acad Sci USA 100:9542–9547 Hantke K (1987) Ferrous iron transport mutants in Escherichia coli K12. FEMS Microbiol Lett 44:53–57 Inoue T, Nishio N, Suzuki S, Kataoka K, Kohzuma T, Kai Y (1999) Crystal structure determinations of oxidized and reduced pseudoazurins from Achromobacter cycloclastes. Concerted movement of copper site in redox forms with the rearrangement of hydrogen bond at a remote histidine. J Biol Chem 274:17845–17852 Ishida T, Kinoshita K (2007) PrDOS: prediction of disordered protein regions from amino acid sequence. Nucleic Acids Res 35:W460–W464 Jones DT, Bryson K, Coleman A, McGuffin LJ, Sadowski MI, Sodhi JS, Ward JJ (2005) Prediction of novel and analogous folds using fragment assembly and fold recognition. Proteins 61:143–151 Kehres DG, Zaharik ML, Finlay BB, Maguire ME (2000) The NRAMP proteins of Salmonella typhimurium and Escherichia coli are selective manganese transporters involved in the response to reactive oxygen. Mol Microbiol 36:1085–1100 Kehres DG, Janakiraman A, Slauch JM, Maguire ME (2002) SitABCD is the alkaline Mn2? transporter of Salmonella enterica Serovar Typhimurium. J Bacteriol 184:3159–3166 Kelley LA, MacCallum RM, Sternberg MJ (2000) Enhanced genome annotation using structural profiles in the program 3D-PSSM. J Mol Biol 299:499–520 Klaassen CD, Liu J, Choudhuri S (1999) Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39:267–294 Kojima T, Binz PA, Ka¨gi JHR (1999) Nomenclature of metallothionein: proposal for a revision. In: Klaassen CD (ed) Metallothionein IV. Birkhauser, Boston, pp 7–13 Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291 Lees JG, Miles AJ, Wien F, Wallace BA (2006) A reference database for circular dichroism spectroscopy covering fold and secondary structure space. Bioinformatics 22:1955–1962 Makui H, Roig E, Cole ST, Helmann JD, Gros P, Cellier MF (2000) Identification of the Escherichia coli K-12 Nramp orthologue (MntH) as a selective divalent metal ion transporter. Mol Microbiol 35:1065–1078
Biometals (2010) 23:1–17 Marsden RL, McGuffin LJ, Jones DT (2002) Rapid protein domain assignment from amino acid sequence using predicted secondary structure. Protein Sci 11:2814–2824 Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29:291–325 McGuffin L (2007) Benchmarking consensus model quality assessment for protein fold recognition. BMC Bioinformatics 8:345 McGuffin LJ (2008) The ModFOLD server for the quality assessment of protein structural models. Bioinformatics 24:586–587 McGuffin LJ, Bryson K, Jones DT (2001) What are the baselines for protein fold recognition? Bioinformatics 17:63–72 Messerschmidt A, Luecke H, Huber R (1993) X-ray structures and mechanistic implications of three functional derivatives of ascorbate oxidase from zucchini: reduced, peroxide and azide forms. J Mol Biol 230:997–1014 Messerschmidt A, Huber R, Poulos T, Wieghardt K (2001) Handbook of metalloproteins. Wiley, New York Mulder NJ, Apweiler R, Attwood TK et al (2007) New developments in the InterPro database. Nucleic Acids Res 35:D224–D228 Murphy A, Taiz L (1995) Comparison of metallothionein gene expression and nonprotein thiols in ten arabidopsis ecotypes (Correlation with copper tolerance). Plant Physiol 109:945–954 Murzin AG, Brenner SE, Hubbard T, Chothia C (1995) SCOP: a structural classification of proteins database for the investigation of sequences and structures. J Mol Biol 247:536–540 Nicholas KB, Nicholas HB, DW D (1997) GeneDoc: analysis and visualization of genetic variation. EMBNEW. NEWS 4:14. www.nrbsc.org/gfx/genedoc. Accessed Feb 2009 Ollinger J, Song KB, Antelmann H, Hecker M, Helmann JD (2006) Role of the Fur regulon in iron transport in Bacillus subtilis. J Bacteriol 188:3664–3673 Palmiter RD (1998) The elusive function of metallothioneins. Proc Natl Acad Sci USA 95:8428–8430 Paronetto MP, Miele R, Maugliani A, Borro M, Bonaccorsi di Patti MC (2001) Cloning of Pichia pastoris Fet3: insights into the high affinity iron uptake system. Arch Biochem Biophys 392:162–167 Pastore C, Franzese M, Sica F, Temussi P, Pastore A (2007) Understanding the binding properties of an unusual metalbinding protein-a study of bacterial frataxin. FEBS J 274:4199–4210 Severance S, Chakraborty S, Kosman DJ (2004) The Ftr1p iron permease in the yeast plasma membrane: orientation, topology and structure–function relationships. Biochem J 380:487–496 Solioz M, Vulpe C (1996) CPx-type ATPases: a class of P-type ATPases that pump heavy metals. Trends Biochem Sci 21:237–241
17 Solomon EI, Sundaram UM, Machonkin TE (1996) Multicopper oxidases and oxygenases. Chem Rev 96:2563– 2606 Stearman R, Yuan DS, Yamaguchi-Iwai Y, Klausner RD, Dancis A (1996) A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science 271: 1552–1557 Stintzi A, Barnes C, Xu J, Raymond KN (2000) Microbial iron transport via a siderophore shuttle: a membrane ion transport paradigm. Proc Natl Acad Sci USA 97:10691– 10696 Sturm A, Schierhorn A, Lindenstrauss U, Lilie H, Bruser T (2006) YcdB from Escherichia coli reveals a novel class of Tat-dependently translocated hemoproteins. J Biol Chem 281:13972–13978 Suzuki S, Kataoka K, Yamaguchi K (2000) Metal coordination and mechanism of multicopper nitrite reductase. Acc Chem Res 33:728–735 Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599 Taylor AB, Stoj CS, Ziegler L, Kosman DJ, Hart PJ (2005) The copper-iron connection in biology: structure of the metallo-oxidase Fet3p. Proc Natl Acad Sci USA 102:15459– 15464 Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680 Wandersman C, Delepelaire P (2004) Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol 58:611–647 Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT (2004) Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol 337:635–645 Wheeler DL, Barrett T, Benson DA et al (2006) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 34:D173–D180 Whitmore L, Wallace BA (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32:W668–W673 Yang ZR, Thomson R, McNeil P, Esnouf RM (2005) RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 21:3369–3376 Zaitseva I, Zaitsev V, Card G, Moshkov K, Bax B, Ralph A, Lindley P (1996) The X-ray structure of human serum ˚ : nature of the copper centres. J ceruloplasmin at 3.1 A Biol Inorg Chem 1:15–23
123
Biometals (2010) 23:19–30 DOI 10.1007/s10534-009-9263-y
Elevated zinc induces endothelial apoptosis via disruption of glutathione metabolism: role of the ADP translocator Dean A. Wiseman Æ Shruti Sharma Æ Stephen M. Black
Received: 23 January 2009 / Accepted: 13 August 2009 / Published online: 22 September 2009 ! Springer Science+Business Media, LLC. 2009
Abstract Zinc is the second-most abundant transition metal within cells and an essential micronutrient. Although adequate zinc is essential for cellular function, intracellular free zinc (Zn2?) is tightly controlled, as sustained increases in free Zn2? levels can directly contribute to apoptotic endothelial cell death. Moreover, exposure of endothelial cells to acute nitrosative and/or oxidative stress induces a rapid rise of Zn2? with mitochondrial dysfunction and the initiation of apoptosis. This apoptotic induction can be mimicked through addition of exogenous ZnCl2 and mitigated by zinc-chelation strategies, indicating Zn2?-dependent mechanisms in this process. However, the molecular mechanisms of Zn2?mediated mitochondrial dysfunction are unknown. Here we report that free Zn2? disrupts cellular redox status through inhibition of glutathione reductase, and induces apoptosis by redox-mediated inhibition of the mitochondrial adenine nucleotide transporter (ANT). Inhibition of ANT causes increased mitochondrial oxidation, loss of ADP uptake, mitochondrial translocation of bax, and apoptosis. Interestingly, pre-incubation with glutathione ethyl ester protects endothelial
D. A. Wiseman ! S. Sharma ! S. M. Black (&) Vascular Biology Center, Medical College of Georgia, 1459 Laney Walker Blvd CB-3210, Augusta, GA 30912-2500, USA e-mail:
[email protected]
cells from these observed effects. We conclude that key mechanisms of Zn2?-mediated apoptotic induction include disruption of cellular glutathione homeostasis leading to ANT inhibition and decreases in mitochondrial ATP synthesis. These pathways could represent novel therapeutic targets during acute oxidative or nitrosative stress in cells and tissues. Keywords Mitochondrial dysfunction ! Apoptosis ! Redox status
Introduction Understanding the nature of how cells transduce, interpret, and respond to stress signals, both in terms of extracellular perception as well as signals from within, is fundamental for discovering and developing new therapies and interventions for situations where cells, tissues, and organs lose the ability to maintain homeostatic balance. It is now apparent reactive oxygen and nitrogen species (ROS, RNS, respectively) serve as signal transduction molecules in biological systems. ROS such as hydrogen peroxide (H2O2) and superoxide (O2•-) are also increasingly understood to have complex and highly nuanced signal transduction roles in cells and tissues (Forman and Torres 2001). However, these same chemical species can also initiate signaling pathways that result in apoptosis (Bauer 2000). We, and others,
123
20
have previously reported that exposure of pulmonary artery endothelial cells to elevated levels of ROS and/ or RNS leads to significant elevation in intracellular free zinc (Zn2?) (Tang et al. 2001; Wiseman et al. 2006, 2007; Bernal et al. 2008). Zinc is the secondmost common transition metal in cells (Atwood and Steed 2004), and zinc ions function in multiple different intracellular processes. It is estimated that at least 3% of the known human genes encode proteins containing zinc-finger domains (Maret 2003). However, the concentration of unbound ‘‘free’’ intracellular zinc is typically found at picomolar levels (Simons 1991). Thus, although Zn2? is classified as ‘‘redox inert,’’ if not adequately sequestered it can also function as a potent disruptive molecule within cells. Here, we present data that demonstrate that the effect of Zn2? on mitochondrial dysfunction is indirect. Further, we show that a key mechanism for this indirect effect is disruption of glutathione homeostasis. Interestingly, we find that a direct consequence of Zn2?-mediated depletion of reduced cellular glutathione is the inhibition of mitochondrial adenine nucleotide transport. Together, these data illustrate a cell-death mechanism whereby mitochondrial dysfunction is initiated through a Zn2?-induced loss of cellular antioxidant capacity, resulting in mitochondria deprived of adequate metabolites for normal function.
Biometals (2010) 23:19–30
CO-BRL, Gaithersburg, MD) and incubated overnight. During serum deprivation, no exogenous sources of Zn2? are available to the cells. Cells were pretreated for 2 h with SF/PRF-DMEM ± glutathione ethyl ester (GSH-EE, 2 mM, Sigma, St. Louis, MO), and then exposed 0–4 h with 0–1 mM ZnCl2 (200 mM in PBS, diluted in SF/PRF-DMEM), 0–1 mM N-[2-aminoethyl]-N-[2-hydroxy-2-nitrosohydrazino]-1,2-ethylenediam-ine (spermine NONOate; Calbiochem, San Diego, CA) in SF/PRF-DMEM. Doses were selected to examine the entire range of potential response in PAECs as we (Wiseman et al. 2006, 2007), and others (Koh and Choi 1994) previously described. At designated time points, cells were subjected to immediate analysis, unless noted. Mitochondrial isolation PAECs were scraped, washed PBS, and pelleted by centrifugation 8509g at 4"C for 2 min. Mitochondria were isolated via the manufacturer’s protocol (Pierce Biotechnology, Rockford, IL). Mitochondrial fractions were resuspended in 0.25 M sucrose, 10 mM Tris-C1, pH 7.4, and 0.5 mM EDTA. In order to avoid potential issues with chelation of Zn2? ions by EDTA, immediately prior to the beginning of each experiment, mitochondrial fractions were centrifuged and resuspended in EDTA-free buffer, and assayed as described below.
Materials and methods Fluorescence microscopy Cell culture Primary cultures of ovine fetal pulmonary artery endothelial cells (PAECs) were isolated and identified as described previously (Wedgwood et al. 2003). Cells between passages 3–10 were maintained in DMEM supplemented with 10% fetal bovine serum (Hyclone, Logan, UT), antibiotics and antimycotics (MediaTech, Herndon, VA) at 37"C with 5% CO2– 95% air. Cells were seeded at *50% confluence, and at *90% confluence. Before experimental treatment, except as noted, cells were trypsinized, counted, re-plated in 6-, 24-, or 96-well plates (Costar, Corning, NY) at a density of 5 9 105 cells/cm2, and incubated 18 h. Cells were serum starved in serumfree, phenol red-free DMEM (SF/PRF-DMEM, GIB-
123
A PC-based imaging system consisting of: an Olympus IX51 microscope equipped with a charge-coupled camera (Hamamatsu Photonics, Hamamatsu City, Japan) was used for acquisition of fluorescent images. Fluorescent-stained cells were observed using appropriate excitation and emission, measuring at least 300 cells per sample, and the average fluorescent intensities (to correct for differences in cell number) were quantified using ImagePro Plus v5.0 software (Media Cybernetics, Silver Spring, MD). High-resolution cellular images were obtained using an Applied Precision, Inc. (Issaquah, WA) DeltaVisionTM imaging system, fitted with an environmental control chamber. Data obtained were quantified using DeltaVisionTM software and compared by statistical analysis.
Biometals (2010) 23:19–30
Detection of bax translocation Ten hours following treatment, mitochondria were isolated and resuspended in lysis buffer (20 mM Tris base, pH 7, 2.5 mM EDTA, 1% Triton-X, 1:100 protease inhibitor cocktail [Sigma]). Lysates were assayed for protein concentration by BCA protein assay (Pierce Biotechnology, Rockford, IL) and normalized for concentration. Sixty microgram of mitochondrial protein per sample was subjected to SDS–PAGE and analyzed by standard Western blot analysis as described previously (Brennan et al. 2003) using anti-bax antibody (Cell Signaling Technology, Boston, MA). Detection of apoptotic events PAECs in 96-well plates were treated as described. Caspase activation was visualized by co-treating cells with 1 lM CaspACE FITC-vad-FMK (Promega, Madison, WI). This fluorescent analog of the pancaspase inhibitor N-benzyloxycarbonyl-Val-Ala-Aspfluor-omethylketone (Z-vad-FMK) readily enters cells and binds irreversibly to activated caspases. After treatment, cells were washed with ZnCl2-free DMEM and incubated overnight in PRF-DMEM media with 1% FBS. Eighteen hours post-exposure, cells were incubated in media with 10 lM FITCconjugated caspase inhibitor (FITC-vad-FMK). After 20 min incubation at 37"C in dark conditions, cells were washed with fresh media and visualized using fluorescence microscopy. A second method involved TUNEL analysis. PAECs were incubated for *18 h in PRF-DMEM supplemented with 1% FBS. Following incubation, analysis was performed as we have previously described (Wedgwood and Black 2003). EPR detection of mitochondrial O2•- levels Mitochondrial-specific O2•- production was measured using electron paramagnetic resonance (EPR) spectroscopy with spin probe, 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethyl-pyrrolidine•HCl (CMH, Alexis Biochemicals, San Diego, CA) as described (Wiseman et al. 2007). Following exposure, mitochondrial isolation was performed as described above. Mitochondrial fractions were incubated for 1 h in the presence of CMH (PBS, pH 7.4 ? 25 lM deferrioxamine mesylate [Calbiochem], CMH 5 mg/ml).
21
Thirty five microliter of sample was loaded into a 50 ll capillary tube and analyzed with a MiniScope MS200 EPR (Magnettech, Berlin, Germany) at a microwave power of 40 mW, modulation amplitude of 3,000 mG, and modulation frequency of 100 kHz. EPR spectra were analyzed measured for amplitude using ANALYSIS software (v2.02; Magnettech). Detection of cellular and mitochondrial redox status PAECs were plated into 10 cm dishes at a density of *15,000 cells/cm2 (*1.25 9 106 cells per dish) and transfected with expression constructs of roGFP, redox-sensitive GFP analogs where surface-exposed residues are substituted with serine, allowing the ability to monitor the cellular thiol redox status of cells. These GFP analogs demonstrate a redoxspecific shift in fluorescence spectra directly correlated to cellular oxidation status (Hanson et al. 2004). Redox-sensitive constructs (generously provided by S. James Remington, University of Oregon) delivered either general cytosolic roGFP expression (‘‘cRo,’’ Fig. 3a), or expression of roGFP specifically within mitochondria (‘‘mRo,’’ Fig. 3a). Transfections were performed via Effectene# lipid-based delivery protocols (Qiagen). Following transfection with either cRo or mRo constructs, cells were subdivided into three groups and re-plated onto cover glass. One group was treated as described above to assess cellular redox status for up to 4 h post-onset of exposure, while the other two groups were used to calibrate maximal reduction (using 1 mM dithiothreitol, Sigma) and maximal oxidation (using 1 mM t-butyl hydroperoxide, Sigma) (Farrow et al. 2008), and cellular fluorescence at 470 and 360 nm excitation wavelengths in order to determine the ratio of reduced versus oxidized GFP for up to 4 h. In addition, an untransfected sample of cells was quantified to determine nonspecific background. Each experimental group was evaluated as a percentage of oxidation, relative to fluorescence values obtained for fully reduced and fully oxidized conditions. Measurement of glutathione reductase activity The assay for glutathione reductase activity is based on oxidation of NADPH to NADP? catalyzed by a limiting concentration of glutathione reductase. One
123
22
GR activity unit is defined as the amount of enzyme catalyzing reduction of one micromole of GSSG per minute at pH 7.6 and 25"C. Given that one molecule of NADPH is consumed for each molecule of GSSG reduced, reduction of GSSG is determined indirectly by measurement of NADPH consumption, observed as a decrease in absorbance at 340 nm (A340) over time. Briefly, PAECs were treated and harvested by scraping and centrifugation at 1,0009g for 10 min at 4"C. Cell pellets were homogenized in 200 ll of icecold KPO4 buffer (100 mM, 0.1% BSA, 5 mM EDTA, pH 7.5) and centrifuged at 10,0009g for 15 min at 4"C, and supernatants kept on ice for immediate assay. To each sample, a known amount of NADPH was added, and A340 was continuously monitored 60 s. Extinction coefficients were calculated and activity determined via comparison to known standards of purified glutathione reductase. To determine if the effect of Zn2? is acting directly upon the glutathione reductase enzyme, samples of purified glutathione reductase was exposed or not to 50 lM ZnCl2 and analyzed as described. Determination of cellular GSH:GSSG ratio This assay used is based on reaction of GSH with DTNB (Ellman’s reagent, [5,50 -dithiobis-2-nitrobenzoic acid]), which produces a detectable product with a maximal absorbance at 412 nm. The rate of product formation is proportional to the concentration of GSH. As GSH typically far exceeds the amount of oxidized GSSG within cells, this assay uses a thiolscavenging reagent, 1-methyl-2-vinylpyridinium trifluoromethanesulf-onate1 (M2VP) to scavenge GSH. Samples are then incubated with a known amount of purified glutathione reductase in the presence of DTNB, and ratios calculated according to the manufacturer’s protocol (Oxis International). For both GSSG and GSH, absorbance curves were generated and concentrations were extrapolated via comparison to known GSH standards.
Biometals (2010) 23:19–30
St. Louis, MO). Mitochondrial isolates were volume adjusted to 800 ll, pH 7.8. Hundred microliter of ATP Assay Mix solution was added to isolates, and allowed to incubate at room temperature for *3 min, during which any endogenous ATP is hydrolyzed, decreasing background signal. The assay was performed by rapidly adding 100 ll of either ATP standard or ADP, with mixing, and measured with a luminometer. Negative controls were performed using mitochondrial-free reactions and mitochondrial fractions absent of exogenous ADP. In addition, we directly measured mitochondrial adenine uptake. [3H]ADP uptake was measured by carboxyatractyloside inhibitor stop-technique described previously (Chan and Barhour 1979). Approximately 50 lg of mitochondria were suspended in 200 ll buffer containing 116 mM KC1, 21 mM Tris/HCI, pH 7.4, 1.05 mM EDTA (KCl buffer), 5.26 mM 2-oxoglutarate, and 5.26 lM p-ruthenium red. Following 5-min incubation at RT, 10 pg oligomycin was added to the suspension and chilled to 2"C. Various concentrations (5 ll) of [3H]ADP were added to 45 l aliquots of mitochondrial suspension under constant mixing. After 12 s, reactions were stopped by 10 ll injection of 200 lM p-carboxy-atractyloside, and mitochondria were pelleted at 12,0009g for 4 min. Supernatant was removed and mitochondria were washed with 200 ll KC1 buffer containing 10 nM carboxyatractyloside and re-pelleted. The mitochondrial pellet was dissolved in 100 ll of 2% SDS, transferred to a scintillation vial containing 3.0 ml of counting fluid, and counted by liquid scintillation. Statistical analyses Statistical calculations were performed using GraphPad Prism V. 4.01 software. The mean ± SD was calculated for all samples and significance determined by either by the unpaired t test or ANOVA. For ANOVA, Neuman-Kuehls post-hoc testing was utilized. A value of P \ 0.05 was considered significant.
Determination of mitochondrial ATP production Results Following exposure to Zn2? (500 lM, 4 h), isolated mitochondria were incubated in physiological conditions with exogenous ADP (100 lM, Sigma, St. Louis, MO) in the presence of ATP-dependent luciferase, according to the manufacturer’s protocol (Sigma,
123
Our previous findings indicate that pulmonary artery endothelial cells (PAECs) undergo mitochondrial dysfunction and apoptosis when exposed to either oxidative or nitrosative stress, and this effect can be
Biometals (2010) 23:19–30
mimicked if cells are exposed in the same fashion to exogenous Zn2?. Initially, we determined if elevated intracellular Zn2? induces mitochondrial dysfunction via a direct or indirect mechanism. Isolated mitochondrial fractions (from *2 9 107 cells) were suspended in metabolic buffer (free from metal chelators, such as EDTA) and acutely exposed to either ZnCl2 (Fig. 1a) or spermine NONOate (Fig. 1b, as a positive control) or for 1 h and superoxide levels determined using the spin-trap, CMH, a cyclic hydroxylamine with relatively specific affinity for O2•- (Fink and Dikalov 2002). CMH-O2•- products were detected by EPR analysis as we have described (Wiseman et al. 2006). Our data indicate that although NO increases mitochondrial-derived O2•- (Fig. 1b), Zn2? alone does not (Fig. 1a), indicating that Zn2?-mediated mitochondrial dysfunction occurs indirectly. Previous studies show an important role for reduced GSH in maintaining mitochondrial function (Garcia-Ruiz et al. 1995). Thus, we next determined if the indirect effect of free Zn2? on mitochondrial function could be due to alterations in cellular GSH homeostasis. We found that Zn2? exposure caused a decrease in the GSH-to-GSSG ratio (Fig. 2a). As the rate-limiting enzyme in the homeostatic maintenance of cellular GSH-to-GSSG ratio is glutathione reductase (GR), we next ascertained if the mechanism by which increased free Zn2? produces elevated GGSG is mediated through inhibition of glutathione reductase (GR) enzymatic activity. Our data indicate that elevated free Zn2? leads to the inhibition of GR activity in PAECs (Fig. 2b). Furthermore, to verify that Zn2? is a direct biochemical inhibitor of GR, we determined if Zn2? inhibits GR in vitro. We found the presence of Zn2? directly inhibits the ability of GR to reduce GSSG to GSH (Fig. 2c). In order to examine the effect of the decreased GSH-to-GSSG ratio induced by elevated free Zn2? on cellular redox status, we utilized redox-sensitive GFP constructs targeted to either cytosol (‘‘cRo’’) or to mitochondria (‘‘mRo’’) (Fig. 3a). Following transfection with either cRo or mRo redox-sensitive GFP, we exposed PAECs to Zn2? (0–1 mM ZnCl2) and monitored average cellular fluorescence for 4 h. Firstly, we observed a dose-dependent, significant shift in mitochondrial roGFP to a more oxidized state (Fig. 3b). Secondly, we observed a shift in both cytosolic and mitochondrial redox status to a more oxidized state, but mitochondrial oxidation occurred
23
Fig. 1 Zinc does not directly increase mitochondrial superoxide generation. Mitochondria were isolated from PAECs as described in ‘‘Methods and materials’’ and resuspended in EDTA-free physiological buffer containing either a 0–1 mM ZnCl2 or b 0–1 mM Spermine NONOate (as a positive control) and incubated at 37"C for 2 h. Following incubation, superoxide levels were determined using EPR. The direct addition of ZnCl2 does not increase mitochondrial superoxide levels while the NO donor does. Graphs represent mean amplitude of superoxide-CMH product EPR waveforms (n = 5), with representative individual waveforms illustrated above. Error bars represent ±SEM. * P \ 0.05 versus control samples; ! P \ 0.05 versus previous dose
earlier (Fig. 3c). Lastly, in cells treated with 1 mM glutathione ethyl ester prior and during onset of exposure to Zn2?, we found significant protection of
123
24
Biometals (2010) 23:19–30
Fig. 2 Zinc-mediated disruption of glutathione homeostasis is mediated by the inhibition of glutathione reductase activity. PAECs exposed to ZnCl2 (0–1 mM) were analyzed to determine GSH-to-GSSG ratio (a) and GR enzymatic activity (b). ZnCl2 causes a dose dependent decrease in the GSH-toGSSG ratio that is correlated with a decrease in GR activity.
Confirming the ZnCl2 mediated inhibition of GR, purified bovine GR was inhibited in vitro when exposed to ZnCl2 (0–100 lM, c). Graph represents average enzymatic activity versus control reaction over 5 min. Error bars ±SD (n = 4). * P \ 0.05 versus control; ! P \ 0.05 versus previous dose
mitochondrial roGFP from Zn2?-induced oxidation (Fig. 3d). GSH is known to be important in preventing oxidation and subsequent inhibition of the adenine nucleotide translocator (ANT) protein in neuronal cells (Vesce et al. 2005). Thus, we next we determined if the shift of the mitochondria to a more oxidized environment had an effect on ANT function. We utilized two assays to measure of ANT function: Initially we examined the ability of mitochondrial isolates to oxidatively phosphorylate ADP into ATP. We found that mitochondria isolated from Zn2?treated PAECs have a significantly diminished capacity to generate ATP relative to controls (Fig. 4a). However, preloading with exogenous GSH (in the form of cell-permeant GSH-ethyl ester [GSH-EE]) restored ANT activity (Fig. 4a). To corroborate this finding, we incubated mitochondrial isolates in the presence of [3H]-ADP, and determined the rate of adenine translocation into mitochondria. We found that Zn2?-exposed mitochondria showed significant, dose-dependent reductions in ADP translocation rate. Furthermore, GSH-EE pre-incubation significantly
protected ANT function from Zn2?-mediated effects (Fig. 4b). To determine if glutathione could ultimately protect PAECs from apoptotic events induced by increased free Zn2?, we examined translocation of pro-apoptotic bax proteins to mitochondria. We found pre-incubation of PAECs with GSH-EE maintained the morphology of PAECs exposed to Zn2? (Fig. 5a). We also observed significant reductions in Zn2?-mediated bax translocation to mitochondria (Fig. 5b). Furthermore, when we examined caspase activation, which we previously found to be elevated in PAECs following acute Zn2? exposure, GSH-EEpreloaded cells showed significant resistance to Zn2? (Fig. 5c). Similarly, GSH-EE preloaded cells had significantly fewer TUNEL positive nuclei versus Zn2?-exposed cells alone (Fig. 5d).
123
Discussion There is an increasing understanding regarding the role of intracellular free zinc (Zn2?) in mediating cell
Biometals (2010) 23:19–30
25
Fig. 3 Exogenous zinc induces a rapid oxidation of the mitochondrial environment. PAECs were transfected with DNA expression constructs of redox sensitive GFP targeted either to the cytosolic (‘‘cRho’’) or mitochondrial (‘‘mRho’’) compartments. a High-resolution fluorescent microscopic images of cells counterstained with MitoTrackerTM Red mitochondrial-specific fluorescent marker demonstrate the non-specific and mitochondrial-specific expression of GFP in cRho or mRho-transfected cells, respectively (bar = 15 lm). b Real-time fluorescent analysis of mRho within ECs incubated at 37"C, 5% CO2 in DMEM ± 0–1 m ZnCl2. c Although both
compartments exhibit a shift to a more oxidized environment on exposure to ZnCl2, the mitochondria appears to be more susceptible, as mRho oxidation occurs more rapidly than cRho. d mRho oxidation is protected from Zn2?-induced oxidation through pre-incubation with glutathione ethyl ester (1 mM, 2 h). Graphs represent mean intracellular ratio of reduced versus oxidized Rho-GFP (three independent replicates) relative to intensity of fully reduced samples (100%, 1 mM DTT, 1 h) and fully oxidized cells (0%, 1 mM t-BH, 1 h) at the onset of the experiment. Error bars represent ±SD. * P \ 0.05 versus control; ! P \ 0.05 versus RhoGFP ? ZnCl2
protection versus cell death. Zn2? is the second-most abundant transition metal in biological systems, and although it is thought to be redox inert, it is kept under extraordinarily tight control. With multiple functional roles within cells (Nyborg and Peersen 2004), free Zn2?, like other transition metals such as calcium, demonstrates different effects depending on its concentration. Thus, free Zn2? could represent a form of biological ‘‘rheostat’’ whereby relatively low release events serve a signaling and/or protective role, while a more profound release within the cell triggers cell death responses. We have previously demonstrated that Zn2?, when elevated to high
enough levels, induces apoptosis in endothelial cells (Wiseman et al. 2006, 2007). In this study, we identify new key events by which elevations in free Zn2? contribute to induction of mitochondrial dysfunction and the apoptotic process. Specifically, we show that elevated Zn2? concentrations disrupt glutathione homeostasis though inhibition of glutathione reductase enzymatic activity. Interestingly, with decreased endogenous reduced glutathione, we observe an associated loss of mitochondrial import of ADP, measured not only by the ability of mitochondria to synthesize ATP in physiological conditions, but also by direct measurement of [3H]-ADP uptake.
123
26
Biometals (2010) 23:19–30 Fig. 5 Elevation of reduced intracellular glutathione protects c ECs from Zn2?-induced induction of apoptosis. The analysis of cell morphology using brightfield microscopy shows extensive cell rounding and reduced plate adherence 18 h after an acute exposure to exogenous Zn2? (ZnCl2, 0–1 mM), whereas cells pre-incubated in 1 mM glutathione ethyl ester (GSH) generally retain a morphology similar to that of untreated cells (a). PAECs were exposed to increasing concentrations of ZnCl2 (0–1 mM, 4 h) in the presence and absence of a GSH-EE (1 mM). After an additional 12 h the cells were analyzed for mitochondrial bax translocation (b), caspase activation (c), and the presence of apoptotic nuclei (d). The increases in mitochondrial bax translocation, caspase activation, and apoptotic nuclei induced by Zn2? are reduced in the presence of GSH-EE. Graphs represent mean ± SD (n [ 3). * P \ 0.05 versus control; ! P \ 0.05 versus next lesser dose; " P \ 0.05 versus control DMEM pre-incubation
Fig. 4 Zinc-mediated oxidation of the mitochondrial environment leads to the inhibition of adenine nucleotide translocator activity and this is prevented by reduced GSH. PAECs were exposed to increasing concentrations of ZnCl2 (0–1 mM, 2 h) in the presence and absence of a cell permeable GSH analogue (glutathione ethyl ester [GSH-EE], 1 mM), then ANT activity determined using either an ATP synthetic activity assay (a) or [3H]-ADP mitochondrial uptake (b). Both ATP generation and [3H]-ADP uptake is inhibited by ZnCl2 and this is prevented by preincubation with GSH-EE. The ‘‘buffer’’ sample represents mitochondrial fraction in reaction buffer in the absence of ADP. Graphs represent mean ± SD (n = 4). * P \ 0.05 versus control; ! P \ 0.05 versus previous dose; " P \ 0.05 versus Zn2? in the absence of GSH-EE
Importantly, this entire process was reversed by supplementation with glutathione ethyl ester, and allowed endothelial cells to withstand extremely high Zn2? concentrations. Here our data not only corroborate the findings of others, which show Zn2?mediated disruption of glutathione homeostasis, but also extend understanding of this process to include a novel specific outcome of glutathione disruption: inhibition of ADP transport into mitochondria. This new finding explains how Zn2?, or any other stimulus
123
which deprives mitochondria the ability to import metabolites like ADP properly, could trigger a negative cycle of mitochondrial dysfunction with subsequent generation of superoxide, increased oxidative stress, and ultimately apoptosis. This mechanism also provides an explanation for why mitochondrial uncoupling proteins such as UCP-2 can provide protective effects during periods of cell stress, and oxidative stress in particular (Echtay et al. 2002). Furthermore, this role of Zn2? levels contributing to glutathione deprivation and oxidative stress appears to be evolutionarily conserved in both animals and plants (Lange et al. 2002; Bittsanszky et al. 2005), indicating that although we utilized a pulmonary cell model system, this mechanism has broad applicability. Adenine nucleotide translocase (ANT) is the major mitochondrial carrier facilitating ADP and ATP transport across the inner mitochondrial membrane (Shertzer and Racker 1976). In mammals, there are multiple isoforms of ANT, including four known in humans, and these isoforms appear to be differentially expressed across tissues. In addition to functioning as a nucleotide transporter, ANT complexes are involved in regulation of apoptosis (Lunardi and Attardi 1991). Specific interaction of ANT protein with both pro- and anti-apoptotic proteins have been reported and demonstrate a highly complex, nuanced mechanism of cell death regulation (Belzacq et al. 2003). Notably, sulfhydryl moieties within the ANT peptide appear to be required for proper ANT activity (Li et al. 2006), and thus represent a significant vulnerability in the face of loss of oxidative protection from glutathione. Previous studies report that
Biometals (2010) 23:19–30
ANT proteins can be oxidatively modified even under relatively mild conditions (Giron-Calle et al. 1994). Therefore, given our data demonstrating that the
27
mitochondrial are rapidly altered to a more oxidized environment during exposure to free Zn2?, we speculate that Zn2?-mediated inhibition of glutathione
123
28
homeostasis allows inappropriate oxidation of ANT, with subsequent reduction of adenine nucleotide transport. Although our data indicate that elevated Zn2? can have a pathologic effect on PAEC it must be emphasized that these findings should not be misconstrued as suggesting that dietary supplementation of zinc is necessarily harmful. Oral zinc intoxication events are rare in humans, and are normally only observed following ingestion of zinc-containing items such as coins (Bennett et al. 1997). This is likely due to the fact that the diet is the single biological source of zinc and metals, and a highly regulated uptake and dietary excretion mechanisms in place which mitigates all but extreme levels of uptake. As intracellular Zn2? has both catalytic roles and structural roles in proteins, despite being considered ‘‘redox inert,’’ Zn2? can bind to cysteine residues to create protein folds important in protecting molecules from oxidation. From both our previous data showing Zn2?-mediated increases in mitochondrial-derived superoxide, as well as data presented here with redox-sensitive GFP, Zn2? appears to be both directly and specifically involved in regulation of cellular redox homeostasis. Several reports have concluded that zinc serves as a cytoprotective agent, defending cells against both oxidative insult and against stimuli that induce apoptosis (Zalewski et al. 1991; Bao and Knoell 2006). Indeed, a recent study found that lowlevel zinc release enhances glutathione synthesis through an Nrf2-mediated transcriptional mechanism (Cortese et al. 2008), seemingly in contradiction to our current findings. However, this same report shows that above a given threshold, similar to our own findings, cell viability drops precipitously. Thus, our data here actually corroborate and extend what was reported. Together these findings suggest that cellular Zn2? release is important cell fate determinant in the face of stress. Furthermore, these data reinforce that Zn2? level must remain within a specific physiological window, and both sub- and super-optimal intracellular Zn2? can result in similar apoptotic consequences. The complexity and difficulty of elucidating Zn2?-specific roles in this mechanism are further illustrated in reports where Zn2? is concluded to serve as a caspase and/or procaspase enzymatic inhibitor (Truong-Tran et al. 2001; Peterson et al. 2009). There are multiple possibilities for this apparent ‘‘zinc paradox,’’ where Zn2? serves simultaneously as both a pro- and/or anti-
123
Biometals (2010) 23:19–30
antiapoptotic regulator. We speculate that this paradox is the result of differences in cellular availability of zinc homeostatic mechanisms (i.e., zinc transporters, metallothionein, etc.), antioxidant systems, and ultimately different proteomic milieus across cells, even similar cells in different metabolic circumstances. The presence—even transient presence—of a particularly zinc-sensitive protein within a cell could potentially have significant impact on how zinc manifests pathological or beneficial effect. Clearly, further examination and clarification of the fundamental biochemical interaction of Zn2? and proteins in the context of cellular physiology is merited. Also notable is the significance of glutathione homeostasis during Zn2?-mediated oxidative stress, despite the fact that several intracellular antioxidant systems are known. These include the thioredoxin (Watson et al. 2004) and peroxyredoxin (Novoselov et al. 2000) antioxidant systems, along with canonical systems of superoxide dismutase and catalase (Machlin and Bendich 1987). As we find that addition of exogenous GSH protects cells from an apoptotic induction, this suggests the glutathione system is more important than these other systems. We further speculate that if glutathione levels could be enhanced, this might provide a comprehensive mechanism to protect cells from the induction of apoptosis. It would also be interesting to determine if enhancing GSH levels can protect cells from necrotic cell death. However, further studies will be required to evaluate GSH as a therapeutic agent. It should be noted that the doses of exogenous Zn2? used here and in our previously published studies appear to be high, and the highest doses administered are likely unattainable in normal physiological situations. This is due to the difficulty of raising intracellular Zn2? without need of chemical agents, notably zinc pyrithione (bis(2pyridylthio)zinc 1,10 -dioxide), thus allowing Zn2? doses that are more ‘‘physiological’’ (Tang et al. 2001). However, while use of these compounds is possible, they are extremely toxic to cells and introduce the possibility of confounding pharmacological effects which may be mistakenly attributed to Zn2?. Furthermore, using ZnCl2 in our ‘‘direct’’ fashion is both direct and effective, given that chloride ions are already present in multiple millimolar concentrations, so addition of up to one additional millimole of chloride is relatively innocuous, especially when compared to potential effects
Biometals (2010) 23:19–30
of anions of other zinc compounds, such as sulfate, although relatively abundant, are orders of magnitude more rare than chloride (Markovich 2001). So as long as pH and osmotic pressures are accounted for, this system provides a simple, repeatable method of modulating intracellular Zn2?. It should also be noted that our ability to protect cells even in the face of super-physiological levels of exposure further reinforces the validity of this protective mechanism. The ramifications of this robust protection may have particular significance in instances of acute respiratory distress syndrome (ARDS) where patients are exposed to toxic levels of metal fumes (Frutos-Vivar et al. 2004) or exposure to aerosolized zinc nanoparticles in smoke (Wilson et al. 2007). Indeed, we speculate that virtually any non-enteric delivery of bioavailable zinc particles/ions may pose a potential hazard, as illustrated by recent events involving nasal neuroreceptor toxicity arising from popular over-thecounter nasally-delivered cold remedies containing significant concentrations of bioavailable zinc, and that caution is merited. In conclusion, this study illustrates potentially new avenues for understanding the specific role of intracellular Zn2? as a key mediator of the cell-fate decision, and the specific mechanism by which Zn2? can function in a pro-apoptotic role. We speculate that developing novel methods of intervention based on reducing free Zn2? levels could be considered in cases of acute cellular oxidative or nitrosative stress. Acknowledgments This research was supported by a Ruth L. Kirschstein National Research Service Award Individual Fellowship, F32HL090198 (to D. A. Wiseman); National Institute of Health Grants HL-60190, HL-67841, HL-72123, HL084739, R21HD057406, and HL-70061, a Transatlantic Network Development Grant from Fondation LeDucq (all to S. M. Black), and an AHA Southeast affiliates Beginning Grant In Aid Award (09BGIA2310050, to S. Sharma).
References Atwood JL, Steed JW (2004) Encyclopedia of supramolecular chemistry. M. Dekker, New York Bao S, Knoell DL (2006) Zinc modulates airway epithelium susceptibility to death receptor-mediated apoptosis. Am J Physiol Lung Cell Mol Physiol 290:L433–L441 Bauer G (2000) Reactive oxygen and nitrogen species: efficient, selective, and interactive signals during intercellular induction of apoptosis. Anticancer Res 20:4115–4139 Belzacq AS, Vieira HL, Verrier F, Vandecasteele G, Cohen I, Prevost MC, Larquet E, Pariselli F, Petit PX, Kahn A,
29 Rizzuto R, Brenner C, Kroemer G (2003) Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res 63:541–546 Bennett DR, Baird CJ, Chan KM, Crookes PF, Bremner CG, Gottlieb MM, Naritoku WY (1997) Zinc toxicity following massive coin ingestion. Am J Forensic Med Pathol 18:148–153 Bernal PJ, Leelavanichkul K, Bauer E, Cao R, Wilson A, Wasserloos KJ, Watkins SC, Pitt BR, St Croix CM (2008) Nitric oxide-mediated zinc release contributes to hypoxic regulation of pulmonary vascular tone. Circ Res 102: 1575–1583 Bittsanszky A, Komives T, Gullner G, Gyulai G, Kiss J, Heszky L, Radimszky L, Rennenberg H (2005) Ability of transgenic poplars with elevated glutathione content to tolerate zinc(2?) stress. Environ Int 31:251–254 Brennan LA, Wedgwood S, Bekker JM, Black SM (2003) Nitric oxide activates p21ras and leads to the inhibition of endothelial NO synthase by protein nitration. DNA Cell Biol 22:317–328 Chan SHP, Barhour KL (1979) Membrane bioenergetics: based on the international workshop held at Cranbrook Schools, Bloomfield Hills, Michigan, July 5–7, 1979 in honor of Efraim Racker. Addison-Wesley, Reading Cortese MM, Suschek CV, Wetzel W, Kroncke KD, KolbBachofen V (2008) Zinc protects endothelial cells from hydrogen peroxide via Nrf2-dependent stimulation of glutathione biosynthesis. Free Radic Biol Med 44:2002– 2012 Echtay KS, Murphy MP, Smith RA, Talbot DA, Brand MD (2002) Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 277:47129–47135 Farrow KN, Groh BS, Schumacker PT, Lakshminrusimha S, Czech L, Gugino SF, Russell JA, Steinhorn RH (2008) Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res 102:226–233 Fink B, Dikalov S (2002) Detection of superoxide with new cyclic hydroxylamine CMH in plasma, cells, isolated heart. Free Radic Biol Med 33:S366 Forman HJ, Torres M (2001) Redox signaling in macrophages. Mol Asp Med 22:189–216 Frutos-Vivar F, Nin N, Esteban A (2004) Epidemiology of acute lung injury and acute respiratory distress syndrome. Curr Opin Crit Care 10:1–6 Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, FernandezCheca JC (1995) Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 48:825–834 Giron-Calle J, Zwizinski CW, Schmid HH (1994) Peroxidative damage to cardiac mitochondria. II. Immunological analysis of modified adenine nucleotide translocase. Arch Biochem Biophys 315:1–7 Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, Tsien RY, Remington SJ (2004) Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem 279:13044–13053
123
30 Koh JY, Choi DW (1994) Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors. Neuroscience 60:1049–1057 Lange A, Ausseil O, Segner H (2002) Alterations of tissue glutathione levels and metallothionein mRNA in rainbow trout during single and combined exposure to cadmium and zinc. Comp Biochem Physiol C Toxicol Pharmacol 131:231–243 Li Q, Sato EF, Kira Y, Nishikawa M, Utsumi K, Inoue M (2006) A possible cooperation of SOD1 and cytochrome c in mitochondria-dependent apoptosis. Free Radic Biol Med 40:173–181 Lunardi J, Attardi G (1991) Differential regulation of expression of the multiple ADP/ATP translocase genes in human cells. J Biol Chem 266:16534–16540 Machlin LJ, Bendich A (1987) Free radical tissue damage: protective role of antioxidant nutrients. Faseb J 1:441–445 Maret W (2003) Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr 133:1460S–1462S Markovich D (2001) Physiological roles and regulation of mammalian sulfate transporters. Physiol Rev 81:1499– 1533 Novoselov VI, Amelina SE, Kravchenko IN, Novoselov SV, Yanin VA, Sadovnikov VB, Fesenko EE (2000) The role of peroxyredoxin in the antioxidant system of respiratory organs. Dokl Biophys 373–375:64–66 Nyborg JK, Peersen OB (2004) That zincing feeling: the effects of EDTA on the behaviour of zinc-binding transcriptional regulators. Biochem J 381:e3–e4 Peterson QP, Goode DR, West DC, Ramsey KN, Lee JJ, Hergenrother PJ (2009) PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition. J Mol Biol 388:144–158 Shertzer HG, Racker E (1976) Reconstitution and characterization of the adenine nucleotide transporter derived from bovine heart mitochondria. J Biol Chem 251:2446–2452 Simons TJ (1991) Intracellular free zinc and zinc buffering in human red blood cells. J Membr Biol 123:63–71 Tang ZL, Wasserloos K, St Croix CM, Pitt BR (2001) Role of zinc in pulmonary endothelial cell response to oxidative
123
Biometals (2010) 23:19–30 stress. Am J Physiol Lung Cell Mol Physiol 281:L243– L249 Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD (2001) The role of zinc in caspase activation and apoptotic cell death. Biometals 14:315–330 Vesce S, Jekabsons MB, Johnson-Cadwell LI, Nicholls DG (2005) Acute glutathione depletion restricts mitochondrial ATP export in cerebellar granule neurons. J Biol Chem 280:38720–38728 Watson WH, Yang X, Choi YE, Jones DP, Kehrer JP (2004) Thioredoxin and its role in toxicology. Toxicol Sci 78:3– 14 Wedgwood S, Black SM (2003) Molecular mechanisms of nitric oxide-induced growth arrest and apoptosis in fetal pulmonary arterial smooth muscle cells. Nitric Oxid 9:201–210 Wedgwood S, Mitchell CJ, Fineman JR, Black SM (2003) Developmental differences in the shear stress-induced expression of endothelial NO synthase: changing role of AP-1. Am J Physiol Lung Cell Mol Physiol 284:L650– L662 Wilson MR, Foucaud L, Barlow PG, Hutchison GR, Sales J, Simpson RJ, Stone V (2007) Nanoparticle interactions with zinc and iron: implications for toxicology and inflammation. Toxicol Appl Pharmacol 225:80–89 Wiseman DA, Wells SM, Wilham J, Hubbard M, Welker JE, Black SM (2006) Endothelial response to stress from exogenous Zn2? resembles that of NO-mediated nitrosative stress, and is protected by MT-1 overexpression. Am J Physiol Cell Physiol 291:C555–C568 Wiseman DA, Wells SM, Hubbard M, Welker JE, Black SM (2007) Alterations in zinc homeostasis underlie endothelial cell death induced by oxidative stress from acute exposure to hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 292:L165–L177 Zalewski PD, Forbes IJ, Giannakis C (1991) Physiological role for zinc in prevention of apoptosis (gene-directed death). Biochem Int 24:1093–1101
Biometals (2010) 23:31–41 DOI 10.1007/s10534-009-9264-x
Zinc activates neutrophils’ oxidative burst Marisa Freitas Æ Grac¸a Porto Æ Jose´ L. F. C. Lima Æ Eduarda Fernandes
Received: 3 May 2009 / Accepted: 25 August 2009 / Published online: 17 September 2009 ! Springer Science+Business Media, LLC. 2009
Abstract Zinc has been shown to disturb the innate host defense response by interfering in the activation of neutrophils and subsequent oxidative burst, although the exact role of this metal, either as an activator or inhibitor, remains a matter of controversy among research groups. These apparent discrepancies may be due to experimental settings, through modification of zinc availability to neutrophils, or to inaccurate detections of reactive species. Thus, the main objective of the present study was to provide clarification on the role of zinc on the activation of human neutrophils and the subsequent oxidative burst. For that purpose, different detection methods and incubation media were used. The obtained results showed that phosphate buffers (PBS and HBSS) complex with zinc and interfere with the results obtained with this metal. By using Tris-G, it was clearly demonstrated that zinc, at low concentrations (5–12.5 lM), activates NADPH oxidase, mainly via protein kinase C, leading to the formation of superoxide radical (O2•-). Higher concentrations of zinc
results on a rapid dismutation of O2•- to oxygen and hydrogen peroxide, which in turn is used by myeloperoxidase to generate hypochlorous acid (HOCl). Keywords Human neutrophils ! Oxidative burst ! Zinc ! Protein kinase C ! NADPH oxidase Abbrevations PMN ROS RNS PKC ABAH PMA PBS HBSS Tris-G APF HRP Amplex Red DPI Go¨6983
Polymorphonuclear leukocytes Reactive oxygen species Reactive nitrogen species Protein kinase C 4-Aminobenzoyl hydrazide Phorbol myristate acetate Dulbecco’s phosphate buffer saline Hank’s balanced salt solution Tris buffer saline 6-(40 -Amino)phenoxy-3H-xanthen-3on-9-yl]benzoic acid Horseradish peroxidase 10-Acetyl-3,7-dihydroxyphenoxazine Diphenyleneiodonium chloride 3-[1-[3-(Dimethylamino)propyl]-5methoxy-1H-indol-3-yl]-4-(1H-indol3-yl)-1H-pyrrole-2,5-dione
M. Freitas ! J. L. F. C. Lima ! E. Fernandes (&) REQUIMTE, Departamento de Quı´mica-Fı´sica, Faculdade de Farma´cia, Universidade do Porto, Rua Anı´bal Cunha 164, 4099-030 Porto, Portugal e-mail:
[email protected]
Introduction
G. Porto Servic¸o de Hematologia Clı´nica, Hospital Geral de Santo Anto´nio, Porto, Portugal
Zinc is one of the most abundant transition metals in the earth’s crust. It is also a relevant trace element in
123
32
the human body, through its involvement in many biological pathways as a constituent of functional proteins, namely as a catalytic component of approximately 300 enzymes (Parkin 2004). The ensuing relevance for cell division and differentiation, as well as for programmed cell death, for gene transcription, for biomembrane functioning, and obviously for many enzymatic activities, has led zinc to be considered as a leading element in assuring correct functioning of various tissues, organs and organ systems in man and animals (Maret and Sandstead 2006; Parkin 2004; Rink and Gabriel 2001; Stefanidou et al. 2006). Most reports in the literature referring to zinc indicate this metal as being relatively non-toxic and that animals, including humans, exhibit considerable tolerance to high zinc intake (Fosmire 1990). Nevertheless, in spite of its safety, some reports suggest that zinc may disturb the innate host defense response, by interfering in the activation of neutrophils and subsequent oxidative burst (Benoni et al. 1998; Lindahl et al. 1998; Takeyama et al. 1995). Furthermore, is has also been argued that zinc inhibits superoxide radical (O2•-) production (DeCoursey et al. 2003; Henderson et al. 1988). We hypothesised that these apparent discrepancies may be related to possible zinc concentration-dependent effects on neutrophils’ NADPH activation pathways, or in the quantitative and/or qualitative ensuing formation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). A frequently overlooked bias in metal research is that even when similar concentrations of a metal are tested in vitro assays, its effective concentrations may be highly dependent on the metal-complexation potential of the incubation media (Frasco et al. 2005). Zinc research corresponds to a paradigmatic example, as it was previously shown that phosphate avidly complexes zinc (Zhang 1996). The aim of the present study was to provide clarification on the role of zinc chloride in the activation human neutrophils and the consequent oxidative burst. For that purpose, we used different methods for the identification of the ROS and RNS produced during the oxidative burst, and applied incubation media with different phosphate concentrations, in order to understand the apparent contradictory results reported in literature. Having confirmed the zinc stimulatory effect, the pathways leading to zinc-induced activation of NADPH
123
Biometals (2010) 23:31–41
oxidase were evaluated, underlining its involvement with protein kinase C (PKC) activation.
Materials and methods Reagents The following reagents were obtained from Sigma Chemical Co. (St. Louis, USA): Dulbecco’s phosphate buffer saline (PBS), Hank’s balanced salt solution (HBSS), luminol, cytochrome c from horse heart, potassium chloride, zinc chloride, N-nitro-Larginine methyl ester (L-NAME), diphenyleneiodonium chloride (DPI), 2-[6-(40 -amino)phenoxy-3H-xanthen3-on-9-yl]benzoic acid (APF), horseradish peroxidase (HRP), 10-acetyl-3,7-dihydroxyphenoxazine (Amplex Red), 3-[1-[3-(dimethylamino)-propyl]-5methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole2,5-dione (Go¨6983), and phorbol myristate acetate (PMA). Tris(hydroxymethyl)-aminomethane (Tris) and mannitol was obtained from Riedel de Hae¨n (Germany). 4-Aminobenzoyl hydrazide (ABAH) was purchased from Calbiochem (San Diego, CA, USA). The chemical composition of buffering media is presented in Table 1. Equipment All determinations were performed in a microplate reader (Synergy HT, BIO-TEK), using colorimetric, fluorimetric or chemiluminometric detection.
Table 1 Composition of incubation media used to test neutrophils (pH = 7.4) Composition (mM)
PBS
HBSS
Tris-G
CaCl2!2H2O MgCl2!6H2O
0.90 0.49
1.26 –
1.26 –
KCl
2.68
5.37
5.37
MgSO4
–
0.81
0.81
NaCl
140
140
140
KH2PO4
1.21
0.36
–
Na2HPO4
8.10
0.34
–
NaHCO3
–
4.17
–
D-Glucose
–
5.55
5.55
Tris
–
–
25
Biometals (2010) 23:31–41
Isolation of human neutrophils by the gradient density centrifugation method Venous blood was collected from healthy human volunteers by antecubital venipuncture, into vacuum tubes with EDTA. The isolation of human neutrophils from whole blood was performed by the gradient density centrifugation method, using Histopaque solutions 1077 and 1119 in polypropylene 12 mL centrifuge tubes, as reported by Freitas et al. (2008). Briefly, 3 mL of Histopaque 1077 was carefully layered on top of 3 mL of Histopaque 1119 in a 12 mL polypropylene tube. Subsequently, 6 mL of the collected blood was decanted on this discontinuous density gradient. The tube was centrifuged at 890g for 30 min at 20"C. Once the centrifugation was complete the neutrophils were carefully removed using a Pasteur pipette. The neutrophils pellet was removed and doubled in volume using PBS without Ca2? and Mg2? (this reduces the viscosity of the Histopaque-neutrophils suspension so that the cells can be centrifuged without the need for high g forces). The neutrophils suspension was then centrifuged at 870g for 5 min at 4"C. The supernatant was decanted and a mixture of 1.25 mL of PBS without Ca2? and Mg2? ? 5.25 mL of sterile distilled water was added to the neutrophils pellet to lyse any remaining red blood cells. The tube was gently inverted for 1.30 min, after which isotonicity was reestablished by adding 2.2 mL of 3% NaCl. This suspension was then submitted to a new centrifugation at 870g for 5 min at 4"C after which the supernatant was decanted and the neutrophils pellet resuspended in PBS with Ca2? and Mg2?. The time taken from venipuncture to the start of the different assays was about the same in all experiments (2 h). Isolated neutrophils were kept in ice until use. The neutrophils were used from one volunteer per experiment. Cell viability and cell yield were evaluated by the Trypan blue exclusion method, using a neubauer chamber and an optic microscope (409). Oxidative burst in human neutrophils Upon activation, neutrophils initiate an oxidative burst by consuming molecular oxygen, resulting in the formation of O2•- through the activity of the plasma membrane bound enzyme NADPH oxidase. O2•rapidly undergoes either spontaneous- or enzyme-
33
catalyzed dismutation (by microorganism-derived superoxide dismutase, SOD) to hydrogen peroxide and oxygen (2O2•- ? 2H? ? H2O2 ? O2; Babior 1999). Concomitantly, myeloperoxidase (MPO), a heme protein present in azurophil granules of neutrophils is released, upon cell activation, into the phagolysosome or into the extracellular space. This enzyme considerably contributes to the bactericidal capabilities of these cells via formation of HOCl from H2O2 and chloride ions (Hampton et al. 1998; Witko-Sarsat et al. 2000). H2O2 also contributes to the formation of hydroxyl radicals (HO!), especially in the presence of metal ions (usually iron), through the Fenton or Haber–Weiss reactions (Mladenka et al. 2006). In addition, H2O2 can react with HOCl, to yield another highly reactive ROS, singlet oxygen (1O2; Costa et al. 2008; Miyamoto et al. 2007). Likewise ROS, the production of RNS is also highly increased in the event of inflammatory processes, and contributes to the antimicrobial activity. Inducible nitric oxide synthase (iNOS) transforms ! L-arginine into nitric oxide ( NO) and L-citrulline. The ! rapid reaction of NO with O2•- leads to the formation of peroxynitrite anion (ONOO-; Denicola and Radi 2005). !NO or ONOO- could also react with H2O2 to generate 1O2 (Costa et al. 2008; Miyamoto et al. 2007). Some of the above mentioned reactive species were measured by using their ability to react with chemiluminometric, fluorimetric and colorimetric probes as described below. Luminol amplified chemiluminescence assay The chemiluminometric probe luminol has been thoroughly studied and used for monitoring reactive species production by neutrophils, namely O2•-, H2O2, HO!, HOCl, !NO, and ONOO- (Freitas et al. 2009a). The measurement of neutrophils’ oxidative burst was undertaken by chemiluminescence, by monitoring the oxidation of luminol by neutrophilgenerated reactive species, according to a previously described procedure (Freitas et al. 2008). Reaction mixtures contained neutrophils and the following reagents at the indicated final concentrations (in a final volume of 200 lL): luminol (50 lM when HBSS was used and 500 lM with the other buffers, as proposed by Freitas et al. (2009b), buffer used to test neutrophils (PBS, HBSS, Tris-G), zinc (0–1,000 lM) and
123
34
neutrophils (final suspension = 1 9 106 cells/mL). In a set of experiments, the effect of the NADPH oxidase inhibitor diphenyleneiodonium chloride (DPI; 10 or 20 lM, 5 min before zinc) was tested against the highest zinc concentration studied (1,000 lM). The reaction mixture was subjected to continuous soft shaking and incubated at 37"C during the course of the assays. Kinetic readings were initiated immediately after cell stimulation. Measurements were taken at the peak of the curve, which varied depending on the buffer saline used. Effects are expressed as chemiluminescence arbitrary units/min. Cytochrome c reduction assay The cytochrome c reduction assay consists in following, colorimetrically, the reduction of cytochrome c by O2•- (Freitas et al. 2009a). The measurement of neutrophils’ oxidative burst was undertaken by colorimetry, through monitoring the reduction of cytochrome c by O2•-, at 550 nm, according to a previously described procedure, with some modifications (Freitas et al. 2009b). Reaction mixtures contained neutrophils and the following reagents at the indicated final concentrations (in a final volume of 200 lL): cytochrome c (50 lM), buffer used to test neutrophils (PBS, HBSS, Tris-G), zinc (0–1,000 lM) and neutrophils (final suspension = 1 9 106 cells/mL). In a set of experiments, the effect DPI (10 or 20 lM, 5 min before zinc) was tested against the zinc concentration that stimulates neutrophils (5 lM). The reaction mixture was subjected to continuous soft shaking and incubated at 37"C during the course of the assays. Kinetic readings were initiated after a lag time of 5 min. Effects are expressed as absorbance arbitrary units/min.
Biometals (2010) 23:31–41
5 min before zinc, was tested against the zinc concentration that provided the best response. The excitation and emission wavelengths used were 530 and 590 nm, respectively. The reaction mixture was subjected to continuous soft shaking and incubated at 37"C during the course of the assays. Kinetic readings were initiated after a lag time of 5 min. Effects are expressed as fluorescence arbitrary units/min. APF (2-[6-(40 -amino)phenoxy-3H-xanthen-3-on9-yl]benzoic acid) assay 2-[6-(40 -amino)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (APF) is a non-fluorescent derivative of fluorescein, which is oxidized by highly reactive ROS and RNS like HO!, HOCl and ONOO- (Freitas et al. 2009a). To distinguish which specie(s) is(are) involved in the measured oxidative burst we used a MPO inhibitor (ABAH), a NOS inhibitor (L-NAME) and a specific scavenger of HO! (mannitol). Reaction mixtures contained neutrophils and the following reagents at the indicated final concentrations (in a final volume of 275 lL): neutrophils (final suspension = 3 9 106 cells/mL) resuspended in Tris-G incubated at 37"C with one of the inhibitors of the enzymes responsible for the generation of reactive species [ABAH (500 lM) or L-NAME (5 mM) or the scavenger of reactive species mannitol (30 mM)]. After 5 min, APF (2 lM) and zinc (1,000 lM) were added. The excitation and emission wavelengths used were 485 and 528 nm, respectively. The reaction mixture was subjected to continuous soft shaking and incubated at 37"C during the course of the assays. Kinetic readings were initiated after a lag time of 5 min. Effects are expressed as fluorescence arbitrary units/min.
Amplex Red assay Amplex Red is a highly sensitive and chemically stable fluorimetric probe for the extracellular detection of H2O2 (Freitas et al. 2009a). Reaction mixtures contained the following reagents at the indicated final concentrations (in a final volume of 200 lL): neutrophils (final suspension = 1 9 106 cells/mL) resuspended in Tris-G, zinc (0–1,000 lM), HRP (0.25 U/mL), Amplex Red (25 lM). In a set of experiments, the effect of catalase (which catalyzes the reaction 2H2O2 ? 2 H2O ? O2), (500 U/mL),
123
Influence of zinc on the activation of neutrophils by phorbol myristate acetate or formyl-methionylleucyl-phenylanine The influence of zinc on the activation of neutrophils by phorbol myristate acetate (PMA) or formylmethionyl-leucyl-phenylanine (fMLP) was evaluated at the same conditions as above, except that neutrophils (final suspension = 1 9 106 cells/mL or 2 9 106 cells/mL, in case of PMA or fMLP, respectively) were activated by PMA (16 nM) or fMLP (5 lM) at
Biometals (2010) 23:31–41
*
10000
5000
5
25
0
50 10 0 25 0 50 10 0 00 + 10 10 DP 00 I 00 +D (10 PI µM ) (2 0µ M )
A crucial observation of the present study was that the activation of human neutrophils’ oxidative burst by zinc varies according to the incubation media used to resuspend neutrophils and the methodology used to detect reactive species. When HBSS and PBS were used, no stimulation of neutrophils by zinc
***
12 .
Activation of human neutrophils’ oxidative burst by zinc
***
5
Results
15000
5
Statistics were calculated using GraphPad PrismTM (version 5.0; GraphPad Software). Results are expressed as mean ± standard error of the mean (SEM; from at least five individual experiments, performed in triplicate in each experiment). Statistical comparisons between groups were estimated using the one-way analysis of variance (ANOVA), followed by the Bonferroni’s post-hoc test. In all cases, P values lower than 0.05 were considered as statistically significant.
2.
Statistical analysis
an k
The purpose of this study was to evaluate the contribution of PKC to the zinc stimulatory effect, by using the PKC specific inhibitor 3-[1-[3-(dimethylamino) propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)1H-pyrrole-2,5-dione (Go¨6983). Neutrophils (final suspension = 1 9 106 cells/mL) were pre-incubated with two concentrations of Go¨6983 (250 and 500 nM), for 5 min, at 37"C, before stimulation by zinc. After incubation, the following reagents were added at the indicated final concentrations (in a final volume of 200 lL): luminol (500 lM) and zinc (1,000 lM). The reaction mixture was subjected to soft shaking and the temperature of incubation was maintained at 37"C during the course of the assays. Kinetic readings were initiated immediately after cell stimulation. Measurements were taken at the peak of the curve. Effects are expressed as chemiluminescence arbitrary units/min.
Bl
Evaluation of PKC contribution to the activation of human neutrophils by zinc
(0–1,000 lM) was detected by any of the methodologies tested (graphical data not shown). However, when Tris-G was used as incubation medium, a significant activation was observed with the different probes used. It was demonstrated that the concentrations of the metal that originate the oxidative burst signal are highly dependent on the technique used. The chemiluminescence technique revealed that neutrophils were activated at concentrations of zinc from 250 to 1,000 lM (Fig. 1). Under these experimental conditions, the NADPH oxidase inhibitor DPI (10 or 20 lM, 5 min before zinc) completely prevented the oxidative burst induced by zinc at the 1,000 lM concentration. The use of cytochrome c to measure neutrophils’ oxidative burst showed that the stimulation of neutrophils by zinc occurs at lower concentrations, 5 to 12.5 lM. Also in this study, DPI (10 lM) decreased the signal close to the blank assay. In turn, higher concentrations of zinc ([100 lM) reduced the oxidative burst mediated signal (Fig. 2). Figure 3 shows that 5–12.5 lM of zinc tendentially increases the amount of H2O2 produced by neutrophils. The signal provided by 5 lM of zinc was inhibited by catalase (500 U/mL) showing that Amplex Red is detecting H2O2. In contrast, higher zinc concentrations (from 500 to 1,000 lM) decrease the H2O2-mediated fluorescence signal. Figure 4
Arbitrary chemiluminescent units/min
37"C, just before the addition of zinc (0–1,000 lM). Luminol (500 lM) was used as probe.
35
[Zn2+] µM
Fig. 1 The effect of zinc on human neutrophils’ oxidative burst, measured by luminol and the effect of the NADPH oxidase inhibitor DPI (10 and 20 lM). * P \ 0.05, *** P \ 0.001 compared to blank assay. Values are given as mean ± SEM (n C 6)
123
Biometals (2010) 23:31–41
BA
H
10 00 (5 00 µM )
50 0
25 0
[Zn2+] µM 10
00
+A
[Zn2+] µM
10 00
50 0
25 0
10 0
50
25
5
12 .5
2. 5
Bl an k
0
0 50
*** ***
10 0
***
50000
25
**
*
100000
5
2
***
150000
12 .5
4
200000
2. 5
**
Bl an k
Absorbance arbitrary units/min
6
Fluorescence arbitrary units/min
36
Fig. 4 The effect of zinc on human neutrophils’oxidative burst, measured by APF and the inhibitory effect of ABAH (500 lM) in neutrophils activated by 1,000 lM of zinc. * P \ 0.05, *** P \ 0.001 compared to blank assay. Values are given as mean ± SEM (n C 6)
600000
Influence of zinc on the activation of human neutrophils by PMA or fMLP 400000
200000
00
U
/m
10
L)
00
0
0
0
50
25
10
50
.5
5
5
25
12
Bl
an
k
0
2.
Fluorescence arbitrary units/min
Fig. 2 The effect of zinc on human neutrophils’ oxidative burst, measured by cytochrome c and the effect of the NADPH oxidase inhibitor DPI (10 lM); *** P \ 0.001 and ** P \ 0.01 compared to blank assay. Values are given as mean ±SEM (n C 6)
2+
5+
ca
ta
la
se
(5
[Zn ] µM
Fig. 3 The effect of zinc on the production of H2O2 by human neutrophils, measured by Amplex Red and the inhibitory effect of catalase (500 U/mL). Values are given as mean ± SEM (n C 6)
reveals that zinc, from 500 to 1,000 lM, significantly increased the APF-mediated fluorescence signal. A MPO inhibitor- ABAH, a NOS inhibitor-L-NAME and a specific scavenger of HO.-mannitol were used to distinguish which species is involved on burst induced by zinc. ABAH (5 mM) and mannitol (30 mM) had no effect on neutrophils activated up to 1,000 lM of zinc (graphical data not shown). Only the inhibitor of MPO decreased the signal to values close to the blank assay (without zinc; Fig. 4).
123
Figure 5 shows the results obtained from the study of the effect of zinc on the activation of human neutrophils by PMA (16 nM) or fMLP (5 lM). This study was performed using Tris-G as incubation media and the technique used to measure the oxidative burst was luminol amplified chemiluminescence. Figure 5a shows that zinc had no effect on neutrophils stimulated by PMA. In contrast, Fig. 5b reveals that zinc tendentially augments the signal provided by the activator fMLP. As a representative example, neutrophils stimulated by fMLP originated 10,551 ± 2,076 arbitrary chemiluminescence units while fMLP ? 500 lM of zinc increased the signal to 22,108 ± 2,469 (mean ± SEM). Contribution of PKC to the activation of human neutrophils by zinc The results obtained from the study of the contribution of PKC to the activation of human neutrophils by zinc shows that the PKC specific inhibitor Go¨6983 inhibited the response of neutrophils to zinc in a concentration-dependent manner. At 500 nM, Go¨6983 provided a complete inhibition of zinc-induced luminol oxidation (Fig. 6).
6
A
2
0
5 3
62
98
3
o6
98
G
+G o6
*
12
5 nc (
n
zi
nc zi
20000
0
The results obtained in the present study clearly demonstrate that zinc activates human neutrophils’ oxidative burst in vitro. Previous studies provided contradictory results about the effect of zinc on NADPH oxidase activation and consequently on production of reactive species, with some authors indicating that zinc induces neutrophils’ oxidative burst (Benoni et al. 1998; Lindahl et al. 1998; Takeyama et al. 1995) while in turn, others argued that zinc inhibits O2•- production (DeCoursey et al. 2003; Henderson et al. 1988).
nM 25
0
12 5
98 3 o6 nc +G
zi
nc
+G
o6 98 3
nc (1 0 zi
Discussion
nM
)
fM
5000
µM
an Bl
LP fM
LP fM
Fig. 5 The effect of zinc on neutrophils’ oxidative burst, stimulated by PMA (16 nM) (a) or fLMP (5 lM) (b), measured by luminol and using Tris-G as incubation media. * P \ 0.05 compared to blank assay. Values are given as mean ± SEM (n C 6)
10000
00
+Z ( n 2+ 5 µ M LP (2 fM .5 ) + LP Zn 2 µM + +Z ) fM n 2+ (5 µ LP (1 M) 2 + fM Zn 2 .5 µ + M LP fM +Z (25 ) LP n 2+ µM ) + fM Zn 2 (50 + µM LP ( 1 fM +Zn 2 00 ) µM + LP ( + ) fM Z 25 LP n 2+ 0 µ M +Z (5 n 2+ 00 ) (1 µM 00 ) 0 µM )
0
***
nk
5000
B
Bl a
10000
Arbitrary chemiluminescent units/min
15000 15000
zi
*
zi
25000
nM
nM
an
B
Bl
30000
µM
k
Bl P an PM MA k A + Z (1 6 n PM n 2+ M ) (2 PM A+Z .5 µ M n 2+ A +Z (5 ) PM n 2+ µM (1 ) A 2. + 5 PM Zn 2+ µM ) (2 A PM +Zn 2 5 µ M + A ) (5 + PM Zn 2+ 0 µ M A (1 ) + 0 P M Z n 2+ 0 µ M (2 A ) PM +Zn 2 50 µ + M A ) +Z (50 n 2+ 0 µ M (1 ) 00 0 µM )
0
*** 4
c+
10000
***
.5
20000
A
)
30000
Absorbance arbitrary units/min
40000
37
k
Arbitrary chemiluminescent units/min
Arbitrary chemiluminescent units/min
Biometals (2010) 23:31–41
Fig. 6 The inhibitory effect of Go¨6983 on human neutrophils’oxidative burst: a Induced by zinc (1,000 lM) and using luminol as detection method; b Induced by zinc (5 lM) and using cytochrome c as detection method. *** P \ 0.001 compared to the blank assay. Values are given as mean ± SEM (n C 6)
It was shown that the ability of zinc to activate human neutrophils in vitro depends on the presence or absence of phosphate in the buffer used in the assay system. Indeed, when phosphate was used in the incubation media (PBS and HBSS), zinc was not
123
38
able to induce neutrophils’ oxidative burst at any of the concentrations tested (0–1,000 lM). The detection of zinc-induced oxidative burst was only possible when neutrophils were tested in Tris-G, since this incubation media is phosphate-free. When different concentrations of phosphates were added to Tris-G, the activation of neutrophils by zinc decreased in a phosphate-concentration dependent manner (graphical data not shown). Collier (1979) quantified free Zn2? concentration in different buffers. The absorbance change at 620 nm is linear with Zn2? concentration. Phosphate buffers had an Abs = 0.072 and Tris buffer an Abs = 0.585 revealing that despite of Tris-binding some of free Zn2?, phosphate buffers had a much stronger binding effect on zinc when compared with Tris, reducing its effective concentrations. This interference could be somehow foreseen, though it is often ignored by those studying the biological effects of metals. More recently, it was clearly demonstrated that phosphate buffers deeply interfere with the biological activity of several other metals in vitro (Frasco et al. 2005). Using Tris-G for testing neutrophils, zinc concentrations as low as 5 lM were shown to stimulate neutrophils’ oxidative burst. Human plasma free levels of free zinc have been reported to lie around 12–16 lM, for a total body content of zinc around 2– 4 g (Rink and Gabriel 2001). Though most of plasma free zinc will be complexed by plasma phosphates, it may reach sufficient concentrations to stimulate neutrophils in case of hypophosphatemia, which is characteristic of certain subgroups of patients, such as those who are hospitalized (2.2–3.1%) or admitted to intensive care units (28.85–33.9%), and those with sepsis (65–80%), chronic alcoholism (2.5–30.4%), major trauma (75%), and chronic obstructive pulmonary disease (21.5%; Brunelli and Goldfarb 2007). In addition, plasma levels of free zinc may increase significantly in specific groups of risk, as it happens with industrial workers from petroleum refineries and diesel distribution, smelters, and chemical plants (Dawson et al. 2000; Muzyka et al. 2002). The use of different detecting probes to measure zinc-activated oxidative burst also provided different results, which proved to be complementary and determinant for a better understanding of its mechanism of action. The results obtained in the luminol amplified chemiluminescence assay revealed that zinc stimulates neutrophils’ oxidative burst from 100 to
123
Biometals (2010) 23:31–41
1,000 lM (P \ 0.001). Importantly, the NADPH oxidase inhibitor DPI completely prevented the zinc-activated oxidative burst, indicating the essential role of this enzyme in the observed formation of reactive species. Since the studied reactive species are formed downstream of NADPH oxidase activation, and contribute to luminol chemiluminescence, these results, together with those obtained in the cytochrome c assay system, at lower concentrations, allows the conclusion that zinc activates human neutrophils’ oxidative burst in vitro. Zinc had no effect on neutrophils previously stimulated with PMA, which suggests common activating mechanisms. In contrast, when fMLP was used, zinc tendentially increases the signal, suggesting different activating mechanisms. By using cytochrome c, the colorimetric signal increased when neutrophils were challenged with zinc at 2.5–12.5 lM. In contrast, zinc, from 100 to 1,000 lM, decreased the colorimetric signal in the assay system. Interestingly, these results are negatively correlated to those obtained for luminol amplified chemiluminescence, but are in agreement with those obtained by Hasegawa et al. (2000) (Hasegawa et al. 2000), who studied the effects of zinc on lucigenin and luminol-dependent chemiluminescence of human neutrophils stimulated by PMA. These authors reported that zinc, at the concentrations window of 10–1,000 lM, lead to a decrease of the lucigenin-dependent chemiluminescence response, while that of luminol-dependent chemiluminescence increased. That divergent response between cytochrome c and luminol could be explained by with the wider capacity of luminol to detect the different reactive species formed, independently to the interconversion among them. The decrease of the cytochrome c-mediated colorimetric signal when zinc concentrations are increased, could reflect a zincdependent faster conversion of O2•- into the other related reactive species. This radical is quickly converted to H2O2 and O2, either spontaneously or by the enzyme SOD. Considering that, under the present experimental conditions, SOD is not present in the phagosome, this catalysis is probably not enzyme-related. The discrepancy of responses among luminol and cytochrome c emphasizes the importance of the use of different methodologies to detect oxidative burst, in order to avoid erroneous conclusions. Indeed, if only cytochrome c was used the results would indicate, like in other reports
Biometals (2010) 23:31–41
(DeCoursey et al. 2003), that zinc decreases O2•production in human neutrophils. The enzymatic complex NADPH oxidase is considered electrogenic because, when activated, transfers electrons from intracellular NADPH to molecular oxygen, producing O2•- in the extracellular or intraphagosomal space (Cross and Segal 2004). This charge movement must be compensated to prevent an extreme depolarization that would directly inactivate NADPH oxidase. It is generally assumed that a proton efflux compensates the charge movement induced by electron translocation (DeCoursey et al. 2003; Henderson et al. 1988). However, Ahluwalia et al. (Ahluwalia et al. 2004) have reported that the foremost ionic conductance in PMA-stimulated human neutrophils and eosinophils is a K? conductance through large-condutance Ca2? activated K? (BK) channels. Neverthless, Femling et al. (2006) and Essin et al. (2007) have recently found no evidence that BK channel inhibition affected O2•production by stimulated neutrophils or compromised their killing function. The assumption that the charge induced by electron translocation, through the NADPH oxidase, is largely compensated by proton fluxes is supported by the fact that both zinc and cadmium, known as proton blockers, were also referred to inhibit O2•- production (Cross and Segal 2004). However, the concentrations of zinc needed to inhibit O2•- production were higher than those required to block proton channels, raising the possibility that these metal directly inhibits NADPH oxidase or affect other processes (DeCoursey et al. 2003). The results obtained in the present study with luminol and the complete inhibition of oxidative burst by DPI (NADPH oxidase inhibitor) of neutrophils activated by 1,000 lM of zinc, allows the conclusion that zinc (up to 1,000 lM) does not inhibit NADPH oxidase. Results depicted in Figs. 1 and 2 clearly show that the concentrations of zinc that decrease the signal of cytochrome c originated an increased of the chemiluminescence signal, indicating that higher concentrations of zinc can accelerate the dismutation of O2•-. Ahluwalia et al. (2004) studied the interference of zinc in the xanthinexanthine oxidase system and revealed that 3 mM of zinc induced the dismutation of O2•- into H2O2 and O2. Once again, Femling et al. (2006) disagree with that hypothesis. The later authors assessed H2O2 production, and observed a progressive and profound
39
reduction of H2O2 production. At 1,000 lM, zinc inhibited H2O2 release by *90%. Thus, these authors concluded that the inhibition of H2O2 release by zinc was due to reduction of NADPH oxidase activity via inhibition of the proton current. We also performed a study to measure H2O2 in zinc-stimulated neutrophils. Our results corroborate those obtained by Femling et al. (2006) since higher concentrations of zinc, from 50 to 1,000 lM, decreased the signal. In contrast, the fluorescence signal tends to be higher with zinc concentrations from 2.5 to 25 lM. However, our conclusions differ from those of Femling et al. (2006), since it seems that higher concentrations of zinc promote the conversion of O2•- into other reactive species beyond H2O2. According to Irato and Albergoni (2005) a greater availability of zinc leads to decrease in the catalase activity. We speculate that this inhibition of catalase augmented H2O2 levels, which then may be rapidly transformed in other reactive species. As such, we performed a study with APF, a fluorescent probe that reacts with HO!, HOCl and ONOO-. To distinguish which species are involved on the measured oxidative burst, we used a MPO inhibitor- ABAH, a NOS inhibitor-L-NAME and a specific scavenger of HO!-mannitol. Only the inhibitor of MPO decreased the signal down to the blank assay (without added zinc), indicating that zinc promotes the dismutation of O2•- to O2 and H2O2, which in turn is used by MPO to generate HOCl. These results are in agreement with Hasegawa et al. (2000) who studied the effect of zinc on human neutrophils stimulated by PMA using luminol and an inhibitor of MPO. The authors observed that the MPO inhibitor prevented PMA-induced luminol amplified chemiluminescence response in a zinc concentrationdependent manner, suggesting that HOCl is involved in the process. Also, Takeyama et al. (1995) reported that the addition of zinc, at 1,000 lM, increased the intracellular MPO activity. Protein kinase C (PKC) can be considered a major mediator in the activation of the NADPH oxidase (Dekker et al. 2000). This enzyme constitutes the primary source of oxidizing agents used by neutrophils to kill invading microorganisms (Freitas et al. 2009a). Neutrophils express only five different PKC isotypes: a, bI, bII, d, and f, which are inhibited by Go¨6983 (Remijsen et al. 2006). PKC contain zinc finger structures that are important for its enzymatic activity (Beyersmann and Haase 2001). For that
123
40
reason, zinc could have regulatory effects on PKC activity. According to Csermely et al. (1988), zinc activates PKC in T-lymphocytes and causes a translocation to the plasma membrane, a central event in the activation of PKC. Zinc-induced NADPH oxidase activation has already been described (Benoni et al. 1998; Kauppinen et al. 2008; Noh and Koh 2000; Suh et al. 2008; Takeyama et al. 1995). Inclusively, Noh and Koh (2000) reported that zinc induces and activates NADPH oxidase in cortical neurons and astrocytes in a PKC-dependent manner. Our results are in agreement with those obtained by Noh and Koh (2000) since the PKC specific inhibitor Go¨6983 decreased the response of neutrophils to zinc in a concentration dependent manner. This finding indicates that zinc induces oxidative burst in neutrophils via activation of PKC, precluding a significant contribution of other cellular pathways for ROS generation mediated by this metal. In conclusion, in the present study we demonstrated that zinc activates human neutrophils’ oxidative burst in vitro, and that the use of phosphates to buffer the incubation media precludes this effect, probably due to the formation of phosphate–zinc complexes. Thus, the use of a phosphate-free incubation media is recommended for evaluating the influence of metals on neutrophils’ oxidative burst. In addition, the use of different methods to detect reactive species is essential to avoid erroneous conclusions, as demonstrated in the present study. It was clearly demonstrated that lower concentrations of zinc (5–12.5 lM) activate NADPH oxidase, mainly via PKC, leading to the formation of O2•-. Higher concentrations of zinc results on a rapid dismutation of O2•- to O2 and H2O2, which in turn is used by MPO to generate HOCl. Acknowledgments Marisa Freitas acknowledges Fundac¸a˜o para a Cieˆncia e Tecnologia (FCT) and Fundo Social Europeu (FSE) her PhD grant (SFRH/BD/28502/2006).
References Ahluwalia J, Tinker A, Clapp LH, Duchen MR, Abramov AY, Pope S, Nobles M, Segal AW (2004) The large-conductance Ca2?-activated K? channel is essential for innate immunity. Nature 427:853–858 Babior BM (1999) NADPH oxidase: an update. Blood 93:1464–1476
123
Biometals (2010) 23:31–41 Benoni G, Cuzzolin L, Marrella M, Crivellente F, Adami A, Bertaso C, Velo G, Milanino R (1998) Neutrophil behavior following exposure to in vivo or in vitro zinc in normal and acutely-inflamed rats: studies on lysozyme secretion, superoxide anion release and platelet adhesion. Inflammation 22:175–189 Beyersmann D, Haase H (2001) Functions of zinc in signalling, proliferation and differentiation of mammalian cells. Biometals 14:331–341 Brunelli SM, Goldfarb S (2007) Hypophosphatemia: clinical consequences and management. J Am Soc Nephrol 18: 1999–2003 Collier HB (1979) Binding of Zn2? by buffers. Clin Chem 25:495–496 Costa D, Gomes A, Lima JL, Fernandes E (2008) Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs. Redox Rep 13:153–160 Cross AR, Segal AW (2004) The NADPH oxidase of professional phagocytes–prototype of the NOX electron transport chain systems. Biochem Biophys Acta 1657:1–22 Csermely P, Szamel M, Resch K, Somogyi J (1988) Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes. J Biol Chem 263:6487–6490 Dawson EB, Evans DR, Harris WA, Powell LC (2000) Seminal plasma trace metal levels in industrial workers. Biol Trace Elem Res 74:97–105 DeCoursey TE, Morgan D, Cherny VV (2003) The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels. Nature 422:531–534 Dekker LV, Leitges M, Altschuler G, Mistry N, McDermott A, Roes J, Segal AW (2000) Protein kinase C-beta contributes to NADPH oxidase activation in neutrophils. Biochem J 347:285–289 Denicola A, Radi R (2005) Peroxynitrite and drug-dependent toxicity. Toxicology 208:273–288 Essin K, Salanova B, Kettritz R, Sausbier M, Luft FC, Kraus D, Bohn E, Autenrieth IB, Peschel A, Ruth P, Gollasch M (2007) Large-conductance calcium-activated potassium channel activity is absent in human and mouse neutrophils and is not required for innate immunity. Am J Physiol Cell Physiol 293:C45–C54 Femling JK, Cherny VV, Morgan D, Rada B, Davis AP, Czirjak G, Enyedi P, England SK, Moreland JG, Ligeti E, Nauseef WM, DeCoursey TE (2006) The antibacterial activity of human neutrophils and eosinophils requires proton channels but not BK channels. J Gen Physiol 127: 659–672 Fosmire GJ (1990) Zinc toxicity. Am J Clin Nutr 51:225–227 Frasco MF, Fournier D, Carvalho F, Guilhermino L (2005) Do metals inhibit acetylcholinesterase (AChE)? Implementation of assay conditions for the use of AChE activity as a biomarker of metal toxicity. Biomarkers 10:360–375 Freitas M, Porto G, Lima JL, Fernandes E (2008) Isolation and activation of human neutrophils in vitro. The importance of the anticoagulant used during blood collection. Clin Biochem 41:570–575 Freitas M, Lima JL, Fernandes E (2009a) Optical probes for detection and quantification of neutrophils’ oxidative burst. A review. Anal Chim Acta 649:8–23
Biometals (2010) 23:31–41 Freitas M, Porto G, Lima JL, Fernandes E (2009b) Optimization of experimental settings for the analysis of human neutrophils oxidative burst in vitro. Talanta 78:1476–1483 Hampton MB, Kettle AJ, Winterbourn CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92:3007–3017 Hasegawa H, Suzuki K, Nakaji S, Sugawara K (2000) Effects of zinc on the reactive oxygen species generating capacity of human neutrophils and on the serum opsonic activity in vitro. Luminescence 15:321–327 Henderson LM, Chappell JB, Jones OT (1988) Superoxide generation by the electrogenic NADPH oxidase of human neutrophils is limited by the movement of a compensating charge. Biochem J 255:285–290 Irato P, Albergoni V (2005) Interaction between copper and zinc in metal accumulation in rats with particular reference to the synthesis of induced-metallothionein. Chem Biol Interact 155:155–164 Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, Swanson RA (2008) Zinc triggers microglial activation. J Neurosci 28:5827–5835 Lindahl M, Leanderson P, Tagesson C (1998) Novel aspect on metal fume fever: zinc stimulates oxygen radical formation in human neutrophils. Hum Exp Toxicol 17:105–110 Maret W, Sandstead HH (2006) Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20:3–18 Miyamoto S, Ronsein GE, Prado FM, Uemi M, Correa TC, Toma IN, Bertolucci A, Oliveira MC, Motta FD, Medeiros MH, Mascio PD (2007) Biological hydroperoxides and singlet molecular oxygen generation. IUBMB Life 59:322–331 Mladenka P, Simunek T, Hubl M, Hrdina R (2006) The role of reactive oxygen and nitrogen species in cellular iron metabolism. Free Rad Res 40:263–272
41 Muzyka V, Bogovski S, Viitak A, Veidebaum T (2002) Alterations of heme metabolism in lymphocytes and metal content in blood plasma as markers of diesel fuels effects on human organism. Sci Total Environ 286: 73–81 Noh KM, Koh JY (2000) Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20:RC111 Parkin G (2004) Synthetic analogues relevant to the structure and function of zinc enzymes. Chem Rev 104:699–767 Remijsen QF, Fontayne A, Verdonck F, Clynen E, Schoofs L, Willems J (2006) The antimicrobial peptide parabutoporin competes with p47(phox) as a PKC-substrate and inhibits NADPH oxidase in human neutrophils. FEBS Lett 580:6206–6210 Rink L, Gabriel P (2001) Extracellular and immunological actions of zinc. Biometals 14:367–383 Stefanidou M, Maravelias C, Dona A, Spiliopoulou C (2006) Zinc: a multipurpose trace element. Arch Toxicol 80: 1–9 Suh SW, Hamby AM, Gum ET, Shin BS, Won SJ, Sheline CT, Chan PH, Swanson RA (2008) Sequential release of nitric oxide, zinc, and superoxide in hypoglycemic neuronal death. J Cereb Blood Flow Metab 28:1697–1706 Takeyama Y, Ogino K, Segawa H, Kobayashi H, Uda T, Houbara T (1995) Effects of zinc on production of active oxygen species by rat neutrophils. Pharmacol Toxicol 76:50–55 Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L (2000) Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 80:617–653 Zhang XG (1996) Corrosion and electrochemistry of zinc. Plenum Press, New York
123
Biometals (2010) 23:43–49 DOI 10.1007/s10534-009-9265-9
Advanced glycation end products and antioxidant status in nondiabetic and streptozotocin induced diabetic rats: effects of copper treatment S. Civelek Æ R. Gelis¸ gen Æ G. Andican Æ A. Seven Æ ¨ zdog˘an Æ G. Burc¸ak S. H. Ku¨c¸u¨k Æ M. O
Received: 29 January 2008 / Accepted: 28 August 2009 / Published online: 19 September 2009 ! Springer Science+Business Media, LLC. 2009
Abstract The effects of Cu(II) supplementation on glycemic parameters, advanced glycation end products (AGEs), antioxidant status (glutathione; GSH and total antioxidant capacity; TAOC) and lipid peroxidative damage (thiobarbituric acid-reactive substances, TBARS) were investigated in streptozotocin (STZ) induced diabetic rats. The study was carried out on Wistar albino rats grouped as control (n = 10), CuCl2 treated (n = 9), STZ (n = 10) and STZ,CuCl2 treated (n = 9). STZ was administered intraperitoneally at a single dose of 65 mg/kg and CuCl2, 4 mg copper/kg, subcutaneously, every 2 days for 60 days. At the end of this period, glucose(mg/dl), Cu(lg/dl), TBARS(lmol/l), TAOC(mmol/l) were measured in plasma, GSH(mg/gHb) in erythrocytes and glycated hemoglobin (GHb)(%) in blood. Plasma AGE-peptides(%) were measured by HPLC flow system with spectrofluorimetric and spectrophotometric detectors connected on-line. Data were analyzed by the nonparametric Kruskal–Wallis and Mann–Whitney U test. In the STZ group glucose, GHb and AGE-peptide levels were all significantly higher than the control
group (P \ 0.01, P \ 0.05, and P \ 0.01, respectively). CuCl2 treated group had significantly lower glucose but significantly higher GHb, TAOC and TBARS levels than the control group (P \ 0.05, P \ 0.001, P \ 0.05 and P \ 0.001, respectively). STZ,CuCl2 treated group had significantly higher GHb, TAOC and TBARS levels compared with the control group (P \ 0.001, P \ 0.05 and P \ 0.05, respectively); but only TAOC level was significantly higher than the STZ group (P \ 0.01). This experimental study provides evidence that copper intake increases total antioxidant capacity in both nondiabetic and diabetic states. However despite the potentiated antioxidant defence, lipid peroxidation and glycation enhancing effects of CuCl2 are evident under nondiabetic conditions. Keywords STZ ! Diabetes mellitus ! Advanced glycation end products ! Glycation ! Copper Introduction
S. Civelek ! R. Gelis¸ gen ! G. Andican ! ¨ zdog˘an ! G. Burc¸ak A. Seven ! S. H. Ku¨c¸u¨k ! M. O Department of Biochemistry, Cerrahpas¸ a Medical _ Faculty, Istanbul University, Istanbul, Turkey S. Civelek (&) Fevzipas¸ a Caddesi, Emirbuhari Sokak, No: 15 Daire: 6 Fatih, Istanbul, Turkey e-mail:
[email protected]
Increased oxidative stress promotes protein glycation (Selvaraj et al. 2002). As free Cu ions are highly redox active and thus might contribute to oxidative tissue damage, in vivo availability of catalytic Cu is usually restricted to a great extent (Cooper et al. 2005). However, glycation due to chronic hyperglycemia has been reported to damage the Cu-binding properties of
123
44
ceruloplasmin and albumin, the main Cu-binding proteins in plasma (Linder 1991; Islam et al. 1995; Argirova and Ortwerth 2003). On one hand, glycation lowers the capacity of these proteins to bind metal ions in strong complexes (Argirova and Ortwerth 2003). On the other hand, the redox active glycochelates are sites for reactive oxygen species (ROS) production (Eaton and Qian 2002). Thus, for restriction of glycoxidation related pathologies in diabetes mellitus, chelation of Cu-ions by clinically acceptable compounds is suggested (Cooper et al. 2005). However, it is also known that copper sulfate treatment started prior to streptozotocin (STZ) injection is beneficial in diabetic mice. It causes preservation of b-cell function (Sitasawad et al. 2001). As yet, it is not known whether Cu intake in the diabetic condition is beneficial or not. This study aims to investigate and compare the effects of Cu treatment on glycemic parameters, advanced glycation end products (AGEs), antioxidant status parameters namely glutathione (GSH) and total antioxidant capacity (TAOC) and lipid peroxidative damage marker, thiobarbituric acid-reactive substances (TBARS) in STZ induced diabetic rats with respect to nondiabetic controls.
Biometals (2010) 23:43–49
confirmed by the presence of hyperglycemia and glycosuria. Diabetic rats manifested polyphagia and glycosuria throughout the experimentation period. Three days after STZ injection, the rats, in groups CuCl2 treated and STZ,CuCl2 treated, started receiving copper subcutaneously at a dose of 4 mg/kg body weight, on every alternate day for 60 days. Copper solutions were prepared immediately before use. At the end of this period, the rats were weighed and killed by decapitation under ether anesthesia (50 mg/kg) after an 8 h fast. Heparinized blood samples were obtained by cardiac puncture. A small aliquot was refrigerated for GHb assay on the following day. After centrifugation at 2,5009g for 5 min, plasma glucose and erythrocyte GSH analyses were done immediately. The samples were stored at -80"C until analysis for TBARS, TAOC, AGE-peptides and Cu. Biochemical analysis Assay of glucose and GHb Glucose was determined using GOD-PAP (Randox) and GHb, by boronic affinity chromatography (Sigma) kits. Assay of AGE
Materials and methods Animal treatment and diabetes induction Male, young adult Wistar albino rats (2.5–3 months, n = 38 weighing 180–200 g) were used in this study. The rats cared for in accordance with the Guide for the Care and Use of Laboratory Animals (Committee on Care and Use of Laboratory Animals 1985) received standard chow diet (20–30 g/rat/day) and water ad libitum during the experimental period of 60 days. The following experimental groups were designed: Control group (control, n = 10); Cu treated group (CuCl2, n = 9); STZ administered group (STZ, n = 10) and STZ administered and Cu treated group (STZ,CuCl2, n = 9). Diabetes was induced by intraperitoneal injection of a single dose of streptozotocin (STZ) (65 mg/kg body weight) (Sigma-Aldrich) freshly dissolved in citrate buffer (pH = 4.5) after an overnight fast. Control rats were injected citrate buffer alone. Three days after STZ injection, development of diabetes was
123
Fluorescent AGE-peptides present in plasma were measured by spectrofluorimetry (kex: 247 nm, kem: 440 nm) and the related peptides by spectrophotometry at 280 nm, in a HPLC flow system with spectrofluorimetric and spectrophotometric detectors connected on-line (Wrobel et al. 1997; Forbes et al. 2004). Briefly, 20 ll plasma was added to 480 ll of 0.15 mmol/l trichloroacetic acid and 100 ll chloroform. Samples were shaken vigorously, centrifuged, and 20 ll of the aqueous layer was then injected into the flow system, consisting a Hewlett Packard high pressure pump (Series 1050 high-performance liquid chromatograph), with integrated sample injector (loop 20 ll) and multiple wavelength spectrophotometric detector (Series 1100) and spectrofluorimetric detector (HP 1046A). Chemstation (Series 1100) was used for data processing. Samples were run in triplicate. The assay was calibrated against AGE-peptide obtained from enzymatic hydrolysis of AGE-BSA (10 g/l). Albumin was incubated for 60 days with glucose to prepare AGE-albumin. Albumin was also
Biometals (2010) 23:43–49
incubated in glucose-free medium under similar conditions. AGE-albumin and albumin were hydrolysed by proteinase K to prepare AGE-peptides and peptide calibrators, respectively. The AGE content of the AGE-peptide calibrator was accepted as 100% and by dilution with the peptide calibrator, different concentrations of the calibrator was prepared. Assay of copper Cu in plasma was determined by flameless atomic absorption spectrophotometry (atomic absorption spectrophotometer, model AA-6800; Shimadzu). The standard, diluted plasma sample is delivered onto a pyroltically coated carbon tube. A temperature program was initiated, and the instrument in turn dries, ashes, and then atomizes the sample. The vaporized neutral atoms absorb light from a copper hollow cathode lamp set at 324.7 nm. The absorbance was directly related to the concentration of copper, expressed in micrograms per deciliter in sample Alcock (1987) and Shimatzu Corp (1998). Assay of thiobarbituric acid-reactive substances (TBARS) Lipid peroxidation end product was determined as TBARS according to a modification of the method of Buege and Aust (1978). One volume of plasma was mixed thoroughly with two volumes of a stock solution of 15% w/v trichloroacetic acid, 0.375% w/v thiobarbituric acid, and 0.25 mol/l hydrochloric acid. The mixture was heated for 30 min in a boiling water bath. After cooling, the flocculent precipitate was removed by centrifugation at 1000 g for 10 min. The absorbance of the sample was determined at 535 nm and the TBARS concentration was calculated using the extinction coefficient, 1.56 9 105 M-1 cm-1. Assay of glutathione (GSH) GSH was measured in erythrocyte lysate. Erythrocytes were separated and washed three times in 5 ml of sterile 9 g/l NaCl solution and hemolyzed by diluting four-fold with water. Erythrocyte GSH concentration was determined according to the method of Beutler et al. (1963) using metaphosphoric acid for protein precipitation and 5,50 dithiobis 2-nitrobenzoic acid for color development. GSH concentration was
45
calculated using 1.36 9 104 M-1 cm-1 as the molar absorption coefficient and was expressed as mg/g Hb. Assay of total antioxidant capacity (TAOC) TAOC was measured using a Randox 2332 kit, according to the method of Miller et al. (1993). ABTS (2,20 -azino-di-[3-ethylbenzthiazoline sulphonate]) is incubated with metmyoglobin and H2O2 to produce a radical cation with an absorbance at 734 nm. This absorbance is inversely proportional to the total antioxidant capacity of plasma.
Statistical analysis All results were expressed as a median (range). Data were analyzed by non-parametric Kruskal–Wallis and Mann–Whitney U test. Correlations were analyzed by Pearsons test. The limit of statistical significance was set at P \ 0.05.
Results Biochemical data of the study groups at the end of the experimental period of 60 days and the statistical evaluation are shown in Table 1. CuCl2 and STZ,CuCl2 treated groups displayed significantly higher median serum Cu levels (227 and 222 lg/dl, respectively) when compared with the control group (189.1 lg/dl) (P \ 0.01, P \ 0.01, respectively). Although no significant difference was noted in median Cu levels between STZ,CuCl2 treated (222 lg/dl) and STZ groups (212 lg/dl), a slight tendency to higher levels was apparent in the STZ,CuCl2 treated group. CuCl2 treated group had significantly lower plasma glucose but higher GHb, TAOC and TBARS levels than the control group (147 vs. 169.5 mg/dl, P \ 0.05; 4.95 vs. 3.07%, P \ 0.001; 1.06 vs. 0.76 mmol/l, P \ 0.05 and 9.23 vs. 6.85 lmol/l, P \ 0.001, respectively). STZ administered rats had significantly higher concentrations of both glucose and the early glycation product GHb than the control group (205 vs. 169.5 mg/dl, P \ 0.01; 4.65 vs. 3.07%, P \ 0.001, respectively). These findings reflected the establishment of diabetes mellitus in STZ administered rats. In
123
46
Biometals (2010) 23:43–49
diabetic rats circulatory AGE-peptides were at significantly higher concentration than nondiabetic rats (21.9 vs. 14.1%, P \ 0.01). STZ,CuCl2 group had significantly higher GHb, TAOC and TBARS levels compared with the control group (6.3 vs. 3.07%, P \ 0.001; 1.1 vs. 0.76 mmol/l, P \ 0.05 and 7.8 vs. 6.85 lmol/l, P \ 0.05, respectively). Only plasma TAOC level was found to be significantly higher in the STZ,CuCl2 treated group compared with the STZ group (1.1 vs. 0.87 mmol/l, P \ 0.01). Pearson correlation analysis results are shown in Table 2. In the CuCl2 treated group, glucose was found to be negatively correlated with both GHb and AGEs (r = -0.783, P \ 0.05; r = -0.722, P \ 0.05, respectively); TBARS was observed to be positively correlated with AGEs (r = 0.679, P \ 0.05). In the
STZ group; copper was positively correlated with glucose and negatively with GSH (r = 0.928, P \ 0.05; r = -0.956, P \ 0.05, respectively); TAOC was found to be negatively correlated with AGEs (r = -0.765, P \ 0.05) (Figs. 1, 2). In the STZ,CuCl2 treated group; positive correlations were observed between Cu and TAOC (r = 0.885, P \ 0.05) and between GHb and AGEs (r = 0.914, P \ 0.05) (Figs. 3, 4, respectively), and negative correlations of GSH and with both glucose and TBARS (r = -0.749, P \ 0.05; r = -0.863, P \ 0.05).
Discussion In this experimental study we investigated the effects of CuCl2 intake on glycemic parameters, circulatory
Table 1 Biochemical parameters in the experimental groups median (minimum–maximum) Control Cu (lg/dl) Glucose (mg/dl)
STZ
CuCl2
189.1 (169.3–211.8)
212 (161.9–262.8)
169.5 (147–190)
a
GHb (%) AGE (%)
3.07 (2.12–4.23) 14.1 (11.12–19.21)
TAOC (mmol/l)
0.76 (0.43–1.3)
205 ** (190–276)
147 * (131–186)
a
4.65 * (2.95–11.86) 21.9a** (15.17–24.8) 0.87 (0.58–1.13)
3.15 (2.5–4.41)
2.81 (1.32–3.87)
TBARS (lmol/l)
6.85 (5.67–8.28)
8.13 (5.6–10.8)
Versus control group
b
Versus STZ group
227a** (212.4–269.8) a
GSH (mg/gHb) a
STZ,CuCl2
a
4.95 *** (3.5–6.3) 17.7 (9.17–31.7) 1.06a* (0.79–1.34) 2.13 (1.26–4.44) 9.23a*** (7.5–13.1)
222a** (212.5–274) 195 (128–212) a
6.3 *** (4.7–8.6) 13 (9.64–38.01) 1.1a*,b** (0.99–1.52) 2.56 (1.37–5.75) 7.8a* (6.2–9.6)
* P \ 0.05; ** P \ 0.01; *** P \ 0.001 Table 2 Pearson correlation coefficients in CuCl2 and STZ,CuCl2 treated, STZ groups Groups
Glucose
TBARS
Cu
TAOC
GHb
r = -0.783* r = -0.722*
– r = 0.679*
– –
– –
– –
Cu
r = 0.928*
–
–
–
–
GSH
–
–
r = -0.956*
–
–
AGE
–
–
–
r = -0.765*
–
CuCl2 Ghb AGE STZ
STZ,CuCl2 TAOC
–
–
r = -0.885*
–
–
GSH
r = -0.749*
r = -0.863*
–
–
–
AGE
–
–
–
–
r = 0.914*
* Correlation is significant at the P \ 0.05 level
123
Biometals (2010) 23:43–49
47
AGE-peptides and oxidative stress related parameters in diabetic and nondiabetic states. Previously, the beneficial effect of supplementation with CuSO4 (20 lg/0.2 ml) intraperitoneally on every alternate day for 30 days) was reported in STZ-diabetic mice (Sitasawad et al. 2001). In this study, the rats were supplemented with CuSO4 before multiple-dose STZ treatment (IDDM) and the effects were evaluated at 10 weeks. CuSO4 supplementation prior to diabetes induction kept the levels of lipid peroxidation and blood glucose within the normal range (Sitasawad et al. 2001). However in another study high Cu intake (60 mg/kg of Cu, by gastric tube, twice a week, for 30 days) in diabetic condition has been reported to cause renal toxicity, high urinary glucose output and
reduction in blood glucose levels (Galhardi et al. 2004). In the presented study we started the CuCl2 treatment (4 mg Cu/kg body weight, subcutaneously on every alternate day for 60 days) on the third day of diabetes induction and continued it throughout the experimentation period of 60 days. CuCl2 treated groups displayed significantly higher serum Cu levels when compared with the control group and a slight tendency to higher levels was also apparent in the STZ,CuCl2 treated group when compared with the STZ group. In the STZ group on 60th of STZ injection, in accordance with hyperglycemia, GHb 280 270
280
Cu(µg/dL)
260
Cu(µg/dL)
260 240
250 240
220
230
200
220
180
210 1,0
1,1
1,2
1,3
1,4
1,5
1,6
TAOC(mmol/L)
160 180
200
220
240
260
280
Glucose(mg/dL) Fig. 1 Correlation between plasma copper and glucose in the ‘‘STZ’’ group (correlation coefficient r = 0.928; P = 0.023)
Fig. 3 Correlation between plasma copper and TAOC in the ‘‘STZ ? CuCl2’’ group (correlation coefficient r = 0.885; P = 0.046)
40
25 24
AGE(%)
30
AGE(%)
23 22
20
21 20 10
19
,5
,6
,7
,8
,9
1,0
1,1
1,2
TAOC(mmol/L) Fig. 2 Correlation between plasma TAOC and AGE in the ‘‘STZ’’ group (correlation coefficient r = -0.765; P = 0.045)
4
5
6
7
8
9
GHb(%) Fig. 4 Correlation between blood GHb and plasma AGE in the ‘‘STZ ? CuCl2’’ group (correlation coefficient r = 0.914; P = 0.030)
123
48
and circulatory AGEs were all at significantly higher concentrations compared with the control group. We noted a slight tendency to higher levels of both Cu and TBARS in the STZ group. Further, blood Cu was correlated positively with blood glucose and negatively with erythrocyte glutathione. The former correlation might be consistent with the increased release of Cu ions from the glycated form of Cucontaining enzymes in diabetic rats (Lin 1996) and the latter might reflect the increased GSH consumption by the increased free radical generation in the presence of Cu ions (Yoshida et al. 1995). In the STZ,CuCl2 treated group we observed that plasma glucose was negatively correlated with glutathione, which in turn was negatively correlated with TBARS. As stated above, high Cu intake in diabetic condition has been reported to reduce the blood glucose levels and this was explained by the increased urinary glucose output (Galhardi et al. 2004). The mechanism underlying renal toxicity was explained by oxidative stress and lipid peroxidation (Galhardi et al. 2004). We observed the highest GHb values and a positive correlation between GHb and AGEs in the STZ,CuCl2 treated group. These findings are all consistent with the fact that hyperglycemia increases oxidative stress, lipid peroxidation and protein glycation (Abou-Seif and Youssef 2004). As to the effects of CuCl2 treatment in the nondiabetic state, we observed substantially lower plasma glucose but higher GHb levels in the treated rats, than the untreated. Furthermore within this group we observed that glucose was negatively correlated with both GHb and AGEs. These findings suggest the presence of factors other than glucose contributing to glycation of hemoglobin and the relative importance of this non-glucose contribution in CuCl2 treated nondiabetic rats. We have noted a tendency to lower glucose but higher GHb values but in the STZ,CuCl2 treated group when compared with the STZ group. In a very recently published paper, it had been shown that lipid peroxidation can contribute to glycation of hemoglobin in nondiabetic renal failure patients. It is well established that Cu ions induce lipid peroxidation (Selvaraj et al. 2005). Accordingly we observed that TBARS values were significantly higher in the CuCl2 treated group than the control group. The highest TBARS and the lowest GSH values were recorded in this group. Additionally, TBARS was positively correlated with AGEs. Taken together, these findings
123
Biometals (2010) 23:43–49
are all indicative of adverse effects of CuCl2 in the nondiabetic state. Metal-catalyzed oxidation reactions and glycation are closely related and potentially accelerate each other (Argirova and Ortwerth 2003). On the other hand, we observed that total antioxidant capacity values was significantly higher in CuCl2 treated groups than the untreated. Importantly, among all the parameters measured in this study total antioxidant capacity was the only parameter, displaying significant difference between STZ,CuCl2 treated and STZ groups. The increase in total antioxidant capacity might be due to elevation in CuZnSOD activity. Trace elements such as Cu and Zn have been reported to be important in antioxidant defence (CuZn SOD) in diabetes mellitus (Eizirik et al. 1996; Sitasawad et al. 2001; Hussein et al. 2007). To conclude, this experimental study provides evidence that copper intake increases total antioxidant capacity in both nondiabetic and diabetic states. However despite the potentiated antioxidant defence, lipid peroxidation and glycation enhancing effects of CuCl2 are evident under nondiabetic conditions. Considering these effects, further studies addressing the effects of copper in diabetes are needed. Acknowledgment This work was supported by the Research Fund of Istanbul University, project no: 1180/070998.
References Abou-Seif MA, Youssef AA (2004) Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 346:161–170 Alcock NW (1987) Copper. In: Pesce AJ, Kaplan LA (eds) Methods in clinical chemistry. Mosby, St Louis, pp 527– 538 Argirova MD, Ortwerth BJ (2003) Activation of protein-bound copper ions during early glycation: study on two proteins. Arch Biochem Biophys 420:176–184 Beutler E, Durgn O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 51:882–888 Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302–310 Committee on Care and Use of Laboratory Animals (1985) Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources, National Research Council, Washington Cooper GJ, Chan YK, Dissanayake AM et al (2005) Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential
Biometals (2010) 23:43–49 elements in normal and diabetic individuals. Diabetes 54:1468–1476 Eaton JW, Qian M (2002) Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Mol Cell Biochem 234–235:135–142 Eizirik DL, Flodstro¨m M, Karlsen AE et al (1996) The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875–890 Forbes JM, Yee LT, Thallas V et al (2004) Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53:1813–1823 Galhardi CM, Diniz YS, Faine LA et al (2004) Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction. Food Chem Toxicol 42:2053–2060 Hussein OA, Gefen Y, Zidan JM et al (2007) LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. Clin Chim Acta 377:114–118 Islam KN, Takahashi M, Higashiyama S et al (1995) Fragmentation of ceruloplasmin following nonenzymatic glycation reaction. J Biochem 118:1054–1060 Lin J (1996) The association between copper ions and peroxidative reaction in diabetic cataract. Nippon Ganka Gakkai Zasshi 100:672–679 Linder MC (1991) Biochemistry of copper. Plenum, New York Miller NJ, Rice-Evans C, Davies MJ et al (1993) A novel method for measuring antioxidant capacity and its
49 application to monitoring the antioxidant status in premature neonates. Clin Sci 84:407–412 Selvaraj N, Bobby Z, Das AK et al (2002) An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients. Clin Chim Acta 324:45–50 Selvaraj N, Bobby Z, Koner BC et al (2005) Reassessing the increased glycation of hemoglobin in nondiabetic chronic renal failure patients: a hypothesis on the role of lipid peroxides. Clin Chim Acta 360:108–113 Shimatzu Corp. (1998) Atomic absorption spectrophotometry cookbook, Sect 1–4. Shimatzu Corp., Kyoto, p 10 Sitasawad S, Deshpande M, Katdare M et al (2001) Beneficial effect of supplementation with copper sulfate on STZdiabetic mice (IDDM). Diabetes Res Clin Pract 52:77–84 Wrobel K, Wrobel K, Garay-Sevilla ME et al (1997) Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin Chem 43:1563–1569 Yoshida K, Hirokawa J, Tagami S et al (1995) Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 38:201–210
123
Biometals (2010) 23:51–58 DOI 10.1007/s10534-009-9266-8
Zinc transporter expression profiles in the rat prostate following alterations in dietary zinc Yang Song Æ Valerie Elias Æ Carmen P. Wong Æ Angus G. Scrimgeour Æ Emily Ho
Received: 15 June 2009 / Accepted: 2 September 2009 / Published online: 17 September 2009 ! Springer Science+Business Media, LLC. 2009
Abstract Zinc plays important roles in numerous cellular activities and physiological functions. Intracellular zinc levels are strictly maintained by zinc homeostatic mechanisms. Zinc concentrations in the prostate are the highest of all soft tissues and could be important for prostate health. However, the mechanisms by which the prostate maintains high zinc levels are still unclear. In addition, the response of the prostate to alterations in dietary zinc is unknown. The current study explored cellular zinc levels and zinc transporter expression profiles in the lobes of the prostate during dietary marginal zinc depletion. Rats were given either zinc-adequate (ZA, 30 mg Zn/kg) or marginal zinc-deficient (MZD, 5 mg Zn/kg) diet for 9 weeks. In addition, a subgroup of the MZD rats was supplemented with phytase (1,500 unit/kg diet) to improve zinc bioavailability. We found that both zinc concentrations and ZnT2 expression in the prostate Y. Song ! V. Elias ! C. P. Wong ! E. Ho (&) Department of Nutrition and Exercise Sciences, Oregon State University, 103 Milam Hall, Corvallis, OR 97331, USA e-mail:
[email protected] A. G. Scrimgeour Military Nutrition Division, US Army Research Institute of Environmental Medicine, Kansas St., Natick, MA 01760, USA E. Ho Linus Pauling Institute, Oregon State University, Corvallis, OR 97331, USA
dorsolateral lobes were substantially higher than in the ventral lobes (P \ 0.05). Marginal zinc depletion significantly decreased ZnT2 expression in the dorsolateral lobes (P \ 0.05), and phytase supplementation had a trend to increase ZnT2 expression. In addition, of all measured zinc transporters, only ZnT2 mRNA abundance was significantly correlated to the zinc concentrations in the dorsolateral lobe. No correlations were found between zinc transporter expression and zinc concentrations in the ventral lobes. These results indicate that ZnT2 may play a significant role in the maintenance of zinc homeostasis in the prostate. Keywords Zinc transporter ! ZnT2 ! Prostate ! Marginal zinc deficiency Introduction Zinc is an essential trace mineral and is ubiquitously distributed in hundreds of proteins in mammalian cells. Since zinc is widely involved in the normal functions of many proteins, zinc is required for a variety of biological activities such as growth and development, immune response, wound healing, neurological function and reproduction. Intracellular zinc levels are strictly controlled by zinc homeostatic mechanisms that maintain stable zinc supply and appropriate zinc distribution in cells. The activities of zinc uptake, efflux and cellular compartmentalization rely on the functions of zinc transporters. Two zinc
123
52
transporter gene families have been identified in mammals: the solute-linked carrier 30A (SLC30A, ZnT) family and the SLC39A (Zip) family of metal ion transporters. The ZnT family of transporters functions in zinc efflux from the cytoplasm to either the extracellular space and/or intracellular organelles. The ZIP family of protein functions in zinc uptake from the extracellular matrix and/or intracellular organelles into the cytoplasm (Lichten and Cousins 2009). These zinc transporters are expressed in a tissue-specific manner, and respond differentially to dietary zinc levels and physiological conditions. Therefore, a loss of function or dysregulation of certain zinc transporters would result in an impairment of zinc homeostasis and predispose the body to zinc-imbalance-related diseases, such as cancer, asthma, diabetes, and Alzheimer’s disease (Devirgiliis et al. 2007). For example, mutations of Zip4 gene have been identified as the cause of human acrodermatitis enteropathica, an autosomal recessively inherited disease (Kury et al. 2002), and polymorphisms in ZnT8 have been associated with type 2 diabetes (Sladek et al. 2007). The maintenance of zinc homeostasis in the prostate may be even more critical than the other organs. The prostate contains the highest zinc concentration of any other soft tissues in the body. The prostate epithelial cells have a characteristic high aerobic glycolytic activity, low respiration (Muntzing et al. 1975; Nyden and Williams-Ashman 1953) and high citrate secretion. Zinc may be required for maintaining these properties by reducing the activity of mitochondrial aconitase and inhibiting the terminal oxidation through the electron transport chain (Costello et al. 1997, 2004). Moreover, as the prostate becomes malignant, prostate zinc concentration decreases by 75–90% (Costello and Franklin 2006). Therefore, it has been proposed that maintaining the high zinc content is essential for prostate health, and loss of ability to accumulate high zinc levels may contribute to the prostate malignancies (Costello et al. 1999; Franklin et al. 2005; Huang et al. 2006; Iguchi et al. 2004; Rishi et al. 2003). However, little is known regarding mechanisms by which the normal prostate maintains high levels of zinc. Therefore, the objectives of the current study were to examine the mechanisms by which the prostate modulates zinc concentrations and profile zinc transporter expression during dietary marginal zinc depletion.
123
Biometals (2010) 23:51–58
In addition, since the prostate lobes differ markedly in zinc concentration, function and embryological origin (Costello and Franklin 1998; Iguchi et al. 2002), we compared the zinc transporter expression between dorsolateral and ventral lobes. Finally, since phytase supplement may improve overall zinc status in rats (McClung et al. 2006; Rimbach and Pallauf 1993), we added phytase to the marginally zincdeficient diet to examine whether phytase supplementation to a low-zinc diet could increase zinc levels and upregulate zinc transporter expression in the prostate. The current study is one of the first to quantitatively evaluate the correlations between zinc transporter expressions and zinc concentration in the prostate with dietary zinc depletion. The results from this study provide insights into the mechanisms by which the prostate regulates cellular zinc levels and provide directions for future studies establishing connections between defects in zinc transporter regulation and the development of prostate diseases.
Materials and methods Animals Male Sprague-Dawley rats (n = 24, 4 weeks old, 125–150 g) from Charles River Laboratories, Inc. (Wilmington, MA), were housed individually in polycarbonate cages and acclimated for 2 weeks to the temperature- and humidity-controlled environment with a 12-h-dark: light cycle. Rats were fed a zinc-adequate (ZA, 30 mg Zn/kg) or marginal zincdeficient (MZD, 5–6 mg Zn/kg) diet for 9 weeks. To further examine the effects of phytase on zinc status and DNA integrity in the prostate, 1,500 phytase units/kg was added to the MZD diets and fed to the rats (MZD ? P). Diets were based on modified AIN93 M diets (Reeves 1997) formulated with egg white and with zinc provided as zinc carbonate (Research Diets Inc). All diet also contained 0.3% phytic acid (Naphytate, Sigma–Aldrich). Deionized water was provided as drinking water. Rats were killed following anesthesia with isoflurane overdose (1–5%; Henry Schein). 24-h dietary intakes and body weights were measured weekly. This study was approved by the Institutional Animal Care and Use Committee (IACUC) at USARIEM and Oregon State University,
Biometals (2010) 23:51–58
and animals were maintained in accordance with IACUC’s guidelines for the care and use of laboratory animals. Tissue and blood collection Blood samples were collected by cardiac puncture into trace element-free vials containing EDTA. Plasma was separated immediately and frozen at -80"C until analysis. For the dissection of rat prostates, the genitourinary complex including the prostate, bladder, seminal vesicles and coagulant glands were removed as a unit. Then the ventral and dorsolateral prostate lobes were detached from the urinary bladder. The urinary bladder and seminal vesicles with coagulation glands were removed. The two ventral lobes were separated from each other and removed from the dorsolateral section. Samples of rat prostate dorsolateral and ventral lobes were immediately either snap frozen at -80"C or stored in RNA stabilization solution (RNAlater, Ambion) until further analysis. Zinc analysis Plasma (n = 16), ventral lobe (n = 12) and dorsolateral lobe (n = 7) zinc concentrations were determined by Inductively Coupled Plasma-Optical Emission Spectroscopy (ICP-OES; Teledyne Leeman Labs) with small modification of a previous described method (Verbanac et al. 1997). Samples were digested in 69–70% OmniTrace nitric acid (VWR) overnight. Following digestion, samples were diluted 10 times with water treated with chelex 100 resin (Bio-Rad Laboratories) and analyzed by ICP-OES against known standards (Bruno et al. 2007). Quantitative real-time PCR analysis (qRT-PCR) The mRNA abundance of zinc transporters in rat prostates (ZnT1-4 and Zip1-4) were measured by qRT-PCR. RNA was extracted from prostates using an RNeasy Mini Kit according to the manufacturer’s instructions (Qiagen). First-strand cDNA was reverse transcribed from the isolated RNA using Superscript First-Strand Synthesis System according to the manufacturer’s instructions (Invitrogen Corporation). Primers and annealing temperatures of each transporter gene are listed in Table 1. Primers were
53
designed by online software Primer3 (v.0.4.0), and the specificity was verified by melting curve and DNA gel. Real time PCR reactions were performed using DyNAmo HS SYBR Green qPCR kit (New England Biolabs). Gene copies were determined using the standard curve which was generated from serial dilutions of purified plasmid DNA that encoded for the gene of interest. Data represent averaged copy number normalized to the 18s housekeeping gene. Western analysis of ZnT2 protein The frozen portions of prostate were placed in the standard immunopreciptation assay lysis buffer, homogenized, centrifuged (15,000 rpm, 5 min, 4"C), and the supernatant was collected for analysis. Protein concentrations were determined using DC Protein Assay (Bio-Rad Laboratories). Proteins (30 lg/lane) were separated by SDS–PAGE on a 4–12% bis–Tris gel (Invitrogen Corporation) and transferred to nitrocellulose membranes (Bio-Rad Laboratories). Equal protein loading were confirmed with b-actin levels. After blocking the membrane, antigens were probed using rabbit anti-ZnT2 (1:1000 dilution with 5% milk in phosphate buffered saline/0.05% Tween 20 (PBST), provided by Dr. Kelleher, Penn State University) Bound antibodies were detected using goat anti-rabbit IgG-HRP (1:30,000 dilution with 5% milk in PBST Santa Cruz Biotechnology), and developed with SuperSignal West Femto chemiluminescent substrate (Pierce, Rockford, IL). Images were acquired using an Alpha Innotech photodocumentation system (Alpha Innotech, Hayward, CA) and analyzed using Image J 1.37v software (NIH, Bethesda, MD). Statistical analysis Statistical analysis was performed with the use of PRISM (version 4.0; GraphPad Software). Significantly differences between means were analyzed by one-way ANOVA followed by Bonferroni post hoc test when appropriate. Pearson correlation coefficients were calculated between zinc transporter expression and zinc concentrations. Logarithm data transformations were taken when uneven variations were detected. Differences were considered statistically significant at P \ 0.05. All data are reported as means ± SEM (standard error of the mean) unless otherwise indicated.
123
54
Biometals (2010) 23:51–58
Table 1 Primers of genes analyzed by qRT-PCR Gene name
Primers
Sequence (50 ? 30 )
Annealing temperature
Amplicon size (bp)
ZnT1
Forward
CACGCTAGTGGCTAACACCA
60
296
Reverse
AGGAAAACACGGGTTCACAC
ZnT2
Forward
TGCTCGTGTACCTGGCTGTA
60
138
Reverse
TCCATGTCCAGACTGATGGA
Forward
GCAGAGTATGCACCACTGGA
60
202
Reverse
CAAGGGCGCAGATAGAGAAG
Forward
CCTTTGGATTTCATCGCCTA
60
144
Reverse
GTTCTCTGCACAGCCTCGTA
Forward
AAGCCTAGTGAGCTGCTTCG
58
148
Reverse
ATGGCCAGGATGAACTCTTG
Zip2
Forward
TTCAGAAATTCGTGGTGCAG
58
140
Reverse
GCGACTCCAAAAGGAAGACA
Zip3
Forward
CGTCTTCCTGGCTACATGCT
58
148
Reverse
TCCACGAACACAGTGAGGAA
Zip4
Forward Reverse
ATGAGCTGCCTCACGAACTT CTGCTAGAGCCACGTAGAGG
58
130
18s
Forward
GGACCAGAGCGAAAGCATTTGC
60
115
Reverse
CGCCAGTCGGCATCGTTTATG
ZnT3 ZnT4 Zip1
Results There was no change in food intake among dietary groups (data not shown, P [ 0.05). At the end of the study, the body weights in the MZD group (312.8 ± 5.3 g) were significantly lower than in the ZA group (368.7 ± 6.8 g, P \ 0.001). Phytase supplementation significantly increased body weights in rats fed the MZD diet (346.2 ± 5.5 g, P \ 0.05). Zinc concentrations in the MZD group decreased 44% in plasma and 68% in the prostate dorsolateral lobes compared to the ZA rats (Table 2, P \ 0.05). In contrast, zinc concentrations in prostate ventral lobes were not affected by marginal zinc depletion,
indicating that prostate dorsolateral lobes were more responsive to marginal zinc depletion. In addition, phytase supplementation significantly increased plasma and dorsolateral lobe zinc concentrations (Table 2, P \ 0.05), indicating that phytase facilitated improved zinc status in the rats fed the MZD diet. Prostate dorsolateral lobes contain higher zinc concentrations than the ventral lobes, which were also observed in the current study. Zinc transporter mRNA expression profiles of the ZA rats were compared between the dorsolateral and ventral lobes. The mRNA levels of ZnT3, Zip2 and Zip4 in both lobes were very low in comparison with the other
Table 2 Zinc concentrations in the plasma and prostates of the rats fed the MZD, MZD ?P or ZA diet MZD Plasma (mg/l)
MZD ? P
ZA
P-value
0.56 ± 0.03a
0.90 ± 0.06b
1.15 ± 0.05c
11.92 ± 0.80a
14.39 ± 0.91a
12.49 ± 0.70a
0.09
a
b
204.17 ± 1.26b
\0.0001
\0.0001
Prostate Ventral lobe (mg/kg) Dorsolateral lobe (mg/kg)
66.06 ± 1.48
169.82 ± 1.58
Values are means ± SEM. Main effects were determined by one-way ANOVA with Bonferroni’s post hoc test. Means without a common letter differ, P \ 0.05
123
Biometals (2010) 23:51–58
55
transporters (Fig. 1). No significant differences in ZnT1, ZnT4, Zip1 and Zip3 mRNA levels were detected between the dorsolateral and ventral lobes. However, ZnT2 gene expression levels were markedly different between the dorsolateral and ventral lobes. The mRNA abundance of ZnT2 in the dorsolateral lobes was about 1,000 times higher than that in the ventral lobes (P \ 0.05), indicating that ZnT2 may play an important role in accumulating very high levels of zinc in rat prostate dorsolateral lobes. Correlations between zinc concentrations and zinc transporter mRNA levels in the dorsolateral lobes of all rats in all dietary groups were analyzed by Pearson analysis. We found that only ZnT2 mRNA levels were significantly correlated to the alterations of zinc concentrations in the dorsolateral lobes (P = 0.034, Table 3). We evaluated the effects of variable dietary zinc intake on ZnT2 expression, and found that marginal zinc depletion significantly decreased ZnT2 mRNA levels specifically in the prostate dorsolateral
0.10 0.08 0.06 0.04 0.02
T1
T2
Zn
T3
Zn
T4
Zn
p1
Zi
p2
p3
Zi
Zi
p4
Zi
Prostate ventral lobe 0.10 0.08 0.06 0.04 0.02
p4 Zi
p3
p2
Zi
Zi
p1 Zi
T4
T3
T2
Zn
Zn
T1
0.00 Zn
Zinc transporter mRNA expression (normalized to 18s)
ZnT1 ZnT2
P-value
0.04
0.81
0.38*
0.034
ZnT3
-0.20
ZnT4
-0.18
0.28 0.32
Zip1
0.24
0.18
Zip2
0.35
0.053
Zip3
-0.12
0.50
Zip4
-0.14
0.45
Sprague–Dawley rats were fed a MZD, MZD ? P or ZA diet for 9 weeks. Zinc concentrations were measured by ICP-OES and ZnT2 mRNA levels were measured by qRT-PCR as described in ‘‘Material and methods’’ Pearson analysis was performed to analyze the correlation between dorsolateral prostate zinc concentrations and zinc transporter mRNA transcript levels, n = 32 * P \ 0.05
0.00
Zn
B
Correlation coefficient
lobes (Fig. 2, P \ 0.05) and phytase supplementation partially restored ZnT2 mRNA levels. However, ZnT2 protein levels in the lysate of prostate dorsolateral lobes were not significantly altered by diet treatments (Fig. 3a, b). No effects on ZnT2 or other zinc transporters were detected in the ventral lobes. Altogether, these results indicate that ZnT2 may play an important role in maintaining dorsolateral lobe zinc homeostasis during dietary zinc depletion.
Prostate dorsolateral lobe
Zn
Zinc transporter mRNA expression (normalized to 18s)
A
Table 3 Correlations between zinc transporter mRNA levels and zinc concentrations in the dorsolateral lobes
Fig. 1 Zinc transporter mRNA abundance profiles in the a prostate dorsolateral and b ventral lobes. Sprague-Dawley rats were fed a ZA diet for 9 weeks. mRNA levels were measured as described in ‘‘Material and methods’’. Results are transcripts copy number normalized to 18s transcripts. Values are means ± SEM (n = 12)
Discussion The regulation of ZnT2 may be particularly important in tissues with high zinc requirements such as the prostate glands. The current study shows that the dorsolateral lobes had higher ZnT2 mRNA levels as well as higher zinc concentrations than the ventral lobes of the prostate. ZnT2 mRNA levels in the dorsolateral lobes were also significantly correlated to dorsolateral zinc concentrations, and ZnT2 decreased with marginal zinc deficiency. These results indicate that ZnT2 may play an essential role in modulating prostate zinc homeostasis. Altogether, the current study gives insights for understanding the mechanisms in place that maintain prostate zinc homeostasis, and helps identify zinc transporters that may play roles in zinc regulation.
123
56
Biometals (2010) 23:51–58 b
ZnT2 mRNA expression (normalized to 18s)
0.10 0.08
a,b
0.06
a
0.04 0.02 0.00 MZD
MZD+P
ZA
ZA
ZA
MZD+P
MZD
MZD+P
MZD
A
NZD
Fig. 2 Effects of dietary marginal zinc depletion on ZnT2 mRNA abundance in the prostate dorsolateral lobes. SpragueDawley rats were fed a MZD, ZA or MZD ? P diet for 9 weeks. mRNA levels were measured as described in ‘‘Material and methods’’. Results are transcripts copy numbers normalized to 18s transcripts. Values are means ± SEM (n = 12). Difference between means is determined by oneway ANOVA followed by Bonferroni’s post hoc test. Means without a common letter differ (P \ 0.05)
ZnT2
~42KD
ZnT2
~35KD
ZnT2 ~42KDa Relative densitometric value
B
ZnT2 ~ 35KDa Relative densitometric value
β-actin
2.5 2.0 1.5 1.0 0.5 0.0 MZD MZD+P ZA
1.5 1.0 0.5 0.0 MZD MZD+P ZA
Fig. 3 Effects of dietary marginal zinc depletion on ZnT2 protein levels in the whole tissue lysate of prostate dorsolateral lobes. Sprague-Dawley rats were fed a MZD, ZA or MZD ? P diet for 9 weeks. a ZnT2 protein levels are shown in 3 representative samples from each dietary group. ZnT2 isoforms with sizes of *42 and *35 kDa are shown in the inserts. b Relative abundance of each protein was determined by densitometry analysis
The prostate contains high levels of zinc compared to many other soft tissues, although the precise function of high cellular zinc in this tissue remains unclear. Zinc may be required for inhibition of terminal oxidation and the activity of mitochondria aconitase in the prostate. (Costello et al. 2004; Ho
123
2004; Muntzing et al. 1975). Therefore, a loss of zinc in the prostate may remove the inhibitory effects of zinc on mitochondrial terminal oxidation, and increase respiration rates and possibly increasing the production of free radicals by the electron transport chain. (Franklin et al. 2005). In our laboratory, we have also postulated an important function of zinc in the prostate may be maintaining DNA integrity by reducing oxidative stress and preserving DNA repair functions (Yan et al. 2008). We found that loss of cellular zinc levels in the prostate epithelial cells resulted in oxidative stress and increased DNA damage. Since high zinc concentrations may be essential for prostate health, a failure to maintain zinc homeostasis may increase the risk of prostate cancer. Dysregulation of zinc transporters including ZnT1, ZnT3, ZnT4, Zip1, Zip2 and Zip3 have been found to be associated with the low intracellular zinc content and tumorgenicity in human prostate cancer tissues or prostate epithelial cancer cell lines (Franklin et al. 2005; Iguchi 2004; Beck et al. 2004). To date, no mutations in ZnT2 have been identified in the prostate, however, ZnT2 mutations have been identified in mammary tissues, a tissue that has similar secretory functions and high zinc requirement (Ryu et al. 2008). These previous studies provide important preliminary evidence for the potential role of specific zinc transporters in prostate cancer progression. The primary function of ZnT2 is to transport zinc from the cytoplasm into vesicles such as endosomes or lysosomes (Jou et al. 2009; Liuzzi et al. 2003). In general, ZnT2 is not ubiquitously expressed among all tissues. Its expression is restricted to tissues with unique zinc requirements such as small intestine, kidney, retina, placenta, pancreas, mammary gland, testis, seminal vesicles, and prostate (Lichten and Cousins 2009). ZnT2 is upregulated in the small intestine during high dietary zinc intake, and during late-stage gestation and early lactation in both maternal and fetal tissues (Liuzzi et al. 2003). In mammary and prostate tissue, hormones such as prolactin also increases ZnT2 expression (Costello et al. 1999; Qian et al. 2009). Zinc transporters such as ZnT5 have alternative isoforms as a result of alternative splicing events in response to zinc and the proteins are differentially localized (Jackson et al. 2007). Recently, using in silico analysis, two distinct isoforms of ZnT2 have been identified, a *42 kDa
Biometals (2010) 23:51–58
protein (NM_032513) and a shorter *35 kDa protein (NM_001004434) that result from alternative splicing of exon 3. Both isoforms appear to function as zinc transporters, but have differing subcellular localization patterns (Lopez and Kelleher 2009). In mammary tissue, the larger 42 kDa isoform localizes to secretory vesicles and predominates in expression level over the 35 kDa isoform that localizes to plasma membrane (Gyorkey et al. 1967). Thus, the long 42 kDa isoform appears to function to transport zinc into the secretory compartment for zinc efflux in a hormone-dependent manner. In the current study, we found that similar to mammary tissue, the larger isoform appears to predominate in the prostate. Thus, it is possible that a decrease in ZnT2 expression with marginal zinc deficiency in the prostate may reduce the amount of zinc transported into endosomes or secretory vesicles. In that case, zinc may be preserved for other cell compartments, such as the mitochondria and nucleus, and may be more available for activities more essential for prostate cell function and survival. Although we detected alterations in RNA expression in the prostate with zinc deficiency, we surprisingly did not see corresponding decreases in protein expression of ZnT2. However, a major limitation of this analysis was that we were restricted to the evaluation of ZnT2 in whole tissue lysates, rather than membrane or subcellular fractions. Given the importance of ZnT2 localization, further studies to examine alterations in specific subcellular fractions or use of in situ immunohistochemistry methods are necessary to confirm changes protein alterations in specific cellular locations are apparent. For example, in the mammary gland, ZnT2 expression remains constant at the basolateral membrane, and only changes at the apical membrane are detectable during lactation (Kelleher and Lonnerdal 2003). Further, it is possible that other alternative splice variants are present in the prostate that have not been identified. In the rat small intestine, ZnT2 has a lower molecular mass protein (*28 kDa) that is localized to the apical membrane. Thus, an important direction of future research would be to identify the ZnT2 localization and function in the prostate. To understand zinc homeostatic mechanisms in the prostate, studies should focus on the redistribution of subcellular zinc levels during zinc depletion and identify cellular compartments which are most resistant to zinc depletion.
57
Although zinc concentrations are high in the whole prostate, zinc is not uniformly distributed among all prostate lobes. The human prostates are composed of the peripheral zone (70%), the central zone (25%) and the transition zone (5%). The peripheral zone contains much higher zinc and citrate concentrations than the other zones, and 80% of prostate malignancies develop in the peripheral zone (Costello and Franklin 1998). Therefore, the differential functional and metabolic properties of prostate epithelial cells in the peripheral zone may determine their high potential for malignant transformation. It has been reported that the dorsolateral lobe of the rat prostate is embryologically homologous to the peripheral zone of the human prostate (Iguchi et al. 2002). The dorsolateral lobe also retains higher levels of zinc compared to the ventral lobe (Iguchi et al. 2002). However, the mechanisms for the uneven distribution of zinc within the prostate are unknown. A previous study done by Iguchi et al. detected higher expression of ZnT2 in the dorsal and lateral lobes of rat prostates than in ventral lobes by using semiquantitative RTPCR. The current study quantitatively assessed that ZnT2 transporter expression was about 1,000 times higher in the dorsolateral lobes than in the ventral lobes where ZnT2 mRNA levels were very low. These findings suggest that ZnT2 may play a role in accumulating high concentration of zinc in prostate dorsolateral lobes and likely important in secretory functions. However, more studies are needed to address the mechanism and significance of this lobespecific expression of ZnT2. In summary, the current study suggests that ZnT2 may play an important role in regulating zinc homeostasis and maintaining high zinc levels in the prostate dorsolateral lobes. The current study also provides evidence and directions for future research to explore the possible interactions among prostate cancer, zinc status, and defects in zinc transporter families. Acknowledgments We thank Dr. Shannon Kelleher for the generous gift of ZnT2 antibodies. We gratefully acknowledge the WM Keck Collaboratory at Oregon State University for their assistance in conducting these studies. This study was funded by Oregon AES (OR00735), and the Environmental Health Science Center at Oregon State University (NIEHS P30 ES00210) and by the US Army MRMC. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Army or the Department of Defense.
123
58
References Beck FW, Prasad AS, Butler CE, Sakr WA, Kucuk O, Sarkar FH (2004) Differential expression of hZnT-4 in human prostate tissues. The Prostate 58:374–381 Bruno RS, Song Y, Leonard SW, Mustacich DJ, Taylor AW, Traber MG, Ho E (2007) Dietary zinc restriction in rats alters antioxidant status and increases plasma F2 isoprostanes. J Nutr Biochem 18:509–518 Costello LC, Franklin RB (1998) Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. The Prostate 35:285–296 Costello LC, Franklin RB (2006) The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 5:17 Costello LC, Liu Y, Franklin RB, Kennedy MC (1997) Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem 272:28875–28881 Costello LC, Liu Y, Zou J, Franklin RB (1999) Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem 274:17499–17504 Costello LC, Guan Z, Kukoyi B, Feng P, Franklin RB (2004) Terminal oxidation and the effects of zinc in prostate versus liver mitochondria. Mitochondrion 4:331–338 Devirgiliis C, Zalewski PD, Perozzi G, Murgia C (2007) Zinc fluxes and zinc transporter genes in chronic diseases. Mutat Res 622:84–93 Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O, Costello LC (2005) hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer 4:32 Gyorkey F, Min KW, Huff JA, Gyorkey P (1967) Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res 27:1348–1353 Ho E (2004) Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 15:572–578 Huang L, Kirschke CP, Zhang Y (2006) Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int 6:10 Iguchi K, Usui S, Inoue T, Sugimura Y, Tatematsu M, Hirano K (2002) High-level expression of zinc transporter-2 in the rat lateral and dorsal prostate. J Androl 23:819–824 Iguchi K, Otsuka T, Usui S, Ishii K, Onishi T, Sugimura Y, Hirano K (2004) Zinc and metallothionein levels and expression of zinc transporters in androgen-independent subline of LNCaP cells. J Androl 25:154–161 Jackson KA, Helston RM, McKay JA, O’Neill ED, Mathers JC, Ford D (2007) Splice variants of the human zinc transporter ZnT5 (SLC30A5) are differentially localized and regulated by zinc through transcription and mRNA stability. J Biol Chem 282:10423–10431 Jou MY, Hall AG, Philipps AF, Kelleher SL, Lonnerdal B (2009) Tissue-specific alterations in zinc transporter expression in intestine and liver reflect a threshold for homeostatic compensation during dietary zinc deficiency in weanling rats. J Nutr 139:835–841
123
Biometals (2010) 23:51–58 Kelleher SL, Lonnerdal B (2003) Zn transporter levels and localization change throughout lactation in rat mammary gland and are regulated by Zn in mammary cells. J Nutr 133:3378–3385 Kury S, Dreno B, Bezieau S, Giraudet S, Kharfi M, Kamoun R, Moisan JP (2002) Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 31:239–240 Lichten LA, Cousins RJ (2009) Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 29:153–176 Liuzzi JP, Bobo JA, Cui L, McMahon RJ, Cousins RJ (2003) Zinc transporters 1, 2 and 4 are differentially expressed and localized in rats during pregnancy and lactation. J Nutr 133:342–351 Lopez V, Kelleher SL (2009) Zinc transporter-2 (ZnT2) variants are localized to distinct subcellular compartments and functionally transport zinc. Biochem J 422:43–52 McClung JP, Stahl CH, Marchitelli LJ, Morales-Martinez N, Mackin KM, Young AJ, Scrimgeour AG (2006) Effects of dietary phytase on body weight gain, body composition and bone strength in growing rats fed a low-zinc diet. J Nutr Biochem 17:190–196 Muntzing J, Varkarakis MJ, Saroff J, Murphy GP (1975) Comparison and significance of respiration and glycolysis of prostatic tissue from various species. J Med Primatol 4:245–251 Nyden SJ, Williams-Ashman HG (1953) Influence of androgens on synthetic reactions in ventral prostate tissue. Am J Physiol 172:588–600 Qian L, Lopez V, Seo YA, Kelleher SL (2009) Prolactin regulates ZnT2 expression through the JAK2/STAT5 signaling pathway in mammary cells. Am J Physiol 297:C369–C377 Reeves PG (1997) Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127:838S–841S Rimbach G, Pallauf J (1993) Enhancement of zinc utilization from phytate-rich soy protein isolate by microbial phytase. Zeitschrift fur Ernahrungswissenschaft 32:308–315 Rishi I, Baidouri H, Abbasi JA, Bullard-Dillard R, KajdacsyBalla A, Pestaner JP, Skacel M, Tubbs R, Bagasra O (2003) Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl Immunohistochem Mol Morphol 11:253–260 Ryu MS, Lichten LA, Liuzzi JP, Cousins RJ (2008) Zinc transporters ZnT1 (Slc30a1), Zip8 (Slc39a8), and Zip10 (Slc39a10) in mouse red blood cells are differentially regulated during erythroid development and by dietary zinc deficiency. J Nutr 138:2076–2083 Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885 Verbanac D, Milin C, Domitrovic R, Giacometti J, Pantovic R, Ciganj Z (1997) Determination of standard zinc values in the intact tissues of mice by ICP spectrometry. Biol Trace Elem Res 57:91–96 Yan M, Song Y, Wong CP, Hardin K, Ho E (2008) Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr 138:667–673
Biometals (2010) 23:59–70 DOI 10.1007/s10534-009-9269-5
First solid state alkaline-earth complexes of monensic acid A (MonH): crystal structure of [M(Mon)2(H2O)2] (M 5 Mg, Ca), spectral properties and cytotoxicity against aerobic Gram-positive bacteria Ivayla N. Pantcheva Æ Rumyana Zhorova Æ Mariana Mitewa Æ Svetlana Simova Æ Heike Mayer-Figge Æ William S. Sheldrick Received: 7 July 2009 / Accepted: 3 September 2009 / Published online: 21 September 2009 ! Springer Science+Business Media, LLC. 2009
Abstract Alkaline-earth metal complexes of the monoanionic form of the polyether ionophore monensin A were isolated for the first time in solid state and were structurally characterized using various spectroscopic methods (IR, NMR, FAB-MS). The stoichiometric reaction of monensic acid (MonH) with M2? (M = Mg, Ca) in the presence of an organic base leads to the formation of mononuclear complexes of composition [M(Mon)2(H2O)2]. The structures of magnesium (1) and calcium (2) monensin complexes in the solid state were established by single crystal X-ray crystallography. The complexes crystallize as [Mg(Mon)2(H2O)2]!5MeCN (1) and [Ca(Mon)2(H2O)2]!H2O!5MeCN (2) in the monoclinic P21 space group. The alkaline-earth metal ion
is placed in a distorted octahedral environment, defined by two monensin anions acting as bidentate ligands in the equatorial plane of the complex as well as by two water molecules occupying the axial positions of the inner coordination sphere. The bactericidal activity of 1 and 2 was evaluated against aerobic Gram-positive microorganisms applying the double layer agar hole diffusion method. Keywords Monovalent carboxylic ionophore ! Alkaline-earth monensin complexes ! Crystal structure ! IR ! NMR ! FAB-MS ! Bactericidal activity
Introduction I. N. Pantcheva (&) ! R. Zhorova ! M. Mitewa Laboratory on Biocoordination and Bioanalytical Chemistry, Department of Analytical Chemistry, Faculty of Chemistry, Sofia University, 1, J. Bourchier Blvd., 1164 Sofia, Bulgaria e-mail:
[email protected] [email protected] S. Simova Institute of Organic Chemistry with Center of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bontchev Str., Bl. 9, 1113 Sofia, Bulgaria H. Mayer-Figge ! W. S. Sheldrick Lehrstuhl fu¨r Analytische Chemie, Ruhr-Universita¨t Bochum, 44780 Bochum, Germany
Recently the most powerful drugs in veterinary medicine effective against coccidiosis and infections induced by Gram-positive organisms represent the group of naturally occurring polyether ionophorous antibiotics (Agtarap et al. 1967; Stern 1977; Berg and Hamill 1978; Liu et al. 1978; Chappe 1979; Long and Jeffers 1982; Westley et al. 1983; Augustine et al. 1987; Koinarski and Sherkov 1987; Folz et al. 1988; Augustine et al. 1992; Varga and Sreter 1996; Wang et al. 2006; Kevin et al. 2009). Their main representative—monensin—is well known and its ability of binding monovalent metal ions is extensively studied.
123
60
The neutral ionophore complexes formed are able to penetrate the cell membrane of the microorganisms and parasites and to disturb a series of homeostatic processes after dissociation in the intracellular space causing a death of the corresponding target (Riddell 2002). Due to the high affinity of monensin to complex alkaline metal ions, it is known for a very long time to be a monovalent polyether ionophore (Lutz et al. 1971; Briggs and Hinton 1978; Duax et al. 1980; Garcla-Rosas et al. 1983; Cox et al. 1984; Walba et al. 1986; Pangborn et al. 1987; Rzeszotarska et al. 1994; Wagner-Czauderna et al. 1997; Paz et al. 2003; Huczynski et al. 2007a, b, c, 2008a, b, c, d; Yildirim et al. 2007). From the 1990s up to the present several research groups have drawn attention to the possible complexation of monensin with divalent metal ions (Hebrant et al. 1992; Mimouni et al. 1994; Dassie and Baruzzi 2002; Hamidinia et al. 2002; Huczynski et al. 2006a, b, c, d, 2007a, b, c, 2008a, b, c, d). Although there was only indirect evidence concerning the unusual coordination behaviour of monensin, it was suggested that the complexation chemistry of the ligand (and of other representatives of the monovalent polyether ionophores group) is much broader than we were previously acquainted with (Stiles et al. 1991; Hamidinia et al. 2002, 2004). The hypothesis that monensin possesses previously unknown reactivity prompted our group to start an extensive study on the coordination ability of the ligand towards di- and three-valent metal ions. In our previous publications we demonstrated that monensin could form two types of divalent transition metal complexes depending on the chemical form used in the reactions (Dorkov et al. 2008; Pantcheva et al. 2008, 2009). The compounds obtained possess enhanced antimicrobial activity towards Gram(?)-bacteria that is most likely due to the unusual coordination mode of the ligand. In order to confirm the ability of monensin to bind divalent metal ions, we have now studied its behaviour towards alkaline-earth metals, in particularly magnesium and calcium ions. In the present paper we describe the structure elucidation of Mg2? and Ca2? complexes of the monoanionic form of monensic acid (MonH, Scheme 1) in the solid state by single crystal X-ray crystallography, report on their spectroscopic characterization and on the evaluation of their bactericidal properties against aerobic Gram-positive microorganisms.
123
Biometals (2010) 23:59–70 33
14 11 31
10 O4 O
29
28
9
5 4 3
O O3
2 27
8
6 30
13
12 O O6
15 O O7
34 32
16
18 17 O O8 O9 O
7 OH O5
O 1 O2
HO O11
25 26
OH O10
19 20 21 35
22 24
23
36
HO O1
Scheme 1 The chemical structure and numbering sequence of monensic acid
Materials and methods Chemicals All chemicals were of reagent grade and were used as received. The commercially available sodium monensin was obtained from BIOVET, Ltd. (Bulgaria). Solvents (MeCN, MeOH, DMSO), organic base (Et4NOH) and metal salts (MgCl2!6H2O, CaCl2) were purchased from Merck. Synthesis of monensic acid The acidic form of monensin A monohydrate (monensic acid, MonH!H2O) was prepared from sodium monensin as previously reported (Gertenbach and Popov 1975). IR: mCOOH = 1700 cm-1. 1H-NMR (600 MHz, d (multiplicity, intensity, J-coupling(s), assignment), CDCl3): 6.25 (br, 1-OH, 10-OH (sharp), 11-OH, H2O), 4.50 (br d, 1H, 7.9, 5-OH), 4.33 (ddd, 1H, 10.8, 5.9, 2.9, 20CH), 4.07 (dd, 1H, 11.6, 2.1, 5CH), 4.03 (d, 1H, 4.0, 17CH), 3.94 (dd, 1H, 10.5, 2.7, 21CH), 3.86 (br s, 1H, 7CH), 3.69 (d, 1H, 11.2, 26CH20 ), 3.50 (d, 1H, 11.2, 26CH200 ), 3.44 (dd, 1H, 10.7, 4.6, 13CH), 3.37 (s, 3H, 28OCH3), 3.22 (dd, 1H, 10.2, 2.1, 3CH), 2.62 (dq, 1H, 10.2, 6.7, 2CH), 2.25–2.13 (4H, 18CH, 15CH20 , 4CH, 19CH20 ), 2.10 (m, 1H, 6CH), 1.98 (dd, 1H, 14.2, 3.5, 8CH20 ), 1.97 (dd, 1H, 12.3, 8.4, 10CH20 ), 1.89 (dt, 1H, 11.9, 8.7, 11CH20 ), 1.74–1.52 (m, 5H, 8CH200 , 11CH200 , 10CH200 , 14CH2), 1.55 (m, 2H, 32CH2), 1.52–1.33 (m, 5H, 23CH20 , 24CH, 15CH200 , 19CH200 , 23CH200 ), 1.48 (s, 3H, 31CH3), 1.35 (m, 1H, 22CH), 1.27 (d,
Biometals (2010) 23:59–70
3H, 6.7, 27CH3), 1.10 (d, 3H, 6.9, 29CH3), 0.95 (t, 3H, 7.4, 33CH3), 0.92 (d, 3H, 6.9, 34CH3), 0.88 (d, 3H, 7.1, 30CH3), 0.87 (d, 3H, 6.4, 36CH3), 0.85 (d, 3H, 6.5, 35CH3). Synthesis of magnesium complex, [Mg(Mon)2(H2O)2], 1 The consecutive addition of Et4NOH (0.5 mmol, 180 ll, 40% in H2O) and of freshly prepared solution of MgCl2.6H2O (0.5 mmol, 100 mg in 5 ml MeCN/ MeOH, 10:1) to a solution of MonH (0.5 mmol, 336 mg in 20 ml MeCN/MeOH, 10:1) afforded the precipitation of white solids with a composition of [Mg(Mon)2(H2O)2], 1, which are insoluble in MeCN (228 mg, 65% yield). The complex was filtered off, washed with MeCN and dried over P2O5 at room temperature. Anal. Calcd for MgC72H126O24 (MW = 1400.08): H, 9.07, C, 61.77, Mg, 1.74; Found: H, 8.76, C, 60.17, Mg, 2.14%. Slow concentration of diluted reaction mixture affords the formation of colourless crystals of composition [Mg(Mon)2(H2O)2]!5MeCN. IR: mCOOasym = 1550 cm-1, mCOOsym = 1400 cm-1. 1 H-NMR (600 MHz, d (assignment), CDCl3): 10.98 (11-OH), 6.60 (10-OH), 4.98 (H2O), 4.85 (5-OH), 4.30 (20CH), 4.09 (21CH), 4.04 (17CH, 5CH), 3.73 (7CH), 3.78 (26CH20 ), 3.68 (26CH200 ), 3.52 (13CH), 3.33 (28OCH3), 3.24 (3CH), 2.46 (2CH), 2.33 (6CH), 2.23 (18CH), 2.17-2.04 (15CH20 , 19CH20 , 4CH), 2.00-1.94 (8CH20 , 10CH20 ), 1.85 (11CH20 ), 1.75–1.68 (14CH20 ), 1.70–1.50 (8CH200 , 11CH200 , 10CH200 , 14CH200 , 32CH20 , 23CH20 ), 1.54 (31CH3), 1.50–1.40 (19CH200 , 32CH200 , 15CH200 ), 1.37 (24CH), 1.29 (23CH200 , 22CH), 1.18 (27CH3), 1.08 (29CH3), 0.98–0.82 (33CH3, 34CH3, 30CH3, 36CH3, 35CH3). Synthesis of calcium complex, [Ca(Mon)2(H2O)2], 2 To a reaction mixture containing MonH (0.5 mmol, 336 mg in 15 ml MeCN/MeOH (10:1)) and Et4NOH (0.5 mmol, 180 ll, 40% in H2O) the addition of CaCl2 (0.5 mmol, 56 mg in 5 ml MeCN/MeOH, 10:1) led to the formation of colourless solution that slowly precipitates within 24 h (240 mg, 68% yield). The solid was filtered off, washed with MeCN and dried over P2O5 at room temperature. The elemental analysis data are in agreement with the general composition of the complex, [Ca(Mon)2(H2O)2], 2.
61
Anal. Calcd. for CaC72H126O24 (MW = 1415.86): H, 8.97, C, 61.08, Ca, 2.83; Found: H, 8.56, C, 58.12, Ca, 3.20%. Complex 2 is soluble in MeOH, CHCl3 and octanol, and possesses very low solubility in MeCN and DMSO. IR: mCOOasym = 1560 cm-1, mCOOsym = 1400 cm-1. 1H-NMR (600 MHz, d (assignment), CDCl3): 4.95 (5-OH), 4.32 (20CH), 4.23 (17CH), 4.04 (5CH, 21CH), 3.86–3.68 (7CH, 26CH20 ), 3.56 (26CH200 ), 3.50 (13CH), 3.37 (28OCH3), 3.24 (3CH), 2.48 (2CH), 2.37 (6CH), 2.30 (18CH), 2.22–2.11 (15CH20 , 19CH20 ), 2.09 (4CH), 2.00–1.88 (8CH20 , 10CH20 , 11CH20 ), 1.76–1.58 (8CH200 , 11CH200 , 10CH200 , 14CH2), 1.58–1.40 (32CH2, 23CH20 , 24CH, 31CH3, 15CH200 , 19CH200 ), 1.40–1.26 (23CH200 , 22CH), 1.19 (27CH3), 1.12 (29CH3), 0.98–0.83 (33CH3, 34CH3, 30CH3, 36CH3, 35CH3). Slow concentration of diluted reaction mixture (2–3 days at ambient temperature) affords the precipitation of 2 as colorless crystals. The X-ray analysis showed that 2 crystallizes as [Ca(Mon)2(H2O)2]!H2O!5MeCN. Physical measurements Infrared spectra (4000–400 cm-1) were recorded on a Specord 75-IR (Carl-Zeiss, Germany) in a nujol mull. FAB-MS spectra were performed using Fisons VG Autospec (Micromass Instruments, UK). 1 H (600.13 MHz) and 13C (150.92 MHz) spectra were acquired on an AVANCE AV600 II? NMR spectrometer (Bruker, Germany). All spectra were recorded in CDCl3 at room temperature. TMS was used as an internal standard for the 1H and 13C spectra. Unambiguous assignment of the signals was made on the basis of the gradient enhanced versions of COSY, TOCSY, HSQC, HMBC and ROESY experiments (Bruker pulse library programs: cosygpmfqf, dipsi2etgpsi, hsqcedetgpsisp2.2, hmbcgplpndqf, roesyph.2, 2007). The chemical shift values of the individual protons in the compounds have been determined from the HSQC spectra. Elemental analysis data (C, H, O) were obtained with a VarioEL V5.18.0 Elemental Analyzer (Elementar Analysen Systeme GmbH, Germany). The metal content of complexes was determined by AAS on a Perkin Elmer 1100 B (Waltham, USA) after decomposition of samples with conc. HNO3 and using a stock standard solution (Merck, 1000 lg/ml); the working reference solutions were prepared after suitable dilution.
123
62
Biometals (2010) 23:59–70
X-ray crystallography Details concerning data collection, structure solution and refinement of complexes 1 and 2 are given in Table 1. X-ray diffraction measurements were performed on an Oxford Diffraction Xcalibur 2 diffractometer at 112 K, operating with Mo-Ka (k = ˚ ) radiation and equipped with a graphite 0.71073 A monochromator. The structures were solved by direct methods and were refined by full-matrix least-square procedures on F2 (Sheldrick 1990; Sheldrick 1997). All non-H atoms were refined isotropically with a riding model. Cytotoxicity assay (determination of MIC) Three aerobic Gram-positive microorganisms were used as test strains to evaluate the cytotoxic properties of the alkaline-earth complexes, MgCl2.6H2O and CaCl2. The bacteria Bacilus subtillis (ATCC 6633), Bacilus mycoides spp. and Sarcina lutea FDA strain PCI 1000 (ATCC 10054) were purchased from the
Table 1 Crystal data and structure refinement for complexes 1, [Mg(Mon)2(H2O)2]! 5MeCN, and 2, [Ca(Mon)2(H2O)2]! H2O!5MeCN
123
National Bank for Industrial Microorganisms and Cell Cultures (Bulgaria). The activity of compounds is determined as their minimum inhibitory concentration [MIC, (lM)], which is the lowest concentration causing the visible inhibition of the bacteria growth. Details concerning the experimental procedures using the double layer agar hole diffusion method were carried in accordance with the literature (Andrews 2001) and were similar to those reported previously (Dorkov et al. 2008; Pantcheva et al. 2008, 2009).
Results and discussion The reaction of monensic acid with MgCl2 or CaCl2 in the presence of an organic base leads to the formation of unique alkaline-earth metal complexes of composition [M(Mon)2(H2O)2] (M = Mg (1), Ca (2)). The reaction proceeds in a mixed solvent system (MeCN/MeOH) and at metal-to-ligand-to-base molar ratio of 1:1:1. The addition of Et4NOH is essential for the coordination of the ligand to the divalent metal
Compound
Complex 1
Complex 2
Formula
C82H141O24N5Mg
C82H143O25N5Ca
M
1605.31
1639.09
Crystal system
Monoclinic
Monoclinic
Space group ˚) a (A
P 21
P 21
12.3337(5)
12.1855(4)
˚) b (A ˚ c (A)
25.1619(9)
25.0185(11)
14.3112(6)
14.6551(5)
b (") ˚ 3) V (A
91.101(4) 4440.5(3)
90.292(3) 4467.7(3)
Z
2
2
Dc (Mg/m3)
1.201
1.218
F(000)
1728
1780
l (mm-1)
0.093
0.145
Crystal size (mm)
0.10 9 0.13 9 0.21
0.38 9 0.35 9 0.17
hmin - hmax (")
3.25–27.66
3.22–27.61
Dataset (h, k, l)
-16/16, -31/32, -18/18
-15/15, -18/31, -18/18
Total Refl./Unique Refl.
57624/20116
33530/14670
Obs. Refl. [I [ 2r(I)]
9019
8758
Data/restraints/parameters
20116/8/984
14670/6/1020
R1, wR2 [I [ 2s(I)] ˚ -3 Residuals/eA
0.0605, 0.1398
0.0490, 0.1052
1.290/-0.363
0.865/-0.439
GOF
0.807
0.850
Biometals (2010) 23:59–70
ions since it facilitates deprotonation of the carboxylic function of monensic acid during the complexation. In the absence of organic base the reaction does not take place, and the use of inorganic bases such as NaOH or KOH exclusively forms the monovalent metal complexes of monensin, MonNa or MonK, respectively. Crystal structures of [Mg(Mon)2(H2O)2], 1 and [Ca(Mon)2(H2O)2], 2 Generally, the magnesium and calcium complexes of monoanionic form of monensic acid consist of a discrete electrically neutral unit [M(Mon)2(H2O)2]. Both compounds crystalize in the monoclinic space group P21. The crystals analyzed by X-ray crystallography additionally contain solvents molecules (MeCN and/or H2O), which do not affect the coordination mode of the ligand and do not participate in the formation of intramolecular H-bonds with the main unit. Such a solvent insertion was already observed in the cases of Mn2?/Co2? complexes of deprotonated monensic acid (Pantcheva et al. 2008) and of Ba2? complex of lasalocid (Johnson et al. 1970a, b). In compounds 1 and 2, two monensic anions (Mon) act as bidentate ligands occupying four places in the inner coordination sphere of the alkaline-earth metal ion. Two of the positions in the equatorial plane of the complexes are filled by deprotonated monodentate carboxylic functions of two monensic anions (COO– M bonds), and other two by methoxy groups of Mon located at the opposite end of the ligand molecule forming two dative HO ? M bonds, respectively.
63
The folding of the ligand due to its bidentate coordination mode affords its pseudo-cyclization referred to as ‘‘head-to-tail’’ cyclization, observed even for the free ligand in the absence of metal ions (Lutz et al. 1971). Similarly to the transition metal complexes of Mon (Pantcheva et al. 2008) and barium complex of lasalocid (Johnson et al. 1970a, b), two water molecules are also included in the structures of 1 and 2, linked by dative H2O ? M bonds in axial positions with respect to the divalent metal ion and completing the octahedral environment of Mg2?/Ca2? (Fig. 1). The data confirm that water molecules in the new monensin complexes play a dual role: first, they occupy the inner coordination sphere of the metal ion, and in the second place they stabilize the strongly folded ligand by various intramolecular H-bonds. Selected bond distances and bond angles of 1 and 2 are presented in Table 2. Intramolecular H-bonds observed are shown in Fig. 2 and Table 3, respectively. No intermolecular H-bonds were detected in the structures. The crystal packing of complexes is depicted in Fig. 3. The comparison of crystallographic data for the Mn2?/Co2? (Pantcheva et al. 2008) and Ca2?/Mg2? complexes of monoanionic monensic acid shows that the divalent metal center reacts in a similar manner in each case both with monensin ligands and with water molecules. The M–O bond lengths decrease in the order of Ca2? [ Mn2? [ Co2? [ Mg2? in accordance with the decrease of the metal ionic radii. The M–O bond angles of metal ion with equatorial monensin ligands forming the xy-plane of complexes deviate from the regular ones (180") by ca. 10" and
Fig. 1 ORTEP of [Mg(Mon)2(H2O)2] (1) and [Ca(Mon)2(H2O)2] (2) at the 30% probability level (protons and solvent molecules are omitted for clarity)
123
64
Biometals (2010) 23:59–70
˚ ) and bond angle (") of Table 2 Selected bond distances (A complexes 1 and 2 Complex 1
M–O1
2.029(3)
2.266(3)
M–O101
2.029(3)
2.253(3)
M–O11
2.130(3)
2.358(3)
M–O111
2.136(3)
2.370(3)
M–O12
2.107(3)
2.341(2)
M–O13
2.102(3)
2.340(3)
86.17(12)
82.44(9)
Bond angles O101–M–O1
88.84(12)
O1–M–O111
171.29(13)
94.63(10) 172.17(9)
O101–M–O111
85.89(12)
O111–M–O11
99.81(12)
101.03(9)
O101–M–O11
172.00(13)
173.94(9)
O12–M–O13
160.41(12)
151.22(9)
82.54(10)
Symmetry position: -x, y ? 1/2, -z
Fig. 2 Intramolecular bonds (in dotted line) observed in the structure of alkaline-earth complexes on the basis of complex 1 (the coordination of Mg2? with one of the ligands is shown)
no significant difference is observed between them in dependence on the divalent metal center. In contrast, the metal-aqueous oxygen bond angles increase with decreasing metal ionic radii as follows: Ca2? (151.2") \ Mn2? (154.4") \ Co2? (159.1") \ Mg2? (160.4"). From the data collected up to now it can be concluded that the nature of the divalent metal ion (i.e. its ionic radius) does not affect significantly the equatorial planarity of complexes, but influences the
123
Complex 1
Complex 2
O2–O11
2.575
2.612
O102–O111
2.587
2.623
O5–O6
2.763
2.808
O105–O106
2.771
2.794
O5–O10
2.676
2.668
O105–O110
2.689
2.650
O5–O12
3.006
2.930
O105–O13
2.909
2.873
O6–O12 O106–O13
3.081 3.024
3.027 2.974
O7–O12
2.778
2.730
O107–O13
2.772
2.720
O8–O12
2.970
2.885
O108–O13
2.968
2.880
Complex 2
Bond length
O1–M–O11
Table 3 Intramolecular H-bonds of complexes 1 and 2
Symmetry position: -x, y ? 1/2, -z
bonding with axial ligands thus leading to different degrees of deformation of the octahedral environment around the divalent cationic center. The structures of 1 and 2 have clearly been established in the solid state by single crystal X-ray diffraction, nevertheless questions concerning the coordination mode of deprotonated monensic acid especially towards Ca2? still remain. These queries arise since calcium and sodium ions are hard acids and their ionic radii are equivalent at coordination number ˚ (Na?) vs. 1.00 A ˚ (Ca2?)], but at the same of 6 [1.02 A 2? time Ca does not ‘‘enter’’ the hydrophilic cavity of ligand at the selected reaction conditions. Although some authors suggest the formation of shell-like alkaline-earth complexes with monovalent ionophores of composition metal-to-ligand ratio = 1:1 (Huczynski et al. 2007a, b, c, 2008a, b, c, d) their isolation as solid phases was not observed in the present research. Despite these hypothesis, the magnesium (1) and calcium (2) complexes of monoanionic monensic acid of composition of M:Mon = 1:2 clearly represent the first example of alkaline-earth monensin complexes to be isolated and fully characterized in solid state. IR spectral properties of complexes 1 and 2 The IR spectra of 1 and 2 obtained in a nujol mull are very similar to those observed for the transition metal
Biometals (2010) 23:59–70
65
Fig. 3 Crystal packing of complexes 1 (a) and 2 (b)
complexes of Mon (Pantcheva et al. 2008) and the results are in agreement with the crystallographic data of new compounds. The main evidence that complexation takes place is found comparing the positions of stretching vibrations of the carboxyl function of MonH and of the carboxylate group of 1 and 2, respectively. The peak due to mCOOH of MonH (1700 cm-1) disappears in the IR spectra of 1 and 2 thus demonstrating that deprotonation of carboxyl moiety occurs during the complexation. This fact was also confirmed by the appearance of two new peaks in the IR spectra of 1 and 2, assigned to the stretching vibrations of the deprotonated carboxylic function, -1 absorbing at 1550 cm-1 (masym COO) and 1400 cm sym (mCOO), respectively. The IR spectral data confirming the coordination both of monensin hydroxyl groups and of water ligands to Mg2? and Ca2? are also in accordance with the data previously reported (Pantcheva et al. 2008). The crystallization water and hydroxyl groups of monensic acid absorb at 3520 and 3320 cm-1, respectively, while in the IR spectra of 1 and 2 the next bands were found and were assigned as follows: mOHwater (3490 cm-1) and mOHOH-groups [3360, 3280 cm21 (1); 3280 cm-1 (2)]. NMR spectra of MonH, 1 and 2 To the best of our knowledge, several research teams solved 1H- and 13C{1H}-NMR spectra of the monovalent metal complexes of Mon (Ajaz et al. 1987; Mimouni et al. 1996; Martinek et al. 2000) or its ester derivatives and their alkali complexes (Huczynski et al. 2006a, b, c, d, 2007a, b, c, 2008a, b, c, d), respectively. The presented study for a first time is
dealing in details with the NMR spectra of monensic acid and its diamagnetic divalent metal derivatives. The 1H-NMR data of MonH, 1 and 2 are presented in ‘‘Materials and methods’’ section. 13C{1H}-NMR resonances are summarized in Table 4, following the numbering sequence of the ligand, shown in Scheme 1. Due to the low solubility of metal complexes in MeCN, the NMR spectra were recorded in CDCl3 where OH-exchange is taking place thus significantly affecting the position of OH-groups. The 1-OH (–COOH), 10-OH and 11-OH resonances in monensic acid appear as a broad signal at 6.25 ppm and 5-OH is observed at 4.50 ppm. The major evidence that the deprotonation of carboxylic function of MonH occurs during the complexation is the disappearance of 1-OH resonance in 1H-NMR spectra of 1 and 2. At the same time a significant positive deviation in the position of 5-OH is observed whose resonance shifts from 4.50 ppm (MonH) to 4.85 ppm (1) and 4.95 ppm (2), respectively. The results obtained suggest that in solution this group is more strongly engaged in intramolecular H-bonding in the complexes than in the free acid and this was confirmed by the solid state structure of metal(II) compounds. As can be seen from the crystallographic data (Table 3; Fig. 3), 5-OH participates in three Hbonds by interacting with the aqua ligand (H2O-12), the ether oxygen O6 and the hydroxyl group 10-OH. The main point of emphasis when discussing the 13 C{1H}-NMR spectra of MonH, 1 and 2 is focused on the positions of those carbon atoms, that are closely attached to the coordination sites of the ligand and whose resonances deviate significantly in the spectra on moving from MonH to complexes 1 and 2. As can
123
66
Biometals (2010) 23:59–70
Table 4 13C{1H}-NMR (150 MHz, CDCl3) resonances of MonH and complexes 1–2 C-atom
d (ppm)
D (ppm) D1
2
D2
MonH
1
1
177.09
181.94
181.81
4.85
4.72
2
41.94
43.70
44.29
1.76
2.35
3
81.56
82.28
82.49
0.72
0.93
4
36.70
37.08
37.40
0.38
0.70
5
67.01
65.66
68.21
-1.35
1.20
6
34.54
34.31
34.23
-0.23
-0.31
7
70.74
70.61
70.71
-0.13
-0.03
8
34.03
34.36
34.33
0.33
0.30
9
107.79
107.65
107.55
-0.14
-0.24
10
38.36
38.51
38.75
0.15
0.39
11 12
33.73 85.14
34.12 85.11
33.83 85.29
0.39 -0.03
0.10 0.15
13
83.42
85.06
83.91
1.64
0.49
14
27.88
27.60
27.78
-0.28
-0.10
15
31.49
29.26
32.83
-2.23
1.34
16
86.18
87.91
87.12
1.73
0.94
17
85.11
85.44
84.35
0.33
-0.76
18
34.45
34.31
34.23
-0.14
-0.22
19
32.58
32.75
31.25
0.17
-1.33
20
77.01
77.58
77.46
0.57
0.45
21
73.83
72.94
73.56
-0.89
-0.27
22
32.80
33.40
33.34
0.60
0.54
23
36.59
36.50
36.73
-0.09
0.14
24
35.68
36.30
35.90
0.62
0.22
25
96.99
98.38
98.63
1.39
1.64
26 27
67.98 15.66
67.85 16.94
66.35 16.81
-0.13 1.28
-1.63 1.15
28
58.03
57.75
57.94
-0.28
-0.09
29
10.37
11.23
11.36
0.86
0.99
30
10.75
10.67
10.76
-0.08
0.01
31
27.69
27.93
27.43
0.24
-0.26
32
31.19
30.66
30.79
-0.53
-0.40
33
8.61
8.84
8.73
0.23
0.12
34
15.75
15.84
15.74
0.09
-0.01
35
17.54
17.39
17.63
-0.15
0.09
36
16.32
16.88
16.97
0.56
0.65
D1 = d1 - dMonH; D2 = d2 - dMonH
be seen (Table 4), the position of 1C shows a very significant downfield shift in the spectra of 1 and 2 comparing to MonH (D = 4.85 ppm (1), D = 4.72 ppm (2), D = dcomplex - dMonH). Such behaviour is in agreement with the presence of monensin
123
deprotonated carboxylic function and reveals that both complexes retain their coordination in solution. A downfield shift in the spectra of 1 and 2 is also observed for the carbons 2, 3, 25, 27 and 29 (D = 0.72.5 ppm), which are in close vicinity of atoms O1 and O11 directly coordinated to the divalent metal ions. The formation of H-bonds between the water ligands (H2O-12 and H2O-13) and ether oxygens O5–O8 also shifts some of the carbon-13 resonances of 1 and 2 significantly. The experimental data obtained show that positive as well as negative shifts are observed depending on the extent of deformation, that the ligand endures through the complexation. The NMR data obtained for Mg- and Ca-complexes of Mon correspond closely and confirm that (i) the coordination mode of monensin is analogous in 1 and 2; (ii) the metal ions retain their linkage with bidentate monensic anions both in solid state and in solution. FAB-MS spectra of complexes 1 and 2 The major species found in the FAB-MS spectra of complexes 1 and 2 are presented in Scheme 2. The spectra consist of a great number of signals some of which are assigned to the molecular ions of complexes after loss of water ligands and association with sodium ions, [M(C36H61O11)Na]? (1a: M = Mg; 2a: M = Ca), as well as to the ions generated from association/dissociation processes occurring with the complex species in the gas phase (1b, 2c–f). It should be mentioned that FAB-MS spectra of monensin complexes contain peaks of [MonH?Na]? due to sodium traces from the matrix used (3-nitrobenzylalcohol), an observation that is in accordance with the high affinity of monensin to bind sodium ions and with data reported previously (Chamberlin and Agtarap 1970; Volmer and Lock 1998). Cytotoxicity assay The aerobic Gram-positive microorganisms B. subtillis, S. lutea and B. mycoides were used as test strains to evaluate the cytotoxicity of 1, 2, MgCl2.6H2O and CaCl2. The bactericidal properties of MonH were also confirmed in the present study and its determined activity is in agreement with the data previously reported (Pantcheva et al. 2008). The alkaline-earth chlorides, similarly to MnCl2 and CoCl2 (Dorkov et al. 2008; Pantcheva et al. 2008),
Biometals (2010) 23:59–70
67 - H+ + Na+
[(MC36H61O11)(MC36H60O11)]+ 2d: C72H121Ca2O22; m/e: 1417.3 (30 %)
[(MC36H60O11)2Na]+ 2e: C72H120Ca2NaO22; m/e: 1439.4 (3 %),
- H+, - Na+ + MC36H60O11
+ M2+ [(MC36H60O11)(MC36H59O11)M]+
[MC36H61O11]+
2f: C72H119Ca3O22; m/e: 1455.5 (3 %),
2c: C36H61CaO11; m/e: 709.2 (100 %)
- C36H61O11Na [M(C36H61O11)2(H2O)2]
- 2 H2O + Na+
- H+ + Na+
[M(C36H61O11)2Na]+
1a: C72H122MgNaO22; m/e: 1385.2 (47 %) 2a: C72H122CaNaO22; m/e: 1401.3 (12 %)
1: M = Mg; 2: M = Ca
[M(C36H61O11)(C36H60O11)Na2]+ 1b: C72H121MgNa2O22; m/e: 1407.32 (35 %)
- M(C36H61O11) + H+, + Na+ [C36H62O11)Na]+ C36H62NaO11; m/e: 693.2 (1g, 100 %; 2g, 27%)
Scheme 2
Major ions observed in the FAB-MS spectra of monensin alkaline-earth complexes 1 and 2
cannot be defined as bactericidal agents because their minimum inhibitory concentrations fall in the millimolar concentration range (Table 5). Thus the effect of metal salts is uninfluential on the visible growth of bacteria strains and can be disregarded in comparison with the corresponding metal complexes studied. The alkaline-earth complexes of monoanionic form of monensic acid possess strongly enhanced cytotoxicity against selected strains in comparison to the free ligand (Table 5) and furthermore, the antimicrobial activity of 1 and 2 cannot be assigned to the simple additive effect of partners in the complexes. Instead, it may probably be attributed to increased penetration of the new compounds through the bacteria’s cell membrane. Previously we suggested that the increased activity of the Co2? complex of
Mon (Pantcheva et al. 2008) could be explained in the terms of an unusual coordination mode of the monovalent polyether ionophorous antibiotic. The current results manifest that the role of divalent metal ion in mononuclear complexes of deprotonated monensic acid should be reconsidered, since the coordination mode of the antibiotic remains unchanged both in transition and in alkaline-earth metal complexes, respectively, but a difference (2–7 multiple) is observed in their cytotoxic properties. It is still early to predict the intimate antibacterial mechanism of monensin divalent metal complexes, although it seems to be closely linked to the ability of the ligand to bind metal(II) ions and to transfer them across the cell membrane as neutral complexes, followed by further dissociation of the compounds
Table 5 Bactericidal activity of MonH and complexes 1–2 expressed as MIC (lM) Compound
B. mycoides
B. subtillis
S. lutea
References
MonH
11.9
23.9
23.9
Pantcheva et al. (2008)
[Ca(Mon)2(H2O)2], 1
0.7
1.4
1.4
This work
[Mg(Mon)2(H2O)2], 2
0.7
1.4
1.4
This work
[Co(Mon)2(H2O)2]
1.4
2.8
2.8
Pantcheva et al. (2008)
[Mn(Mon)2(H2O)2]
5.1
10.3
10.3
Pantcheva et al. (2008)
CaCl2
1 9 103
5 9 103
5 9 103
This work
MgCl2.6H2O
1 9 103
5 9 103
5 9 103
This work
MnCl2!4H2O
3
3
5 9 10
5 9 103
Dorkov et al. (2008) and Pantcheva et al. (2008)
2 9 103
2 9 103
Dorkov et al. (2008) and Pantcheva et al. (2008)
CoCl2!6H2O
5 9 10
2 9 103
123
68
and by subsequent disturbance of homeostatic processes thus causing inhibition of bacteria growth. Conclusion Alkaline-earth complexes of monoanionic form of monensic acid with Mg2? and Ca2? were isolated for the first time in solid state. The complexes are of general composition [M(Mon)2(H2O)2] (M = Mg, Ca) and consist of an alkaline-earth metal ion placed in distorted octahedral environment. Monensin ligands act in a bidentate coordination mode via their monodentately bound carboxylate- and methoxy functions positioned at the both opposite sites of monensic anions. Additionally, two water molecules form two dative bonds with the alkaline-earth metal ion completing the sixfold geometry around the metal center and stabilizing the ‘‘head-to-tail’’ cyclization of the ligand molecule. The cytotoxicity assay against aerobic Gram-positive bacteria shows strongly enhanced activity of alkaline-earth monensin complexes in comparison to monensic acid that is most likely due to the unusual coordination mode of the ligand although the influence of the divalent metal ion should be also taken into account. Supplementary data CCDC 734913 (1) and 734912 (2) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via http://www.ccdc.cam.ac.uk (or an application from Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: ?44 01223 336033; or e-mail:
[email protected]. Acknowledgements The present research is financially supported from the National Science Fund (NSF), DO-02-84/ 2009. SS is grateful to NSF (UNA-17/2005) for the purchase of Bruker Avance AVII? 600 NMR spectrometer. The authors are thankful to Assoc. Prof. A. Nakov and MSci P. Dorkov (BIOVET Ltd.) for supplying sodium monensin.
References Agtarap A, Chamberlin JW, Pinkerton M, Steinrauf LK (1967) The structure of monensic acid, a new biologically active compound. J Am Chem Soc 89:5737–5739 Ajaz AA, Robinson JA, Turner DL (1987) Biosynthesis of the polyether ionophore antibiotic monensin A: assignment of
123
Biometals (2010) 23:59–70 the carbon-13 and proton n. m. r. spectra of monensin A by two-dimensional spectroscopy. Incorporation of oxygen-18 labeled molecular oxygen. J Chem Soc Perkin Trans 1:27–36 Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48:5–16 Augustine PC, Smith CK, Danforth HD, Ruff MD (1987) Effect of ionophorous anticoccidials on invasion and development of Eimeria: comparison of sensitive and resistant isolates and correlation with drug uptake. Poultry Sci 66:960–965 Augustine PC, Watkins KL, Danforth HD (1992) Effect of monensin on ultrastructure and cellular invasion by the turkey coccidia Eimeria adenoeides and Eimeria meleagrimitis. Poultry Sci 71:970–978 Berg HH, Hamill RL (1978) The isolation and characterization of narazin, a new polyether antibiotic. J Antibiot 31:1–6 Briggs RW, Hinton JF (1978) Thallium-205 and proton nuclear magnetic resonance investigation of the complexation of thallium by the ionophores monensin and nigericin. Biochemistry 17:5576–5578 Chamberlin JW, Agtarap A (1970) Observations on the mass spectrometry of monensin and related compounds. Org Mass Spectrom 3:271–285 Chappe LR (1979) The site of action of the anticoccidial salinomycin (Coxistac). J Parasitol 65:137–143 Cox BG, Vantruong N, Rzeszotarska J, Schneider H (1984) Rates and equilibria of alkali metal and silver ion complex formation with monensin in ethanol. J Am Chem Soc 106:5965–5969 Dassie SA, Baruzzi AM (2002) Alkaline-earth cation transfer assisted by monensin across the water vertical bar 1,2dichloroethane interface in the presence of alkali cations. J Electroanal Chem 522:158–166 Dorkov P, Pantcheva IN, Sheldrick WS, Mayer-Figge H, Petrova R, Mitewa M (2008) Synthesis, structure and antimicrobial activity of manganese(II) and cobalt(II) complexes of the polyether ionophore antibiotic sodium monensin A. J Inorg Biochem 102:26–32 Duax WL, Smith GD, Strong PD (1980) Complexation of metal ions by monensin—crystal and molecular structure of hydrated and anhydrous crystal forms of sodium monensin. J Am Chem Soc 102:6725–6729 Folz SD, Lee BL, Nowakowski LH, Conder GA (1988) Anticoccidial evaluation of halofuginone, lasalocid, maduramicin, monensin and salinomycin. Vet Parasitol 28:1–9 Garcla-Rosas J, Schneider H, Cox BG (1983) Silver complexation by the ionophorous antibiotic monensin in nonaqueous solvents. J Phys Chem 87:5467–5472 Gertenbach PG, Popov AI (1975) Solution chemistry of monensin and its alkali-metal ion complexes—potentiometric and spectroscopic studies. J Am Chem Soc 97:4738–4744 Hamidinia SA, Shimelis OI, Tan B, Erdahl WL, Chapman CJ, Renkes GD, Taylor RW, Pfeiffer DR (2002) Monensin mediates a rapid and selective transport of Pb2?—possible application of monensin for the treatment of Pb2? intoxication. J Biol Chem 277:38111–38120 Hamidinia SA, Tan B, Erdahl WL, Chapman CJ, Taylor RW, Pfeiffer DR (2004) The ionophore nigericin transports
Biometals (2010) 23:59–70 Pb2? with high activity and selectivity: a comparison to monensin and ionomycin. Biochemistry 43:15956–15965 Hebrant M, Mimouni M, Tissier M, Pointud Y, Juillard J, Dauphin G (1992) Complexing ability of ionophore monensin for divalent cations. New J Chem 16:999–1008 Huczynski A, Michalak D, Przybylski P, Brzezinski B, Bartl F (2006a) Monensin A benzyl ester and its complexes with monovalent metal cations studied by spectroscopic, mass spectrometry and semiempirical methods. J Mol Struct 797:99–110 Huczynski A, Przybylski P, Brzezinski B (2006b) Complexes of monensin A methyl ester with Mg2?, Ca2?, Sr2?, Ba2? cations studied by electrospray ionization mass spectrometry and PM5 semiempirical method. J Mol Struct 788:176–183 Huczynski A, Przybylski P, Brzezinski B, Bartl F (2006c) Monensin A methyl ester complexes with Li?, Na? and K? cations studied by ESI–MS, 1H- and 13C-NMR, FTIR, as well as PM5 semiempirical method. Biopolymers 81:282–294 Huczynski A, Przybylski P, Brzezinski B, Bartl F (2006d) Spectroscopic, mass spectrometry, and semiempirical investigation of a new ester of monensin A with ethylene glycol and its complexes with monovalent metal cations. Biopolymers 82:491–503 Huczynski A, Przybylski P, Brzezinski B (2007a) NMR, FTIR, ESI–MS and semiempirical study of a new 2-(2-hydroxyethoxy)ethyl ester of monensin A and its complexes with alkali metal cations. Tetrahedron 63:8831–8839 Huczynski A, Przybylski P, Schroeder G, Brzezinski B (2007b) Investigation of complex structures of a new 2-hydroxyethyl ester of monensin A with Mg2?, Ca2?, Sr2?, Ba2? cations using electrospray ionization mass spectrometry and semiempirical PM5 methods. J Mol Struct 829: 111–119 Huczynski A, Ratajczak-Sitarz M, Katrusiak A, Brzezinski B (2007c) Molecular structure of the 1:1 inclusion complex of monensin A lithium salt with acetonitrile. J Mol Struct 871:92–97 Huczynski A, Brzezinski B, Bartl F (2008a) Structures of complexes of benzyl and allyl esters of monensin A with Mg2?, Ca2?, Sr2?, Ba2? cations studied by ESI–MS and PM5 methods. J Mol Struct 886:9–16 Huczynski A, Lowicki D, Brzezinski B, Bartl F (2008b) Spectroscopic, mass spectrometry and semiempirical investigation of a new 2-methoxyethyl ester of monensin A and its complexes with Li?, Na? and K? cations. J Mol Struct 874:89–100 Huczynski A, Lowicki D, Brzezinski B, Bartl F (2008c) Spectroscopic, mass spectrometry, and semiempirical investigations of a new 2-(2-methoxyethoxy)ethyl ester of monensin A and its complexes with monovalent cations. J Mol Struct 879:14–24 Huczynski A, Ratajczak-Sitarz M, Katrusiak A, Brzezinski B (2008d) Molecular structure of rubidium six-coordinated dihydrate complex with monensin A. J Mol Struct 888:224–229 Johnson SM, Herrin J, Liu SJ, Paul IC (1970a) Crystal structure of a barium complex of antibiotic X-537A, Ba(C34 H53O8)2!H2O. J Chem Soc D Chem Commun 2:72–73
69 Johnson SM, Herrin J, Liu SJ, Paul IC (1970b) Crystal and molecular structure of the barium salt of an antibiotic containing a high proportion of oxygen. J Am Chem Soc 92:4428–4435 Kevin DA II, Meujo DAF, Hamann MT (2009) Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug resistant bacteria and parasites. Expert Opin Drug Discov 4:109–146 Koinarski V, Sherkov SN (1987) Effect of anticoccidial preparations in the prevention of coccidiosis in turkeys caused by Eimeria adenoides. Vet Med Nauki 24:81–85 Liu WC, Slusarchyk DS, Astle G, Trejo WH, Brown NE, Meyers E (1978) Ionomycin, a new polyether antibiotic. J Antibiot 9:815–819 Long PL, Jeffers TK (1982) Studies on the stage of action of ionophorous antibiotics against Eimeria. J Parasitol 68:363–371 Lutz WK, Winkler FK, Dunitz JD (1971) Crystal structure of the antibiotic monensin: similarities and differences between free acid and metal complex. Helv Chim Acta 54:1103–1108 Martinek T, Riddell FG, Wilson C, Weller CT (2000) The conformations of monensin A metal complexes in solution determined by NMR spectroscopy. J Chem Soc Perkin Trans 2:35–41 Mimouni M, Pointud Y, Juillard J (1994) Interactions in methanol of divalent metal cations with bacterial ionophores, lasalocid and monensin—thermodynamical aspects. Bull Soc Chim Fr 131:58–65 Mimouni M, Hebrant M, Dauphin G, Juillard J (1996) Monovalent cation salts of the bacterial ionophore monensin in methanol. Structural aspects from NMR experiments. J Chem Res 6:278–279 Pangborn W, Duax WL, Langs D (1987) The hydrated potassium complex of the ionophore monensin A. J Am Chem Soc 109:2163–2165 Pantcheva IN, Mitewa M, Sheldrick WS, Oppel IM, Zhorova R, Dorkov P (2008) First divalent metal complexes of the polyether ionophore monensin A: X-ray structures of [Co(Mon)2(H2O)2] and [Mn(Mon)2(H2O)2] and their bactericidal properties. Curr Drug Discov Technol 5:154–161 Pantcheva IN, Dorkov P, Atanasov VN, Mitewa M, Shivachev BL, Nikolova RP, Mayer-Figge H, Sheldrick WS (2009) Crystal structure and properties of the copper(II) complex of sodium monensin A. J Inorg Biochem. doi: 10.1016/ j.jinorgbio.2009.08.007 Paz FAA, Gates PJ, Fowler S, Gallimore A, Harvey B, Lopes NP, Stark CBW, Staunton J, Klinowski J, Spencer JB (2003) Sodium monensin dihydrate. Acta Cryst E59: m1050–m1052 Riddell FG (2002) Structure, conformation, and mechanism in the membrane transport of alkali metal ions by ionophoric antibiotics. Chirality 14:121–125 Rzeszotarska J, Wagner-Czauderna E, Kalinowski MK (1994) Complexation of Tl? ions by monensin anion in binary mixtures of dipolar aprotic solvents. J Chem Res 10: 400–401 Sheldrick G (1990) SHELXS-97. Program for crystal structure solution. Institut fu¨r Anorganische Chemie der Universita¨t, Go¨ttingen, Germany
123
70 Sheldrick G (1997) SHELXL-97. Program for crystal structure refinement. Institut fu¨r Anorganische Chemie der Universita¨t, Go¨ttingen, Germany Stern PH (1977) Ionophores: chemistry, physiology and potential applications to bone biology. Clin Orthop Relat Res 122:273–298 Stiles MK, Craig ME, Gunnel SL, Pfeiffer DR, Taylor DR (1991) The formation constants of ionomycin with divalent cations in 80% methanol/water. J Biol Chem 266:8336–8342 Varga I, Sreter T (1996) Efficacy of a monensin-duokvin combination against Eimeria acervulina in chickens. Folia Parasitol (Praha) 43:153–155 Volmer DA, Lock CM (1998) Electrospray ionization and collision-induced dissociation of antibiotic polyether ionophores. Rapid Commun Mass Spectrom 12:157–164 Wagner-Czauderna E, Rzeszotarska J, Orlowska E, Kalinowski MK (1997) Complexing ability of monensin anion for
123
Biometals (2010) 23:59–70 alkali metal cations in binary mixtures of dipolar aprotic solvents. Phys Chem Chem Phys 101:1154–1157 Walba DM, Hermsmeier M, Haltiwanger RC, Noordik JH (1986) Crystal structures of monensin B lithium and silver salts. J Org Chem 51:245–247 Wang Z, Suo X, Xia X, Shen J (2006) Influence of monensin on cation influx and Na? -K? -ATPase activity of Eimeria tenella sporozoites in vitro. J Parasitol 92:1092–1096 Westley JW, Liu CM, Evans RHJr, Sello LH, Troupe N, Hermann T (1983) Preparation, properties and biological activity of natural and semisynthetic urethanes of monensin. J Antibiot 36:1195–1200 Yildirim SO, McKee V, Khardli FZ, Mimouni M, Hadda TB (2007) Rubidium(I) monensinate dihydrate. Acta Cryst E64:m154–m155
Biometals (2010) 23:71–81 DOI 10.1007/s10534-009-9267-7
Quantitative analysis and functional evaluation of zinc ion in the D-hydantoinase from Pseudomonas putida YZ-26 Xueyao Zhang • Jingming Yuan • Lixi Niu Aihua Liang
•
Received: 23 November 2008 / Accepted: 9 September 2009 / Published online: 5 November 2009 ! Springer Science+Business Media, LLC. 2009
Abstract D-Hydantoinase (HDT) is a metal-dependent enzyme that is widely used in industrial bioconversion to D-amino acids as valuable intermediates in the fields of food, pharmaceutical industry and agriculture. In this report, we prepared apo-HDT (metal-removed HDT) and Zn2?-HDT (Zn2?-added HDT) in vitro from a recombinant HDT (re-HDT) expressed in E. coli. The Zn2?-HDT and re-HDT contain 2.17 and 0.95 mol Zn2? per mol subunit, respectively, and they have comparable enzymatic activities. In contrast, the apo-HDT only retains 0.04 mol Zn2? per mol subunit with less than 10% activity, compared with the re-HDT. When the apoHDT was reconstituted with ZnCl2, the enzymatic activity recovery was about 75%. Moreover, the fluorescence intensity, circular dichroism spectra and thermo-stability of the apo-HDT and Zn2?-HDT are quite different from those of the re-HDT. These data suggest that the re-HDT may have two Zn2?-binding sites, one is an intrinsic or tight-binding site (zinc-a) essential for its activity and the other is a vacant or
X. Zhang ! J. Yuan (&) ! L. Niu ! A. Liang Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Institute of Biotechnology, Shanxi University, 92 Wu-cheng Road, 030006 Taiyuan, People’s Republic of China e-mail:
[email protected] X. Zhang e-mail:
[email protected]
loose-binding site (zinc-b) possibly non-essential for the activity. Keywords D-Hydantoinase ! Zn2? analysis ! Functional evaluation
Introduction D-Hydantoinase (HDT, EC 3.5.2.2) catalyses the substrate 50 -monosubstituted hydantoin to enantiomerical N-carbamoyl-amino acids which, in turn, can be chemically or enzymatically converted into the corresponding optically active amino acids (Altenbuchner et al. 2001). Hydantoinase is ubiquitously found in microorganisms, plants and animals (Pozo et al. 2002). The enzyme is also well known as dihydropyrimidinase in higher organisms and is responsible for dihydropyrimidine hydrolysis as the second step in the reductive catabolism of pyrimidine. Based on its chiral specificity for the substrate and product, HDT can be divided into three types: L-, D- and DL-configuration. A number of bacterial D-hydantoinases with different enantioselectivities and substrate specificities have been used in industrial bioconversion to optically active D-amino acids. As unnatural chiral products, D-amino acids are important intermediates in the synthesis of various b-lactam semisynthetic antibiotics, such as
123
72
ampicillin, amoxicillin, aspoxicillin and cefbuperazone, as well as of other products, such as antiviral agents, artificial sweeteners, pesticides, peptide hormones and pyrethroids etc. (Altenbuchner et al. 2001). HDT, similar to other amidohydrolases, has been characterized as a typical metal-dependent enzyme, either in the fundamental research or in the industrial application (May et al. 1998a, b). It is demonstrated that divalent metal ions, especially Zn2?, play an important role in the catalytic process of the enzyme (May et al. 1998a, b). In the last decades, some reports regarding the metal dependence of HDT have been mainly focused on the function of Zn2? and its quantitative determination (Gojkovic et al. 2003; Cheon et al. 2003; Kikugawa et al. 1994; Brooks et al. 1983). Thereinto, most HDTs contain two Zn2? ions per subunit (Gojkovic et al. 2003; Cheon et al. 2003). The first Zn2? may bind to the carbonyl oxygen of hydantoin and subsequently polarize the carbonyl bond, while the second Zn2? only activates the bridge water and does not bind to the substrate. In contrast, a few HDTs only contain one catalytic Zn2? per subunit, such as the HDTs from bovine liver and rat liver (Kikugawa et al. 1994; Brooks et al. 1983). No matter how many Zn2? per subunit HDT contains, they are all essential for the catalytic reaction. However, the potential structural and functional roles for Zn2? have not been well established in hydantoinase family, although the role of Zn2? has been well established in other amidohydrolases. Our previous work indicated that the D-hydantoinase from Pseudomonas putida YZ-26 was dissociated into monomer subunit from its dimer in the presence of 1 mM Zn2? (Shi et al. 2006). To further explore the function of Zn2? in the HDT, we prepared re-HDT, apo-HDT and Zn-HDT to study the relationship between its zinc content and catalytic activity. This report preliminarily demonstrates that the re-HDT has two different Zn2?-binding sites, a tight one linked to its activity is filled with Zn2? and a loose one related to its structure is vacant.
Materials and methods Strain, plasmid, reagents and equipments The host cell, Escherichia coli BL21 (DE3) and a recombinant plasmid pE-p479 used in this study were
123
Biometals (2010) 23:71–81
stored at -80"C in this laboratory. Hydantoin, 4-(2-hydroxyerhyl) piperazine-1-ethanesulfonic acid (HEPES, ultra pure grade) and Tris (Hydroxymethyl) aminomethane (Tris, ultra pure grade) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Pyridine2, 6-dicarboxylic acid (DPA) and EDTA were purchased from Alfa Aesar (Ward Hill, MA, USA). The protein purification equipment and separation materials were from Amersham Pharmacia Biotech. All reagents and buffer solutions used here were prepared using ultra-pure water with more than 18.2 MX m from a Milli-Q water purification system (Millipore Corporation, France). All other chemicals used were of the highest purity commercially available, unless otherwise indicated. Expression and purification of the recombinant D-hydantoinase Recombinant plasmid pE-p479 was introduced into E. coli BL21 and expressed in 1 l Luria-Bertani (LB) culture supplemented with ampicillin (100 lg/ml) at 30"C for 12–14 h without adding any inducers. The culture was harvested by centrifugation at 6,000g for 10 min at 4"C. Then pellets were suspended in chilled 50 mM Tris–HCl buffer, pH 8.0 (TB8) and sonicated. The resulting supernatant was purified by a two-step purification procedure to obtain the purified D-hydantoinase, as described previously (Zhang et al. 2008). The protein concentration was performed by the Bradford or Folin-phenol methods with bovine serum albumin as the assay standard. Enzymatic assay D-Hydantoinase activity was measured by a colorimetric method (Niu et al. 2007). An aliquot of the enzyme was added into the reaction mixture in a total volume of 1.5 ml, contained 100 mM hydantoin and 50 mM TB8. After being incubated at 37"C for 30 min, the reaction mixture was terminated by adding 0.25 ml trichloro-acetic acid (10% w/v), then 0.25 ml dimethylaminobenzaldehyde (DMBA) solution (10% w/v in 6 M HCl) and finally diluted with distilled water to 3 ml. After centrifugation, the product, N-carbamoylglycine, in the supernatant was measured at 430 nm wavelength and its amount was calculated from a standard calibration plot. One D-hydantoinase unit is equivalent to the formation of
Biometals (2010) 23:71–81
1 lmol of N-carbamoylglycine per min under the above assay condition. Apo-HDT and Zn2?-HDT preparation in vitro Apo-HDT was prepared by mixing re-HDT and 100 mM DPA to remove the intrinsic Zn2? at 25"C for 8 h. Then the reaction mixture was thoroughly dialyzed against 10 mM TB8 at 4"C with buffer changes for four times to remove trace metal ions. Zn2?-HDT was prepared with the re-HDT by addition of ten fold (ca. 0.3 mM) ZnCl2. The reaction mixture was dialyzed as described above. Finally, the enzymatic activity, protein concentration and Zn2? content of each sample were examined by DMBA, Folin-phenol and ICP-AES methods, respectively. Determination of divalent metal ions Divalent metal ions in re-HDT, apo-HDT and Zn2?HDT were determined by ICP-AES (inductively coupled plasma-atomic emission spectrometry, an ICP-AtomScan 16 apparatus from Thermo Jarrell Ash Co., USA) with a direct injection. All samples were prepared to be SDS-PAGE pure.